Document:

Exhibit 10.90

 

 

RADIATION THERAPY INVESTMENTS, LLC

 

A Delaware Limited Liability Company

 

 

SECOND AMENDED AND RESTATED

 

LIMITED LIABILITY COMPANY AGREEMENT

 

Dated as of March 25, 2008

 

THE
COMPANY INTERESTS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED
LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE SECURITIES
LAWS. SUCH INTERESTS MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED
OF AT ANY TIME WITHOUT EFFECTIVE REGISTRATION UNDER SUCH ACT AND LAWS OR
EXEMPTION THEREFROM, AND COMPLIANCE WITH THE OTHER SUBSTANTIAL RESTRICTIONS ON
TRANSFERABILITY SET FORTH HEREIN.

 

THE
COMPANY INTERESTS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY
COMPANY AGREEMENT ARE ALSO SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFER
SPECIFIED IN THE AMENDED AND RESTATED SECURITYHOLDERS AGREEMENT, DATED AS OF
THE DATE HEREOF, BY AND AMONG THE COMPANY AND CERTAIN INVESTORS, AS AMENDED OR
MODIFIED FROM TIME TO TIME, AND THE COMPANY RESERVES THE RIGHT TO REFUSE THE
TRANSFER OF SUCH INTERESTS UNTIL SUCH TRANSFER IS IN COMPLIANCE WITH SUCH
SECURITYHOLDERS AGREEMENT. A COPY OF THE AMENDED AND RESTATED SECURITYHOLDERS
AGREEMENT SHALL BE FURNISHED BY THE COMPANY TO THE HOLDER OF SUCH INTERESTS
UPON WRITTEN REQUEST AND WITHOUT CHARGE.

 

 

TABLE OF CONTENTS

 

	
   

  	
  Page

  
	
   

  	
   

  
	
  ARTICLE I DEFINITIONS

  	
  2

  
	
   

  	
  Section
  1.1

  	
  Definitions

  	
  2

  
	
   

  	
  Section
  1.2

  	
  Terms
  Generally

  	
  16

  
	
  ARTICLE II GENERAL PROVISIONS

  	
  17

  
	
   

  	
  Section
  2.1

  	
  Formation

  	
  17

  
	
   

  	
  Section
  2.2

  	
  Name

  	
  17

  
	
   

  	
  Section
  2.3

  	
  Term

  	
  17

  
	
   

  	
  Section
  2.4

  	
  Purpose;
  Powers

  	
  17

  
	
   

  	
  Section
  2.5

  	
  Foreign
  Qualification

  	
  18

  
	
   

  	
  Section
  2.6

  	
  Registered
  Office; Registered Agent; Principal Office; Other Offices

  	
  18

  
	
   

  	
  Section
  2.7

  	
  No
  State-Law Partnership

  	
  18

  
	
  ARTICLE III CAPITALIZATION;
  REDEMPTION RIGHTS

  	
  18

  
	
   

  	
  Section
  3.1

  	
  Units;
  Initial Capitalization; Schedules

  	
  18

  
	
   

  	
  Section
  3.2

  	
  Authorization
  and Issuance of Additional Units

  	
  19

  
	
   

  	
  Section
  3.3

  	
  Issuance
  of Class B Units and Class C Units; Service Providers

  	
  19

  
	
   

  	
  Section
  3.4

  	
  Capital
  Accounts

  	
  21

  
	
   

  	
  Section
  3.5

  	
  Negative
  Capital Accounts

  	
  21

  
	
   

  	
  Section
  3.6

  	
  No
  Withdrawal

  	
  21

  
	
   

  	
  Section
  3.7

  	
  Loans
  From Unitholders

  	
  21

  
	
   

  	
  Section
  3.8

  	
  No
  Right of Partition

  	
  21

  
	
   

  	
  Section
  3.9

  	
  Non-Certification
  of Units; Legend; Units Are Securities

  	
  22

  
	
  ARTICLE IV DISTRIBUTIONS

  	
  22

  
	
   

  	
  Section
  4.1

  	
  Distributions;
  Priority

  	
  22

  
	
   

  	
  Section
  4.2

  	
  Priority
  over Form of Consideration

  	
  24

  
	
   

  	
  Section
  4.3

  	
  Successors

  	
  24

  
	
   

  	
  Section
  4.4

  	
  Tax
  Distributions

  	
  24

  
	
   

  	
  Section
  4.5

  	
  Catch-up
  Distributions to Class B Unitholders and Class C Unitholders

  	
  25

  
	
   

  	
  Section
  4.6

  	
  Security
  Interest and Right of Set-Off

  	
  25

  
	
   

  	
  Section
  4.7

  	
  Certain
  Distributions

  	
  25

  
	
  ARTICLE V ALLOCATIONS

  	
  26

  
	
   

  	
  Section
  5.1

  	
  Allocations

  	
  26

  
	
   

  	
  Section
  5.2

  	
  Special
  Allocations

  	
  26

  
	
   

  	
  Section
  5.3

  	
  Tax
  Allocations

  	
  27

  
	
   

  	
  Section
  5.4

  	
  Unitholders’
  Tax Reporting

  	
  28

  
	
   

  	
  Section
  5.5

  	
  Indemnification
  and Reimbursement for Payments on Behalf of a Unitholder

  	
  28

  
	
  ARTICLE VI MANAGEMENT

  	
  28

  
	
   

  	
  Section
  6.1

  	
  The
  Board of Managers; Delegation of Authority and Duties

  	
  28

  
	
   

  	
  Section
  6.2

  	
  Establishment
  of Board of Managers

  	
  30

  
	
   

  	
  Section
  6.3

  	
  Board
  of Managers Meetings

  	
  32

  
	
   

  	
  Section
  6.4

  	
  Chairman

  	
  33

  

 

i

 

	
   

  	
  Section
  6.5

  	
  Approval
  or Ratification of Acts or Contracts

  	
  33

  
	
   

  	
  Section
  6.6

  	
  Action
  by Written Consent

  	
  33

  
	
   

  	
  Section
  6.7

  	
  Meetings
  by Telephone Conference or Similar Measures

  	
  34

  
	
   

  	
  Section
  6.8

  	
  Officers

  	
  34

  
	
   

  	
  Section
  6.9

  	
  Management
  Matters

  	
  35

  
	
   

  	
  Section
  6.10

  	
  Consent
  Rights

  	
  35

  
	
   

  	
  Section
  6.11

  	
  Securities
  in Subsidiaries

  	
  38

  
	
   

  	
  Section
  6.12

  	
  Liability
  of Unitholders

  	
  38

  
	
   

  	
  Section
  6.13

  	
  Indemnification
  by the Company

  	
  39

  
	
   

  	
  Section
  6.14

  	
  Investment
  Representations of Unitholders

  	
  39

  
	
  ARTICLE VII WITHDRAWAL;
  DISSOLUTION; TRANSFER OF MEMBERSHIP INTERESTS; ADMISSION OF NEW MEMBERS

  	
  39

  
	
   

  	
  Section
  7.1

  	
  Unitholder
  Withdrawal

  	
  39

  
	
   

  	
  Section
  7.2

  	
  Dissolution

  	
  40

  
	
   

  	
  Section
  7.3

  	
  Transfer
  by Unitholders

  	
  40

  
	
   

  	
  Section
  7.4

  	
  Admission
  or Substitution of New Members

  	
  41

  
	
   

  	
  Section
  7.5

  	
  Compliance
  with Law

  	
  42

  
	
  ARTICLE VIII BOOKS AND RECORDS;
  FINANCIAL STATEMENTS AND OTHER INFORMATION; TAX MATTERS

  	
  42

  
	
   

  	
  Section
  8.1

  	
  Books
  and Records; Management Interviews

  	
  42

  
	
   

  	
  Section
  8.2

  	
  Financial
  Statements and Other Information

  	
  43

  
	
   

  	
  Section
  8.3

  	
  Fiscal
  Year; Taxable Year

  	
  45

  
	
   

  	
  Section
  8.4

  	
  Certain
  Tax Matters

  	
  45

  
	
  ARTICLE IX MISCELLANEOUS

  	
  46

  
	
   

  	
  Section
  9.1

  	
  Schedules

  	
  46

  
	
   

  	
  Section
  9.2

  	
  Governing
  Law

  	
  46

  
	
   

  	
  Section
  9.3

  	
  Successors
  and Assigns

  	
  47

  
	
   

  	
  Section
  9.4

  	
  Confidentiality

  	
  47

  
	
   

  	
  Section
  9.5

  	
  Amendments

  	
  47

  
	
   

  	
  Section
  9.6

  	
  Notices

  	
  47

  
	
   

  	
  Section
  9.7

  	
  Counterparts

  	
  48

  
	
   

  	
  Section
  9.8

  	
  Power
  of Attorney

  	
  49

  
	
   

  	
  Section
  9.9

  	
  Entire
  Agreement

  	
  49

  
	
   

  	
  Section
  9.10

  	
  Arbitration

  	
  49

  
	
   

  	
  Section
  9.11

  	
  Waiver
  of Jury Trial

  	
  50

  
	
   

  	
  Section
  9.12

  	
  Severability

  	
  50

  
	
   

  	
  Section
  9.13

  	
  Creditors

  	
  50

  
	
   

  	
  Section
  9.14

  	
  Waiver

  	
  50

  
	
   

  	
  Section
  9.15

  	
  Further
  Action

  	
  50

  
	
   

  	
  Section
  9.16

  	
  Delivery
  by Facsimile or Email

  	
  50

  

 

ii

 

SCHEDULES
AND EXHIBITS

 

	
  Schedule
  A

  	
  —

  	
  Schedule
  of Units

  	
   

  
	
  Schedule
  B

  	
  —

  	
  Schedule
  of Members

  	
   

  

 

iii

 

SECOND AMENDED AND RESTATED

LIMITED LIABILITY COMPANY AGREEMENT

OF

RADIATION THERAPY INVESTMENTS, LLC

A Delaware Limited Liability Company

 

This
SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of Radiation
Therapy Investments, LLC, dated and effective as of March 25, 2008 (this “Agreement”),
by and among Radiation Therapy Investments, LLC, a Delaware limited liability
company (the “Company”), Vestar Capital Partners V, L.P., a Delaware
limited partnership (“Vestar V”), Vestar Capital Partners V-A, L.P., a
Cayman Islands exempted limited partnership, Vestar Executive V, L.P., a Cayman
Islands exempted limited partnership, Vestar Holdings V, L.P., a Cayman Islands
exempted limited partnership, Vestar/Radiation Therapy Investments, LLC, a
Delaware limited liability company (“Vestar/RTS” and, together with
Vestar V, Vestar Capital Partners V-A, L.P., Vestar Executive V, L.P. and
Vestar Holdings V, L.P., “Vestar”). TCW/Crescent Mezzanine Partners V,
L.P., a Delaware limited partnership, TCW/Crescent Mezzanine Partners VB, L.P.,
a Delaware limited partnership, TCW/Crescent Mezzanine Partners VC, L.P., a
Delaware limited partnership, MAC Equity Holdings, LLC, a Delaware limited
liability company, New York Life Investment Management Mezzanine Partners II,
LP, a Delaware limited partnership, NYLIM Mezzanine Partners II Parallel Fund,
LP, a Delaware limited partnership, the persons set forth on the signature pages
hereto as Management Members and each other Person who at any time becomes a
Member in accordance with the terms of this Agreement and the Act, is approved
and adopted by the Board of Managers of the Company on the date hereof without
consent of the Members in accordance with Section 9.5 of the Original Agreement
(as defined below). Any reference in this Agreement to Vestar or any other
Member shall include such Member’s Successors in Interest, to the extent such
Successors in Interest have become Substituted Members in accordance with the
provisions of this Agreement.

 

WHEREAS,
the Company was formed as a limited liability company pursuant to the Act by
the filing of its Certificate of Formation with the Secretary of State of the
State of Delaware on October 9, 2007;

 

WHEREAS,
the Company executed and delivered that certain Limited Liability Company
Agreement of the Company on October 10,2007;

 

WHEREAS,
on February 21, 2008, pursuant to that certain Agreement and Plan of Merger
(the “Merger Agreement”), dated as of October 19, 2007, by and among
Radiation Therapy Services, Inc., a Delaware corporation (“RTS”),
Radiation Therapy Services Holdings, Inc., a Delaware corporation and a
wholly-owned subsidiary of the Company (“Parent”), RTS MergerCo, Inc., a
Florida corporation and wholly owned subsidiary of Holdings (“Merger Sub”),
and the Company (solely for purpose of Section 7.2 thereof), (i) Merger Sub
merged with and into RTS, with RTS surviving as a direct wholly-owned Subsidiary
of the Parent, and (ii) certain Management Members either contributed common
stock of RTS to the Company or invested cash in the Company, in each case, in
exchange for Preferred Units and Class A Units of the Company pursuant to
certain Management Stock Contribution and Unit Subscription Agreements (the “Contribution
Agreements”).

 

 

WHEREAS,
in connection with the consummation of the transactions contemplated by the
Merger Agreement, the Company and its Members entered into an Amended and
Restated Limited Liability Company Agreement on February 21, 2008 (the “Original
Agreement”);

 

WHEREAS,
under the Company’ s 2008 Unit Award Plan, the Board of Managers of the Company
or any person designated by the Board of Managers may grant the right to purchase
Class B Units and Class C Units of the Company to participants in the plan, in
each case pursuant to those certain incentive unit subscription agreements (the
“Management Grant Agreements”),;

 

WHEREAS,
in connection with the issuance of Units to certain lenders who are providing
mezzanine financing to RTS, the Board of Managers desires to amend and restate
the Original Agreement in accordance with Section 9.5 of the Original
Agreement; and

 

WHEREAS,
concurrent with the execution of this Agreement, the parties hereto are
entering into that certain Amended and Restated Securityholders Agreement (the “Securityholders
Agreement”), setting forth certain rights, powers and obligations of the
Members with respect to the Company and their membership interests therein.

 

NOW
THEREFORE, in consideration of the mutual covenants and agreements contained
herein, the parties hereto, each intending to be legally bound, agree that the
Original Agreement is hereby amended and restated in its entirety as follows:

 

ARTICLE I

DEFINITIONS

 

Section
1.1 Definitions.

 

Unless
the context otherwise requires, the following terms shall have the following
meanings for purposes of this Agreement:

 

“Act”
means the Delaware Limited Liability Company Act, 6 Del. L. Sections 18-101 et seq., as it may be amended from time to
time, and any successor to the Act.

 

“Additional
Member” means any Person that has been admitted to the Company as a Member
pursuant to Section 7.4 by virtue of having received its Membership
Interest from the Company and not from any other Member or Assignee.

 

“Adjusted
Capital Account Deficit” means, with respect to any Person’s Capital
Account as of the end of any taxable year, the amount by which the balance in
such Capital Account is less than zero. For this purpose, such Capital Account
balance shall be (i) reduced for any items described in Regulations Section l.704-1(b)(2)(ii)(d)(4), (5) and (6), and (ii) increased for any amount such Person is
obligated to contribute or is treated as being obligated to contribute to the
Company pursuant to Regulations Section 1.704-l(b)(2)(ii)(c) (relating to partner liabilities to a
partnership) or Regulations Sections 1.704-2(g)(l) and 1.704-2(i) (relating to
minimum gain).

 

2

 

“Affiliate”
when used with reference to another Person means any Person (other than the
Company), directly or indirectly, through one or more intermediaries,
controlling, controlled by, or under common control with, such other Person. In
addition, Affiliates of a Member shall include all partners, officers,
directors, employees and former partners, officers and employees of, all
consultants or advisors to, and all other Persons who directly or indirectly
receive compensation from, such Member.

 

“Agreement”
has the meaning set forth in the preamble hereto.

 

“Assignee”
means any Transferee to which a Member or another Assignee has Transferred all
or any portion of its interest in the Company in accordance with the terms of
this Agreement, but that is not a Member.

 

“Assumed
Tax Rate” means, for any taxable year, the highest marginal effective rate
of federal, state and local income tax applicable to an individual resident in
New York, New York (or, if higher, a corporation doing business in New York,
New York), taking account of any differences in rates applicable to ordinary
income, dividends and capital gains and any allowable deductions in respect of
such state and local taxes in computing a Member’s liability for federal income
tax; provided that the Assumed Tax Rate for ordinary income initially
shall be set at 45 percent, with the right of the Vestar Majority Holders to
request, by written notice to the Company, a recomputation of the Assumed Tax
Rate, which recomputation shall remain in effect until such time as the Vestar
Majority Holders request a subsequent recomputation.

 

“Bankruptcy”
means, with respect to any Person, the occurrence of any of the following
events: (i) the filing of an application by such Person for, or a consent to,
the appointment of a trustee or custodian of such Person’s assets; (ii) the
filing by such Person of a voluntary petition in Bankruptcy or the seeking of
relief under Title 11 of the United States Code, as now constituted or
hereafter amended, or the filing of a pleading in any court of record admitting
in writing such Person’s inability to pay its debts as they become due; (iii) the
failure of such Person to pay its debts as such debts become due; (iv) the
making by such Person of a general assignment for the benefit of creditors; (v)
the filing by such Person of an answer admitting the material allegations of,
or such Person’s consenting to, or defaulting in answering, a Bankruptcy
petition filed against him in any Bankruptcy proceeding or petition seeking
relief under Title 11 of the United States Code, as now constituted or as
hereafter amended; or (vi) the entry of an order, judgment or decree by any
court of competent jurisdiction adjudicating such Person a bankrupt or
insolvent or for relief in respect of such Person or appointing a trustee or
custodian of such Person’s assets and the continuance of such order, judgment
or decree unstayed and in effect for a period of 60 consecutive calendar days.

 

“Board
of Managers” means the Board of Managers established pursuant to Section
6.2.

 

“Business
Day” means any day other than a Saturday, Sunday or other day on which
commercial banks in New York, New York are authorized or required to close.

 

“Capital
Account” has the meaning set forth in Section 3.5(a).

 

3

 

“Capital
Contributions” means the amount of any cash or cash equivalents, or the
Fair Market Value of other property, that a Member contributes to the Company
with respect to any Unit or other Equity Securities issued pursuant to Article
III (net of liabilities assumed by the Company or to which such property is
subject).

 

“Catch-up
Account” has the meaning set forth in Section 4.5.

 

“Catch-up
Amount” has the meaning set forth in Section 4.5.

 

“CEO”
means the Chief Executive Officer of the Company.

 

“Certificate”
has the meaning set forth in Section 2.1.

 

“CFO”
means the Chief Financial Officer of the Company.

 

“Change
of Control” has the meaning set forth in Section 6.10(b)(i).

 

“Class
A Members” means the Members holding Class A Units.

 

“Class
A Unitholders” means the Unitholders holding an Economic Interest in Class A
Units.

 

“Class
A Units” means the Units having the rights and obligations specified with
respect to Class A Units in this Agreement.

 

“Class
B Fraction” means, as of any date of determination, the lesser of (A) one
and (B) a fraction, the numerator of which is the number of Class B Units
outstanding at the date of any such determination (provided that, as to any
portion of a distribution in which a particular Class B Unit does not
participate, by reason of the proviso to Section 4.1(d), relating to the Floor
Amount for that Class B Unit, such Class B Unit shall not be considered to be
outstanding for this purpose) and the denominator of which is the number of Class
B Units authorized at the date of any such determination, as each of the
numerator and denominator may be adjusted in the event of a recapitalization,
split, dividend or other reclassification affecting the Class B Units.

 

“Class
B Members” means the Members holding Class B Units.

 

“Class
B Unitholders” means the Unitholders holding an Economic Interest in Class B
Units.

 

“Class
B Units” means the Units having the rights and obligations specified with
respect to Class B Units in this Agreement.

 

“Class
C Fraction” means, as of any date of
determination, the lesser of (A) one and (B) a fraction, the numerator of which
is the number of Class C Units outstanding at the date of any such
determination (provided that, as to any portion of a distribution in which a particular
Class C Unit does not participate, by reason of the proviso to Section 4.1(d),
relating to the Floor Amount for that Class C Unit, such Class C Unit shall not
be considered to be outstanding for this purpose) and the denominator of which
is the number of Class C Units authorized at the date

 

4

 

of
any such determination, as each of the numerator and denominator may be
adjusted in the event of a recapitalization, split, dividend or other
reclassification affecting the Class C Units.

 

“Class
C Members” means the Members holding Class C Units.

 

“Class
C Unitholders” means the Unitholders holding an Economic Interest in Class C
Units.

 

“Class
C Units” means the Units having the rights and obligations specified with
respect to Class C Units in this Agreement.

 

“Code”
means the United States Internal Revenue Code of 1986, as amended from time to
time, or any successor statute. Any reference herein to a particular provision
of the Code shall mean, where appropriate, the corresponding provision in any
successor statute.

 

“Company”
has the meaning set forth in the preamble hereto.

 

“Company
Minimum Gain” has the meaning set forth for the term “partnership minimum
gain” in Regulations Section 1.704-2(d).

 

“Company
Sale” shall mean the dissolution of the Company in accordance with this
Agreement or the consummation of a transaction, whether in a single transaction
or in a series of related transactions that are consummated contemporaneously
(or consummated pursuant to contemporaneous agreements), with any other Person
or group of related Persons (other than Vestar) on an arm’s-length basis,
pursuant to which such Person or group of related Persons (i) acquires (whether
by merger, stock purchase, recapitalization, reorganization, redemption,
issuance of capital stock or otherwise) more than 50 percent of (A) the Company’s
Units or (B) the total number of shares of RTS or Parent’s common stock
outstanding (in each case assuming that all Equity Securities convertible into
or exercisable for the Company’s Units or for shares of common stock of RTS or
Parent have been so converted or exercised), or (ii) acquires assets
constituting all or substantially all of the assets of the Company’s
Subsidiaries on a consolidated basis; provided that in no event shall a
Company Sale be deemed to include any transaction effected for the purpose of (x)
changing, directly or indirectly, the form of organization or the
organizational structure of the Company or any of its Subsidiaries or (y) contributing
equity securities to entities controlled by the Company.

 

“Compensation
Committee” means the compensation committee of the Board of Managers, if
any. For the avoidance of doubt, if no Compensation Committee has been formed
by the Board of Managers (or if the Compensation Committee has been dissolved
by the Board of Managers), then all actions and decisions permitted or required
to be taken by the Compensation Committee hereunder shall be taken by the Board
of Managers.

 

“Control”
means, when used with reference to any Person, the power to direct the
management or Policies of such Person, directly or indirectly, by or through
stock or other equity ownership, agency or otherwise, or pursuant to or in
connection with an agreement, arrangement or other understanding (written or
oral); the terms “controlling” and “controlled” shall have meanings correlative
to the foregoing.

 

5

 

“Contribution
Agreements” has the meaning set forth in the recitals hereof.

 

“Controlled
Affiliate” of a Person means any Affiliate of such Person for which such
Person either (i) owns in excess of 50% of the voting securities of such
Affiliate, or (ii) has the right to designate a majority of the members of
the board of directors (or similar governing body) of such Affiliate.

 

“Current
Preferred Return” with respect to each holder of Preferred Units, means
such Unitholder’s Preferred Return for the current quarterly period that has
accrued but has not yet compounded (in accordance with the definition of
Preferred Return).

 

“Depreciation”
means, for each Fiscal Year or other period, an amount equal to the
depreciation, amortization or other cost recovery deduction allowable for
federal income tax purposes with respect to an asset for such year or other
period, except that if the Gross Asset Value of an asset differs from its
adjusted basis for federal income tax purposes at the beginning of such year or
other period, then Depreciation shall be an amount that bears the same ratio to
such beginning Gross Asset Value as the federal income tax depreciation,
amortization or other cost recovery deduction for such year or other period
bears to such beginning adjusted tax basis; provided, however,
that if the federal income tax depreciation, amortization or other cost
recovery deduction for such year is zero, then Depreciation shall be calculated
with reference to such beginning Gross Asset Value using any reasonable method
selected by the Board of Managers.

 

“Distributable
Assets” means, with respect to any fiscal period, all cash receipts of the
Company (including from any operating, investing and financing activities) and,
if distribution thereof is determined to be necessary or desirable by a
majority of the Board of Managers, other assets of the Company from any and all
sources, reduced by cash operating expenses, contributions of capital to
Subsidiaries of the Company and payments (if any) required to be made in connection
with any loan to the Company and any reserve for contingencies or escrow
required, in each case, as is determined in Good Faith by the Board of
Managers.

 

“Economic
Interest” means a Member’s or Assignee’s share of the Company’s net
profits, net losses and distributions pursuant to this Agreement and the Act,
but shall not include any right to participate in the management or affairs of
the Company, including the right to vote in the election of Managers, vote on,
consent to or otherwise participate in any decision of the Members or Managers,
or any right to receive information concerning the business and affairs of the
Company, in each case, except as expressly otherwise provided in this Agreement
or required by the Act.

 

“Equity
Securities” means, as applicable, (i) any capital stock, membership
interests or other share capital, (ii) any securities directly or
indirectly convertible into or exchangeable for any capital stock, membership
interests or other share capital or containing any profit participation
features, (iii) any rights or options directly or indirectly to subscribe
for or to purchase any capital stock, membership interests, other share capital
or securities containing any profit participation features or to subscribe for
or to purchase any securities directly or indirectly convertible into or
exchangeable for any capital stock, membership interests, other share capital
or securities containing any profit participation features, (iv) any share
appreciation rights,

 

6

 

phantom
share rights or other similar rights, or (v) any Equity Securities issued
or issuable with respect to the securities referred to in clauses (i) through
(iv) above in connection with a combination of shares, recapitalization,
merger, consolidation or other reorganization.

 

“Exempt
Employee Transfer” has the meaning set forth for such term in the
Securityholders Agreement.

 

“Exempt
Individual Transfer” has the meaning set forth for such term in the
Securityholders Agreement.

 

“Exempt
NYLIM Transfer” has the meaning set forth for such term in the
Securityholders Agreement.

 

“Exempt
TCW Transfer” has the meaning set forth for such term in the
Securityholders Agreement.

 

“Expert”
means an independent investment bank, accounting firm or other Person of
national standing having particular expertise in the valuation of businesses
comparable to that of the Company and its Subsidiaries.

 

“Fair
Market Value” means, with respect to any asset or securities, the fair
market value for such assets or securities as between a willing buyer and a
willing seller in an arm’s length transaction occurring on the date of
valuation, taking into account all relevant factors determinative of value, as
is determined in Good Faith by the Board of Managers, and subject to the
approval of the Vestar Majority Holders.

 

“Fiscal
Quarter” means each fiscal quarter of the Company and its Subsidiaries,
ending on the last day of each of March, June, September and December of
any Fiscal Year.

 

“Fiscal
Year” means the fiscal year of the Company and its Subsidiaries, ending on December 31
of each calendar year.

 

“Floor
Amount” means, as to each Class B Unit and Class C Unit, as
applicable, the excess, if any, as of the date of issuance of such Unit, of (i) the
aggregate Fair Market Value of all of the equity of the Company, over (ii) the
sum of (A) the aggregate Unpaid Preferred Return, including Current
Preferred Return, with respect to all Preferred Units, (B) the aggregate
Unreturned Preferred Capital with respect to all Preferred Units, (C) the
aggregate Unreturned Class A Capital with respect to all Class A
Units, (D) the aggregate Unreturned Class B Capital with respect to
all Class B Units and (E) the aggregate Unreturned Class C
Capital with respect to all Class C Units. The Floor Amount may be
expressed as an amount per outstanding Unit (taking into account any existing
Floor Amount for the outstanding Units), such that, pursuant to the proviso to Section 4.
l(d), a newly-issued Class B Unit or Class C Unit shall begin to
share in distributions under Section 4.1(d) from and after the
point at which the aggregate distributions made pursuant to Section 4.1(d),
after the date of issuance of the newly-issued Class B Unit or Class C
Unit and with respect to the Units that were outstanding immediately prior to
the issuance of the newly-issued Class B Unit or Class C Unit, is
equal to the Floor Amount. The Floor Amount for each Class B Unit and Class C
Unit issued on February 21, 2008 is equal to zero.

 

7

 

“GAAP”
means accounting principles generally accepted in the United States of America,
consistently applied and maintained throughout the applicable periods.

 

“Good
Faith” shall mean a Person having acted in good faith and in a manner such
Person reasonably believed to be in or not opposed to the best interests of the
Company, and, with respect to a criminal proceeding, having had no reasonable
cause to believe such Person’s conduct was unlawful.

 

“Governmental
Entity” means the United States of America or any other nation, any state
or other political subdivision thereof, or any entity exercising executive,
legislative, judicial, regulatory or administrative functions of government,
including any court, in each case, having jurisdiction over the Company or any
of its Subsidiaries or any of the property or other assets of the Company or
any of its Subsidiaries.

 

“Gross
Asset Value” means, with respect to any asset, the asset’s adjusted basis
for federal income tax purposes, except as follows:

 

(i) The initial Gross Asset Value of any asset
contributed by a Unitholder to the Company shall be the gross Fair Market Value
of such asset on the date of the contribution.

 

(ii) The Gross Asset Values of all Company assets
shall be adjusted to equal their respective gross Fair Market Values as of the
following times:

 

(A) the acquisition of an additional interest in
the Company after February 21, 2008 by a new or existing Unitholder in
exchange for more than a de minimis Capital
Contribution, if the Board of Managers reasonably determines that such
adjustment is necessary or appropriate to reflect the relative Economic
Interests of the Unitholders in the Company;

 

(B) the grant of an interest in the Company
(other than a de minimis interest)
as consideration for the provision of services to or for the benefit of the
Company by an existing or a new Member acting in a partner capacity or in
anticipation of becoming a partner;

 

(C) the distribution by the Company to a
Unitholder of more than a de minimis amount
of Company property as consideration for an interest in the Company, if the
Board of Managers reasonably determine that such adjustment is necessary or
appropriate to reflect the relative Economic Interests of the Unitholders in
the Company;

 

(D) the liquidation of the Company within the
meaning of Regulations Section 1.704-1 (b)(2)(ii)(g); and

 

(E) such other times as the Board of Managers
shall reasonably determine to be necessary or advisable in order to comply with
Regulations promulgated under Subchapter K of Chapter 1 of the Code.

 

8

 

(iii) The Gross Asset Value of any Company asset
distributed to a Unitholder shall be the gross Fair Market Value of such asset
on the date of distribution.

 

(iv) The Gross Asset Values of Company assets
shall be increased (or decreased) to reflect any adjustments to the adjusted
basis of such assets pursuant to Section 734(b) or Section 743(b) of
the Code, but only to the extent that such adjustments are taken into account
in determining Capital Accounts pursuant to Regulations Section 1.704-l(b)(2)(iv)(M); provided, however, that
Gross Asset Values shall not be adjusted pursuant to this subparagraph (iv) to
the extent that the Board of Managers determine that an adjustment pursuant to
subparagraph (ii) of this definition of Gross Asset Value is necessary or
appropriate in connection with a transaction that would otherwise result in an
adjustment pursuant to this subparagraph (iv).

 

(v) With respect to any asset that has a Gross
Asset Value that differs from its adjusted tax basis, Gross Asset Value shall
be adjusted by the amount of Depreciation rather than any other depreciation,
amortization or other cost recovery method.

 

“HSR
Act” has the meaning set forth in Section 7.2(f).

 

“Income”
means individual items of Company income and gain determined in accordance with
the definitions of Net Income and Net Loss.

 

“Indebtedness”
shall mean, for any Person at the time of any determination, without duplication,
the following obligations, contingent or otherwise: (i) all obligations
for borrowed money, (ii) all obligations evidenced by notes, bonds,
debentures, acceptances or instruments, or arising out of letters of credit or
bankers’ acceptances issued for such Person’s account, (iii) all
obligations, whether or not assumed, secured by any Lien or payable out of the
proceeds or production from any property or assets now or hereafter owned or
acquired by such Person other than a Permitted Lien, (iv) the capitalized
portion of lease obligations under capitalized leases, (v) all obligations
arising from installment purchases of property or representing the deferred
purchase price of property or services in respect of which such person is
liable, contingently or otherwise, as obligor or otherwise (other than trade
payables and other current liabilities incurred in the Ordinary Course of
Business), (vi) all obligations of such Person upon which interest charges
are customarily paid or accrued and (vii) any other obligations,
contingent or otherwise, of such Person that, in accordance with GAAP, should
be classified upon the balance sheet of such Person as indebtedness (other than
trade payables or current liabilities incurred in the Ordinary Course of
Business).

 

“Initial
Capital Contribution” means any Capital Contribution made by a Member or
other Person in connection with the issuance of new units or other securities
of the Company.

 

“Initial
Issuance Date” means February 21,2008.

 

“Lien”
means any mortgage, pledge, security interest, encumbrance, lien or charge of
any kind (including any conditional sale or other title retention agreement or
lease in the nature thereof), any sale of receivables with recourse against the
Company or any of its Subsidiaries, any filing or agreement to file a financing
statement as a debtor under the Uniform

 

9

 

Commercial
Code or any similar statute other than to reflect ownership by a third party of
property leased to the Company or any of its Subsidiaries under a lease that is
not in the nature of a conditional sale or title retention agreement.

 

“Loss”
means individual items of Company loss and deduction determined in accordance
with the definitions of Net Income and Net Loss.

 

“Management
Grant Agreements” has the meaning set forth in the recitals hereof.

 

“Management
Member” means any Member that is an employee of the Company or any of its
Subsidiaries.

 

“Managers”
has the meaning set forth in Section 6.2(a).

 

“Member”
means Vestar, the other Persons listed on Schedule B attached hereto and
each other Person who is hereafter admitted as a Member in accordance with the
terms of this Agreement and the Act. The Members shall constitute the “members”
(as such term is defined in the Act) of the Company. Except as otherwise set
forth herein or in the Act, the Members shall constitute a single class or
group of members of the Company for all purposes of the Act and this Agreement.

 

“Member
Minimum Gain” means minimum gain attributable to Member Nonrecourse Debt
determined in accordance with Regulations Section 1.704-2(i).

 

“Member
Nonrecourse Debt” has the meaning set forth for the term “partner
nonrecourse debt” in Regulations Section 1.704-2(b)(4).

 

“Member
Nonrecourse Deduction” has the meaning set forth for the term “partner
nonrecourse deduction” in Regulations Section 1.704-2(i)(2).

 

“Membership
Interest” means, with respect to each Member, such Member’s Economic
Interest and rights as a Member.

 

“Merger
Agreement” has the meaning set forth in the recitals hereof.

 

“Net
Income” or “Net Loss” means, for each Fiscal Year or other period,
an amount equal to the Company’s taxable income or loss for such Fiscal Year or
other period, determined in accordance with Section 703(a) of the
Code (for this purpose, all items of income, gain, loss or deduction required
to be stated separately pursuant to Section 703(a)(l) of the Code
shall be included in such taxable income or loss), with the following
adjustments:

 

(i) any income of the Company that is exempt from
federal income tax and not otherwise taken into account in computing Net Income
or Net Loss pursuant to this definition of Net Income or Net Loss shall be
added to such taxable income or loss;

 

(ii) any expenditures of the Company described in
Section 705(a)(2)(B) of the Code or treated as Section 705(a)(2)(B) of
the Code expenditures

 

10

 

pursuant
to Regulations Section 1.704-l(b)(2)(iv)(i),
and not otherwise taken into account in computing Net Income or Net Loss
pursuant to this definition of Net Income or Net Loss shall be subtracted from
such taxable income or loss;

 

(iii) in the event the Gross Asset Value of any
Company asset is adjusted pursuant to subparagraph (ii) or (iii) of
the definition of Gross Asset Value, the amount of such adjustment shall be
taken into account as gain (if the adjustment increases the Gross Asset Value
of the asset) or loss (if the adjustment decreases the Gross Asset Value of the
asset) from the disposition of such asset for purposes of computing Net Income
or Net Loss;

 

(iv) gain or loss resulting from any disposition
of property with respect to which gain or loss is recognized for federal income
tax purposes shall be computed by reference to the Gross Asset Value of the
property disposed of, notwithstanding that the adjusted tax basis of such
property differs from its Gross Asset Value;

 

(v) in lieu of the depreciation, amortization,
and other cost recovery deductions taken into account in computing such taxable
income or loss, Depreciation shall be taken into account for such Fiscal Year
or other period;

 

(vi) to the extent an adjustment to the adjusted
tax basis of any Company asset pursuant to Section 734(b) or 743 (b) of
the Code is required pursuant to Regulations Section 1.704-l(b)(2)(iv)(m) to be taken into account in
determining Capital Accounts as a result of a distribution other than in
liquidation of a Unitholder’s interest in the Company, the amount of such
adjustment shall be treated as an item of gain (if the adjustment increases the
basis of the asset) or loss (if the adjustment decreases the basis of the
asset) from the disposition of the asset and shall be taken into account for
purposes of computing Net Income or Net Loss; and

 

(vii) notwithstanding any other provision of this
definition of Net Income or Net Loss, any items that are specially allocated
pursuant to Section 5.2 shall not be taken into account in
computing Net Income or Net Loss. The amounts of the items of Income or Loss
available to be specially allocated pursuant to Section 5.2 shall
be determined by applying rules analogous to those set forth in this
definition of Net Income or Net Loss.

 

“Nonrecourse
Deductions” has the meaning set forth for the term “nonrecourse deductions”
in Regulations Section 1.704-2(c).

 

“Notice”
has the meaning set forth in Section 3.3(c).

 

“Officer”
means each Person designated as an officer of the Company pursuant to and in
accordance with the provisions of Section 6.8, subject to any
resolution of the Board of Managers appointing such Person as an officer or
relating to such appointment.

 

“Ordinary
Course of Business” means the ordinary course of the business of the
Company and its Subsidiaries consistent with past custom and practice
(including with respect to quantity, quality and frequency).

 

11

 

“Original
Agreement” has the meaning set forth in the recitals hereof.

 

“Other
Business” has the meaning set forth in Section 6.2(b)(iii).

 

“Parent”
has the meaning set forth in the recitals hereof.

 

“Permitted
Liens” means:

 

(i) Liens
securing Indebtedness permitted to be incurred under Section 6.10(b)(v);

 

(ii) Liens
with respect to taxes, assessments and other governmental charges or levies not
yet due and payable;

 

(iii) deposits
or pledges made in the Ordinary Course of Business in connection with, or to
secure payment of, utilities or similar services, workers’ compensation,
unemployment insurance, old age pensions or other social security, governmental
insurance and governmental benefits, or to secure the performance of tenders,
statutory obligations, surety and appeal bonds, bids, leases, government
contracts, performance and return of money bonds and similar obligations;

 

(iv) purchase
money Liens in any property acquired by the Company or any of its Subsidiaries
in the Ordinary Course of Business to the extent permitted by this Agreement;

 

(v) interests
or title of a licensor, licensee, lessor or sublessor under any license or
lease permitted by this Agreement;

 

(vi) Liens
in respect of property of the Company or any of its Subsidiaries imposed by
applicable law which were incurred in the Ordinary Course of Business, such as
warehousemen’s, mechanic’s, statutory landlord’s, materialmen’s, carriers’ or
contractors’ liens or encumbrances or any similar Lien or restriction for
amounts not yet due and payable;

 

(viii) easements,
rights-of-way, restrictions and other similar charges and encumbrances on real
property and minor defects or irregularities in the title thereof that do not (A) secure
obligations for the payment of money or (B) materially impair the value of
such property or its use by the Company or any of its Subsidiaries in the
Ordinary Course of Business; and

 

(ix) Liens
securing Indebtedness under the Senior Credit Agreement.

 

“Person”
means an individual, a partnership (including a limited partnership), a
corporation, a limited liability company, an association, a joint stock
company, a trust, a joint venture, an unincorporated organization, association
or other entity or a Governmental Entity.

 

“Preferred
Return” with respect to each Preferred Unitholder means an amount equal to
12% per annum, accrued on a daily basis and compounded quarterly on March 31,
June 30, September 30 and December 31 of each year (i.e., 3.0%
quarterly), beginning February 21, 2008, from the day on which such
Unitholder makes a Capital Contribution in respect of its

 

12

 

Preferred
Units through the date of distribution, of the excess, if any, of (i) such
Unitholder’s aggregate Capital Contributions in respect of its Preferred Units
plus the aggregate amount compounded pursuant to this definition through the
end of the previous quarter on each day during such period over (ii) the
aggregate amount of all distributions made on or prior to such day to such
Unitholder in respect of its Preferred Units, other than Tax Distributions and
distributions with respect to Current Preferred Return. For purposes of
computing the Preferred Return, each Capital Contribution shall be treated as
having been made on the last day of the calendar month in which such Capital
Contribution is received by the Company (except for the Initial Capital
Contribution, which shall be deemed to have been made on the date of
contribution), and distributions shall be deemed to have been made on the last
day of the month in which they are made. The Preferred Return shall be computed
based on a 360-day year consisting of 12 equal months.

 

“Preferred
Members” means the Members holding Preferred Units.

 

“Preferred
Unitholders” means the Unitholders holding an Economic Interest in
Preferred Units.

 

“Preferred
Units” means the Units having the rights and obligations specified with
respect to Preferred Units in this Agreement..

 

“Proceeding”
has the meaning set forth in Section 6.13.

 

“Management
Agreement” means, that certain Management Agreement, dated as of February 21,
2008, by and among Vestar Capital Partners, the Company, Parent and RTS.

 

“Public
Offering” has the meaning set forth for such term in the Securityholders
Agreement.

 

“RTS”
has the meaning set forth in the recitals hereof.

 

“Regulations”
means the regulations, including temporary regulations, promulgated by the
United States Treasury Department under the Code, as such regulations may be
amended from time to time (including corresponding provisions of succeeding
regulations).

 

“Regulatory
Allocations” has the meaning set forth in Section 5.2(e).

 

“Securities”
means any debt securities or Equity Securities of any issuer, including common
and preferred stock and interests in limited liability companies (including
warrants, rights, put and call options and other options relating thereto or
any combination thereof), notes, bonds, debentures, trust receipts and other
obligations, instruments or evidences of indebtedness, other property or
interests commonly regarded as securities, interests in real property, whether
improved or unimproved, interests in oil and gas properties and mineral
properties, short-term investments commonly regarded as money market
investments, bank deposits and interests in personal property of all kinds,
whether tangible or intangible.

 

“Securityholders
Agreement” has the meaning set forth in the recitals hereof.

 

13

 

“Senior
Credit Agreement” means RTS’ principal senior credit facility, which shall
initially be that certain Credit Agreement, dated February 21, 2008, by
and among Radiation Therapy Services Holdings, Inc., a Delaware
corporation, RTS, Merger Sub, the several banks and other financial
institutions or entities from time to time parties to this Credit Agreement and
Wachovia Bank, National Association, as administrative agent, issuing bank and
swingline lender, and any successor principal credit facility in replacement
thereof.

 

“Subsidiary”
means, with respect to any Person, any corporation, limited liability company,
partnership, association or business entity of which (i) if a corporation,
a majority of the total voting power of shares of stock entitled (without
regard to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time owned or controlled,
directly or indirectly, by that Person or one or more of the other Subsidiaries
of that Person or a combination thereof, or (ii) if a limited liability
company, partnership, association or other business entity (other than a
corporation), a majority of partnership or other similar ownership interest
thereof is at the time owned or controlled, directly or indirectly, by any
Person or one or more Subsidiaries of that Person or a combination thereof. For
purposes hereof, a Person or Persons shall be deemed to have a majority
ownership interest in a limited liability company, partnership, association or
other business entity (other than a corporation) if such Person or Persons
shall be allocated a majority of limited liability company, partnership,
association or other business entity gains or losses or shall be or control any
managing director or general partner of such limited liability company,
partnership, association or other business entity. For purposes hereof,
references to a “Subsidiary” of any Person shall be given effect only at such
times that such Person has one or more Subsidiaries and, unless otherwise
indicated, the term “Subsidiary” refers to a Subsidiary of the Company.

 

“Substituted
Member” means any Person that has been admitted to the Company as a Member
pursuant to Section 7.4 by virtue of such Person receiving all or a
portion of a Membership Interest from a Member or its Assignee and not from the
Company.

 

“Successor
in Interest” means any (i) trustee, custodian, receiver or other
Person acting in any Bankruptcy or reorganization proceeding with respect to, (ii) assignee
for the benefit of the creditors of, (iii) trustee or receiver, or current
or former officer, director or partner, or other fiduciary acting for or with
respect to the dissolution, liquidation or termination of, or (iv) other
executor, administrator, committee, legal representative or other successor or
assign of, any Unitholder, whether by operation of law or otherwise.

 

“Tax
Distribution” has the meaning set forth in Section 4.4.

 

“Tax
Distribution Amount” has the meaning set forth in Section 4.4.

 

“Tax
Matters Member” has the meaning set forth in Section 8.4(d).

 

“Transaction
Documents” means, collectively, this Agreement, the subscription agreements
between the Company and the Members, the Securityholders Agreement, the Merger
Agreement, the Management Agreement, the Management Grant Agreements, the
Senior Credit Agreement and all other agreements to which the Company is a
party arising out of or in

 

14

 

connection
with the transactions contemplated under the Merger Agreement, the subscription
agreements and the Senior Credit Agreement.

 

“Transfer”
means any sale, transfer, assignment, pledge, mortgage, exchange,
hypothecation, grant of a security interest or other direct or indirect
disposition or encumbrance of an interest (whether with or without
consideration, whether voluntarily or involuntarily or by operation of law).
The terms “Transferee.” “Transferor,” “Transferred.” and
other forms of the word “Transfer” shall have the correlative meanings.

 

“Unit”
has the meaning set forth in Section 3.1(a).

 

“Unitholder”
means a Member or Assignee that holds an Economic Interest in any of the Units.

 

“Unpaid
Preferred Return” with respect to each Preferred Unitholder means the
excess, if any, of (i) such Unitholder’s Preferred Return as of the
date of any such determination, over (ii) the aggregate amount of
all distributions made to such Unitholder pursuant to or in accordance with Section 4.1(c)(A).

 

“Unreturned
Class A Capital” means, with respect to each Class A Unitholder, the
excess, if any, of (i) such Unitholder’s aggregate Capital
Contributions made in exchange for or on account of its Class A Units,
over (ii) the aggregate amount of all distributions made to such
Unitholder pursuant to Section 4.1(b).

 

“Unreturned
Class B Capital” means, with respect to each Class B Unitholder, the
excess, if any, of (i) such Unitholder’s aggregate Capital
Contributions made in exchange for or on account of its Class B Units,
over (ii) the aggregate amount of all distributions made to such
Unitholder pursuant to Section 4.l(c)(B).

 

“Unreturned
Class C Capital” means, with respect to each Class C Unitholder, the
excess, if any, of (i) such Unitholder’s aggregate Capital
Contributions made in exchange for or on account of its Class C Units,
over (ii) the aggregate amount of all distributions made to such
Unitholder pursuant to Section 4.1(c)(C).

 

“Unreturned
Preferred Capital” means, with respect to each Preferred Unitholder, the
excess, if any, of (i) such Unitholder’s aggregate Capital
Contributions made in exchange for or on account of its Preferred Units, over
(ii) the aggregate amount of all distributions made to such Unitholder
pursuant to or in accordance with Section 4.1(a).

 

“Vestar”
has the meaning set forth in the preamble hereto.

 

“Vestar
Group” means, collectively, Vestar V, Vestar/RTS and their respective
Affiliates.

 

“Vestar
Group Majority” means the holders of a majority of the Units then held by
members of the Vestar Group.

 

15

 

“Vestar
Majority Holders” means, at any time, the Members holding a majority of the
Units then held by the Vestar Unitholders.

 

“Vestar
Unitholders” means the Unitholders holding an Economic Interest in any
Units initially issued to Vestar.

 

Section
1.2 Terms Generally. In this Agreement, unless otherwise specified or
where the context otherwise requires:

 

(a) the headings of particular provisions of this
Agreement are inserted for convenience only and will not be construed as a part
of this Agreement or serve as a limitation or expansion on the scope of any
term or provision of this Agreement;

 

(b) words importing any gender shall include other
genders;

 

(c) words importing the singular only shall include
the plural and vice versa;

 

(d) the words “include,” “includes” or “including”
shall be deemed to be followed by the words “without limitation”;

 

(e) the words “hereof,” “herein” and “herewith” and
words of similar import shall, unless otherwise stated, be construed to refer
to this Agreement as a whole and not to any particular provision of this
Agreement;

 

(f) references to “Articles,” “Exhibits,” “Sections”
or “Schedules” shall be to Articles, Exhibits, Sections or Schedules of or to
this Agreement;

 

(g) references to any Person include the successors and
permitted assigns of such Person;

 

(h) the use of the words “or,” “either” and “any”
shall not be exclusive;

 

(i) wherever a conflict exists between this Agreement
and any other agreement, this Agreement shall control but solely to the extent
of such conflict;

 

(j) references to “$” or “dollars” means the lawful
currency of the United States of America;

 

(k) references to any agreement, contract or schedule,
unless otherwise stated, are to such agreement, contract or schedule as
amended, modified or supplemented from time to time in accordance with the
terms hereof and thereof; and

 

(l) the parties hereto have participated jointly in
the negotiation and drafting of this Agreement; accordingly, in the event an
ambiguity or question of intent or interpretation arises, this Agreement shall
be construed as if drafted jointly by the parties

 

16

 

hereto,
and no presumption or burden of proof shall arise favoring or disfavoring any
party hereto by virtue of the authorship of any provisions of this Agreement.

 

ARTICLE II

GENERAL PROVISIONS

 

Section
2.1 Formation. The Company was formed as a Delaware limited liability
company on October 9, 2007 by the execution and filing of a Certificate of
Formation (the “Certificate”) by an authorized person under and pursuant
to the Act. The Members agree to continue the Company as a limited liability
company under the Act, upon the terms and subject to the conditions set forth
in this Agreement. The rights, powers, duties, obligations and liabilities of
the Members shall be determined pursuant to the Act and this Agreement. To the
extent that the rights, powers, duties, obligations and liabilities of any
Member are different by reason of any provision of this Agreement than they would
be in the absence of such provision, this Agreement shall, to the extent
permitted by the Act, control.

 

Section
2.2 Name. The name of the Company is “Radiation Therapy Investments,
LLC,” and all Company business shall be conducted in that name or in such other
names that comply with applicable law as the Board of Managers may select from
time to time. The Board of Managers may change the name of the Company at any
time and from time to time. Prompt notification of any such change shall be
given to all Members.

 

Section
2.3 Term. The term of the Company commenced on the date the Certificate
was filed with the office of the Secretary of State of the State of Delaware
and shall continue in existence perpetually until termination or dissolution in
accordance with the provisions of Section 7.2.

 

Section
2.4 Purpose; Powers.

 

(a) General Powers. The nature of the business
or purposes to be conducted or promoted by the Company is to engage in any
lawful act or activity for which limited liability companies may be organized
under the Act. The Company may engage in any and all activities necessary,
desirable or incidental to the accomplishment of the foregoing. Notwithstanding
anything herein to the contrary, nothing set forth herein shall be construed as
authorizing the Company to possess any purpose or power, or to do any act or
thing, forbidden by law to a limited liability company organized under the laws
of the State of Delaware.

 

(b) Company Action. Subject to the provisions
of this Agreement and except as prohibited by applicable law, (i) the Company
may, with the approval of the Board of Managers, enter into and perform any and
all documents, agreements and instruments, all without any further act, vote or
approval of any Member and (ii) the Board of Managers may authorize any Person
(including any Member or Officer) to enter into and perform any document on
behalf of the Company.

 

(c) Merger. Subject to the provisions of this
Agreement, the Company may, with the approval of the Board of Managers and
without the need for any further act, vote or approval of any Member, merge
with, or consolidate into, another limited

 

17

 

liability
company (organized under the laws of Delaware or any other state), a
corporation (organized under the laws of Delaware or any other state) or other
business entity (as defined in Section 18-209(a) of the Act), regardless of
whether the Company is the survivor of such merger or consolidation.

 

Section
2.5 Foreign Qualification. Prior to the Company’s conducting business in
any jurisdiction other than the State of Delaware, the Board of Managers shall
cause the Company to comply, to the extent procedures are available and those
matters are reasonably within the control of the Officers, with all
requirements necessary to qualify the Company as a foreign limited liability
company in that jurisdiction.

 

Section
2.6 Registered Office; Registered Agent: Principal Office; Other Offices.
The registered office of the Company required by the Act to be maintained in
the State of Delaware shall be the office of the initial registered agent named
in the Certificate or such other office (which need not be a place of business
of the Company) as the Board of Managers may designate from time to time in the
manner provided by law. The registered agent of the Company in the State of
Delaware shall be the initial registered agent named in the Certificate or such
other Person or Persons as the Board of Managers may designate from time to
time in the manner provided by law. The principal office of the Company shall
be at such place as the Board of Managers may designate from time to time,
which need not be in the State of Delaware, and the Company shall maintain
records at such place. The Company may have such other offices as the Board of
Managers may designate from time to time.

 

Section
2.7 No State-Law Partnership. The Unitholders intend that the Company
shall not be a partnership (including a limited partnership) or joint venture,
and that no Unitholder, Manager or Officer shall be a partner or joint venturer
of any other Unitholder, Manager or Officer by virtue of this Agreement, for
any purposes other than as is set forth in the last sentence of this Section
2.7, and this Agreement shall not be construed to the contrary. The
Unitholders intend that the Company shall be treated as a partnership for
federal and, if applicable, state or local income tax purposes, and each
Unitholder and the Company shall file all tax returns and shall otherwise take
all tax and financial reporting positions in a manner consistent with such
treatment.

 

ARTICLE III

CAPITALIZATION; REDEMPTION RIGHTS

 

Section
3.1 Units; Initial Capitalization; Schedules.

 

(a) Units; Initial Capitalization. Each Member’s
interest in the Company, including such Member’s interest, if any, in the
capital, income, gain, loss, deduction and expense of the Company and the right
to vote, if any, on certain Company matters as provided in this Agreement shall
be represented by units of limited liability company interest (each a “Unit”).
The Company initially shall have four authorized classes of Units, designated
Preferred Units, Class A Units, Class B Units and Class C Units, with
527,521.8175 Preferred Units, 10,000,000.0000 Class A Units, 526,262.5000 Class
B Units and 967,848.8492 Class C Units authorized for issuance. On the date
hereof, the issued and outstanding Units consist of 527,521.8175 Preferred
Units,

 

18

 

10,000,000.0000
Class A Units, 505,212.0000 Class B Units and 913,407.3514 Class C Units. The
ownership by a Unitholder of Units shall entitle such Unitholder to allocations
of profits and losses and other items and distributions of cash and other
property as is set forth in Article IV and Article V. The Company
may not issue any fractional Units.

 

(b) Schedule of Units: Schedule of Members. The
aggregate number of Units of each class and the aggregate amount of cash
Capital Contributions that have been made by the Members and the Fair Market
Value of any property other than cash contributed by the Members with respect
to the Units (including, if applicable, a description and the amount of any
liability assumed by the Company or to which contributed property is subject)
shall be set forth on Schedule A attached hereto. The Fair Market Value
of any property contributed by any Management Member with respect to any Units
issued on the Initial Issuance Date shall be equal to the amounts set forth in
such Management Member’s Contribution Agreement as the consideration for the
issuance of the relevant Units. The name and address of each Member shall be
set forth on Schedule B attached hereto. Schedules A and B
shall remain strictly confidential and shall only be disclosed by the Company
to Vestar and the CEO.

 

Section
3.2 Authorization and Issuance of Additional Units. Subject to the
provisions of Section 6.10, the Board of Managers shall have the right
to cause the Company to issue and/or create and issue at any time after the
date hereof, and for such amount and form of consideration as the Board of
Managers may determine, additional Units or other Equity Securities of the
Company (including issuing additional Class B Units or Class C Units or
creating other classes or series of Units or other Equity Securities having
such powers, designations, preferences and rights as may be determined by the
Board of Managers). The Board of Managers shall have the power to make such
amendments to this Agreement in order to provide for such powers, designations,
preferences and rights as the Board of Managers in its discretion deems
necessary or appropriate to give effect to such additional authorization or
issuance; provided that any such amendment shall not reasonably be
expected to have a material and adverse effect on any Unitholder, in its
capacity as such, that would be borne disproportionately by such Unitholder
relative to other Unitholders holding Units of the same class under this
Agreement (unless such Unitholder consents in writing thereto).

 

Section
3.3 Issuance of Class B Units and Class C Units; Service Providers.

 

(a) Authorization of Class B Units and Class C
Units. Subject to Section 6.10(b), the Class B Units and Class C
Units are authorized and reserved for issuance to employees, officers,
directors and other service providers of or to the Company and its
Subsidiaries, and the Board of Managers or the Compensation Committee from time
to time may establish such vesting, forfeiture and repurchase criteria, and
such Floor Amount, for any Class B Units and Class C Units as the Board of
Managers or the Compensation Committee in its discretion determines (and as may
be set forth in the applicable Management Grant Agreement). Any Class B Unit or
Class C Unit that is forfeited by any Person pursuant to the provisions of the
applicable agreement between such Person and the Company shall be deemed to
have been acquired by the Company and may, subject to Section 6.10(b),
be re-issued to employees, officers,

 

19

 

directors
or other service providers of or to the Company and its Subsidiaries at such
time and upon such terms and subject to such conditions as the Board of
Managers or the Compensation Committee determines.

 

(b) Profits Interests. Each Person receiving Class
B Units and/or Class C Units shall make a timely election under Section 83(b) of
the Code with respect to such Units upon their issuance, in a manner reasonably
prescribed by the Company. The Company and each Person receiving Class B Units
and/or Class C Units hereby acknowledges and agrees that each Person’s Class B
Units and/or Class C Units, and the rights and privileges associated with such Class
B Units and/or Class C Units, collectively are intended to constitute a “profits
interest” in the Company within the meaning of Revenue Procedure 93-27, 1993-2
C.B. 343, or any successor Internal Revenue Service or Treasury Department
regulation or other pronouncement applicable at the date of issuance of Class B
Units and/or Class C Units. For so long as Revenue Procedure 2001-43, 2001-2
C.B. 343, is effective, the Company and each Person who receives Class B Units
and/or Class C Units hereby agrees (i) that all such Persons will be treated as
Unitholders and as partners for federal income tax purposes immediately upon
issuance of such Units and (ii) to comply with the provisions of Revenue
Procedure 2001-43, and neither the Company nor any such Person shall perform
any act or take any position inconsistent with the application of Revenue
Procedure 2001-43.

 

(c) Authorization of Safe Harbor Election. By
executing this Agreement, each Member authorizes and directs the Company to
elect to have the “safe harbor” described in the proposed Revenue Procedure set
forth in Internal Revenue Service Notice 2005-43, 2005-24 I.R.B. 1221 (the “Notice”),
apply to any interest in the Company Transferred to a service provider by the
Company on or after the effective date of such Revenue Procedure in connection
with services provided to the Company (and, to the extent that then-applicable
guidance permits, in connection with services provided to any Subsidiary). For
purposes of making such safe harbor election, the Tax Matters Member is hereby
designated as the “partner who has responsibility for federal income tax
reporting” by the Company and, accordingly, for execution of a “safe harbor
election” in accordance with Section 3.03(1) of the Notice. The Company and
each Member hereby agree to comply with all requirements of the safe harbor
described in the Notice, including the requirement that each Member shall
prepare and file all federal income tax returns reporting the income tax
effects of each safe harbor partnership interest issued by the Company in a
manner consistent with the requirements of the Notice.

 

(d) Amendment by Tax Matters Member. Each
Member authorizes the Tax Matters Member to amend this Section 3.3 to
the extent necessary to achieve substantially the same tax treatment with
respect to any profits interest in the Company Transferred to a service
provider by the Company in connection with services provided to the Company
(and, to the extent that then applicable guidance permits, in connection with
services provided to any Subsidiary) as is set forth in, as applicable, Revenue
Procedure 93-27, Revenue Procedure 2001-43 or Section 4 of the Notice e.q.,  to reflect changes from the rules set
forth in the Notice in subsequent Internal Revenue Service or Treasury
Department guidance), provided that such amendment is not materially
adverse to any Member (as compared with the after-tax consequences that would
result if the provisions

 

20

 

of
the Notice applied to all profits interests in the Company Transferred to a
service provider by the Company in connection with services provided to the
Company or any of its Subsidiaries).

 

Section
3.4 Capital Accounts.

 

(a) The Company shall maintain a separate capital
account for each Unitholder according to the rules of Regulations Section 1.704-l(b)(2)(iv)
(each a “Capital Account”). The Capital Account of each Unitholder shall
be credited initially with an amount equal to such Unitholder’s cash
contributions and the Fair Market Value of property contributed to the Company
by the Unitholder (net of any liabilities securing such contributed property
that the Company is considered to assume or take subject to).

 

(b) The Capital Account of each Unitholder shall (i) be
credited with all Income allocated to such Unitholder pursuant to Section 5.1
and Section 5.2, and with the amount equal to such Unitholder’s cash
contributions and the Fair Market Value of property contributed to the Company
by the Unitholder (net of any liabilities securing such contributed property
that the Company is considered to assume or take subject to) and (ii) be
debited with all Loss allocated to such Unitholder pursuant to Section 5.1
or Section 5.2, and with the amount of cash and the Gross Asset Value of
any property (net of liabilities assumed by such Unitholder and liabilities to
which such property is subject) distributed by the Company to such Unitholder.

 

(c) The Company may, upon the occurrence of the events
specified in Regulation Section 1.704-1 (b)(2)(iv)(f), increase or decrease the Capital Accounts of the
Unitholders in accordance with the rules of such Regulation and Regulation Section
1.704-1(b)(2)(iv)(g) to reflect a
revaluation of Company property.

 

Section
3.5 Negative Capital Accounts. No Unitholder shall be required to pay to
any other Unitholder or the Company any deficit or negative balance that may
exist from time to time in such Unitholder’s Capital Account (including upon
and after dissolution of the Company).

 

Section
3.6 No Withdrawal. No Person shall be entitled to withdraw any part of
such Person’s Capital Contributions or Capital Account or to receive any
distribution from the Company, except as expressly provided herein.

 

Section
3.7 Loans From Unitholders. Loans by Unitholders to the Company shall
not be considered Capital Contributions. If any Unitholder shall loan funds to
the Company, then the making of such loans shall not result in any increase in
the Capital Account balance of such Unitholder. The amount of any such loans
shall be a debt of the Company to such Unitholder and shall be payable or
collectible in accordance with the terms and conditions upon which such loans
are made.

 

Section
3.8 No Right of Partition. No Unitholder shall have the right to seek or
obtain partition by court decree or operation of law of any property of the
Company or any of its Subsidiaries or the right to own or use particular or
individual assets of the Company or any

 

21

 

of
its Subsidiaries, or, except as expressly contemplated by this Agreement, be
entitled to distributions of specific assets of the Company or any of its
Subsidiaries.

 

Section
3.9 Non-Certification of Units; Legend; Units Are Securities.

 

(a) Units shall be issued in non-certificated form; provided
that the Board of Managers may cause the Company to issue certificates to a
Member representing the Units held by such Member. If any Unit certificate is
issued, then such certificate shall bear a legend as is set forth in Section 9.2
of the Securityholders Agreement and also substantially in the following form:

 

This
certificate evidences a [Preferred] [Class [A][B][C]] Unit representing an
interest in Radiation Therapy Investments, LLC and shall be a security within
the meaning of Article 8 of the Uniform Commercial Code.

 

The
interest in Radiation Therapy Investments, LLC represented by this certificate
is subject to restrictions on transfer set forth in (i) the Second Amended and
Restated Limited Liability Company Agreement of Radiation Therapy Investments,
LLC, dated as of March 25, 2008, by and among Radiation Therapy Investments,
LLC and each of the members from time to time party thereto, as the same may be
amended from time to time and the (ii) the Amended and Restated Securityholders
Agreement of Radiation Therapy Investments, LLC dated as of March 25, 2008 by
and among Radiation Therapy Investments, LLC and some or all of the members
from time to time party thereto, as the same may be amended from time to time.

 

(b) The Company hereby irrevocably elects that all
Units shall be “securities” governed by Article 8 of the Uniform Commercial
Code as in effect from time to time in the State of Delaware or analogous
provisions in the Uniform Commercial Code in effect in any other jurisdiction.
This Section 3.9(b) shall not be amended without the prior written
consent of all of the Members, and any purported amendment to this Section 3.9(b)
in violation of the foregoing shall be null and void.

 

ARTICLE IV

DISTRIBUTIONS

 

Section
4.1 Distributions; Priority. Distributable Assets will be distributed at
such times as are determined by the Board of Managers, subject to Section 4.4,
in the order and priority set forth below:

 

(a) first, 100% of the Distributable Assets
shall be distributed to the Preferred Unitholders pro rata in accordance
with each such Unitholder’s Unreturned Preferred Capital, until each such Unitholder’s
Unreturned Preferred Capital has been reduced to zero;

 

22

 

(b) second, after the required distributions
pursuant to subparagraph (a) above, 100% of the Distributable Assets shall be
distributed to the Class A Unitholders, pro rata in accordance with each
such Unitholder’s Unretumed Class A Capital, until each such Unitholder’s
Unretumed Class A Capital has been reduced to zero;

 

(c) third, (A) after the required distributions
pursuant to subparagraphs (a) and (b) above, 100% of the Distributable Assets
shall be distributed to the Preferred Unitholders, (i) pro rata in
accordance with the aggregate amount of such Unitholders’ Current Preferred
Return, until each such Unitholder’s Current Preferred Return has been reduced
to zero; and (ii) thereafter, pro rata in accordance with each such
Unitholder’s remaining Unpaid Preferred Return, until each such Unitholder’s
Unpaid Preferred Return has been reduced to zero; (B) after the required
distributions pursuant to subparagraph (A) of this Section 4.1(c), 100% of the
Distributable Assets shall be distributed to the Class B Unitholders, pro
rata in accordance with each such Unitholder’s Unretumed Class B Capital,
until each such Unitholder’s Unretumed Class B Capital has been reduced to
zero; and (C) after the required distributions pursuant to subparagraphs (A) and
(B) of this Section 4.1(c), 100% of the Distributable Assets shall be
distributed to the Class C Unitholders, pro rata in accordance with each
such Unitholder’s Unretumed Class C Capital, until each such Unitholder’s
Unretumed Class C Capital has been reduced to zero; and

 

(d) fourth, after the required distributions
pursuant to subparagraphs (a), (b) and (c) above, all remaining Distributable
Assets shall be distributed as follows:

 

(i) eighty-seven percent (87%) to the Class A
Unitholders, ratably among such Unitholders based on the aggregate number of Class
A Units held by each such Unitholder immediately prior to such distribution;

 

(ii) a percentage, equal to the product of (x) five
percent (5.00%) multiplied by (y) the Class B Fraction, to the Class B
Unitholders, pro rata in accordance with the number of Class B Units held by
each such Unitholder immediately prior to such distribution, and (ii) a
percentage equal to the product of (x) five percent (5.00%) multiplied by (y) one
minus the Class B Fraction, to the Class A Unitholders, pro rata in accordance
with the number Class A Units held by each such Unitholder immediately prior to
such distribution; and

 

(iii) a percentage, equal to the product of (x) eight
percent (8.00%) multiplied by (y) the Class C Fraction, to the Class C
Unitholders, pro rata in accordance with the number of Class C Units held by
each such Unitholder, and (ii) a percentage equal to the product of (x) eight
percent (8.00%) multiplied by (y) one minus the Class C Fraction, to the Class A
Unitholders, pro rata in accordance with the number of Class A Units held by
each such Unitholder immediately prior to such distribution;

 

provided, however, that any Class B Unit or Class C Unit shall share in
distributions pursuant to this Section 4.1(d) only from and after the
point at which the aggregate

 

23

 

amount
of distributions to the Unitholders pursuant to this Section 4. l (d) after
the date of issuance of the Class B Unit or Class C Unit is equal to the Floor
Amount for such Class B Unit or Class C Unit.

 

Section
4.2 Priority over Form of Consideration. Notwithstanding any other provision
in this Agreement, if the Company makes a distribution pursuant to Section 4.1
that includes more than one kind of asset (e.g., cash, equity or debt
securities or any combination thereof), then the assets available for
distribution shall be distributed ratably among all Unitholders entitled to
participate in such distribution; provided that, to the extent cash is
included in such assets, such cash shall first be distributed to the Preferred
Unitholders if they so elect by vote of holders of a majority of the Preferred
Units.

 

Section
4.3 Successors. For purposes of determining the amount of distributions
under Section 4.1, each Unitholder shall be treated as having made the
Capital Contributions and as having received the distributions made to or
received by its predecessors with respect to any of such Unitholder’s Units.

 

Section
4.4 Tax Distributions. Subject to the Act and to any restrictions
contained in any agreement to which the Company is bound and notwithstanding
the provisions of Section 4.1, no later than the tenth day of each
April, June and September of any calendar year and January of the following
calendar year, the Company shall, to the extent of available cash of the
Company, make a distribution in cash (each, a “Tax Distribution”) to
each Unitholder in an amount equal to the excess of (a) the product of (i) the
cumulative taxable income allocated by the Company to the Unitholder through
the end of the month immediately preceding the distribution date, in excess of
the cumulative taxable loss allocated by the Company to such Unitholder for
that period, to the extent that such taxable loss would be available (without
regard to any other Tax item of the Unitholder) to offset such taxable income,
in each case based upon (x) the information returns filed by the Company, as
amended or adjusted to date, and (y) estimated amounts, in the case of periods
for which the Company has not yet filed information returns, and (ii) the
Assumed Tax Rate applicable to each period, over (b) all prior distributions
pursuant to Section 4.1(d) and this Section 4.4. All distributions made
to a Unitholder pursuant to this Section 4.4 shall be treated as advance
distributions under Section 4.1(d) and shall be taken into account in
determining the amount subsequently distributable to a Unitholder under Section
4.1(d). In particular, if, at the time that the Company makes any
distribution under Section 4. l (d). any Unitholder has received a share
of the aggregate distributions made pursuant to Section 4. l (d) and Section
4.4 that is less than the share that it would have received if all such
distributions had been made pursuant to Section 4.1(d) without regard to
Section 4.4, then, notwithstanding Section 4.1(d), distributions
first shall be made 100 percent to the Unitholders having such a shortfall in
such amounts as are required so that each Unitholder has received its
appropriate share, determined under Section 4.1(d), of all distributions
made by the Company under Section 4.l (d) and this Section 4.4.
For the avoidance of doubt, Tax Distributions shall be made only with respect
to income of the Company allocated to the Unitholders (as opposed to income
recognized by any Member with respect to the issuance or vesting of such Member’s
Units). For the purpose of determining the amount of distributions under Section
4.4, each Unitholder shall be treated as having been allocated the cumulative
taxable income and received the distributions made to or received by its
predecessors with respect to any of such Unitholder’s Units.

 

24

 

Section
4.5 Catch-up Distributions to Class B Unitholders and Class C Unitholders.
Notwithstanding any other provision in this Agreement, if, after taking into
account distributions made pursuant to Section 4.4, the Company
otherwise would make a distribution pursuant to Section 4.1 (d) to
holders of unvested Class B Units and/or Class C Units, then the Company shall
instead promptly deposit, to the extent of available cash, into a
non-segregated bank account held in the name of the Company or any of its
Subsidiaries (the “Catch-up Account”) an amount equal to the
distributions that would have been made to the holders of such unvested Class B
Units and/or Class C Units (as to each unvested Class B Unit or Class C Unit, a
“Catch-up Amount”). Upon the vesting of any Class B Unit or Class C Unit
in accordance with the terms of the applicable Management Grant Agreement or
lapsing of other repurchase criteria established pursuant to Section 3.3(a),
the Company shall make a distribution from the Catch-up Account to the holder
of such vested Unit in an amount equal to the aggregate Catch-up Amounts with
respect to such Unit (together with any amounts earned on such Catch-up Amounts
from the respective dates of deposit in the Catch-up Account). If the Company
does not have a sufficient amount of available cash in the Catch-up Account to
satisfy such Catch-up Amount, then, notwithstanding any other provision in this
Agreement, any distribution made pursuant to Section 4.1(d) shall be
distributed, first, to the holder of such vested Unit in an amount equal
to such shortfall, until the Catch-up Amount in respect of such vested Unit is
equal to zero, and, second, in the order and priority set forth in Section
4.l (d). If any unvested Class B Unit or Class C Unit is forfeited or
repurchased by the Company in accordance with the provisions of the applicable
Management Grant Agreement or other repurchase criteria established pursuant to
Section 3.3(a), then the Catch-up Amount with respect to such forfeited
Unit (the “Forfeited Amount”), if any, shall be distributed to the Class
A Unitholders, ratably among such Unitholders based on the aggregate number of Class
A Units held by such Unitholder immediately prior to such distribution. If, at
any time, a Catch-up Amount is payable with respect to more than one Class B
Unit and/or Class C Unit, then the amount available in the Catch-up Account or
to be distributed under Section 4.1(d), as applicable, shall be allocated pro
rata among such Units based on their relative Catch-up Amounts until the
full Catch-up Amount for each such Unit has been distributed.

 

Section
4.6 Security Interest and Right of Set-Off. As security for any
liability or obligation to which the Company may be subject as a result of any
act or status of any Unitholder, or to which the Company may become subject
with respect to the interest of any Unitholder, the Company shall have (and
each Unitholder hereby grants to the Company) a security interest in all Distributable
Assets distributable to such Unitholder to the extent of the amount of such
liability or obligation. Whenever the Company is to pay any sum to any
Unitholder or any Affiliate or related Person thereof pursuant to the terms of
this Agreement, any amounts that such Unitholder or such Affiliate or related
Person owes to the Company may be deducted from that sum before payment.

 

Section
4.7 Certain Distributions. For purposes of this Article IV, a
distribution to a Member of property (other than cash) shall be treated as a
Tax Distribution pursuant to Section 4.4 (rather than as, for example, a
distribution pursuant to Section 4.1 (a), (b) or (c)), in an amount equal to
the hypothetical amount of tax that the Member would pay, at the Assumed Tax
Rate, if (i) such property were not treated as a distribution of money pursuant
to Section 731(c)(2) of the Code (to the extent that Section 731(c)(2) otherwise
applies) and (ii) the Member sold the property immediately after receiving such
distribution.

 

25

 

ARTICLE V

ALLOCATIONS

 

Section
5.1 Allocations. Except as otherwise provided in Section 5.2, Net
Income and Net Loss (and, if necessary, individual items of Income and Loss)
shall be allocated annually (and at such other times as the Board of Managers
determines) to the Unitholders in such manner that the Capital Account balance
of each Unitholder shall, to the greatest extent possible, be equal to the
amount, positive or negative, that would be distributed to such Unitholder (in
the case of a positive amount) or for which such Unitholder would be liable to
the Company under this Agreement (in the case of a negative amount), if (a) the
Company were to sell the assets of the Company for their Gross Asset Values, (b)
all Company liabilities were satisfied (limited with respect to each
nonrecourse liability to the Gross Asset Values of the assets securing such
liability), (c) the Company were to distribute the proceeds of sale pursuant to
Section 4.1 (including to the holders of unvested Class B Units and Class
C Units that are treated as Unitholders pursuant to Section 3.3) and (d) the
Company were to dissolve pursuant to Article VII, minus such Unitholder’s
share of Company Minimum Gain and Member Minimum Gain, computed immediately
prior to the hypothetical sale of assets.

 

Section
5.2 Special Allocations.

 

(a) Loss attributable to Member Nonrecourse Debt shall
be allocated in the manner required by Regulations Section 1.704-2(i). If there
is a net decrease during a taxable year in Member Minimum Gain, Income for such
taxable year (and, if necessary, for subsequent taxable years) shall be
allocated to the Unitholders in the amounts and of such character as is
determined according to Regulations Section 1.704-2(i)(4). This Section 5.2(a)
is intended to be a “partner nonrecourse debt minimum gain chargeback”
provision that complies with the requirements of Regulations Section 1.704-2(i)(4),
and shall be interpreted in a manner consistent therewith.

 

(b) Except as otherwise provided in Section 5.2(a),
if there is a net decrease in Company Minimum Gain during any taxable year,
each Unitholder shall be allocated Income for such taxable year (and, if
necessary, for subsequent taxable years) in the amounts and of such character as
is determined according to Regulations Section 1.704-2(f). This Section 5.2(b)
is intended to be a “minimum gain chargeback” provision that complies with the
requirements of Regulations Section 1.704-2(f), and shall be interpreted in a
manner consistent therewith.

 

(c) If any Unitholder that unexpectedly receives an
adjustment, allocation or distribution described in Regulations Section 1.704-l(b)(2)(ii)(d)(4),
(5) or (6) has an Adjusted
Capital Account Deficit as of the end of any taxable year, computed after the
application of Section 5.2(a) and Section 5.2(b) but before the
application of any other provision of this Article V, then Income for
such taxable year shall be allocated to such Unitholder in proportion to, and
to the extent of, such Adjusted Capital Account Deficit. This Section 5.2(c)
is intended to be a “qualified income offset” provision as described in
Regulations Section 1.704-1 (b)(2)(ii)(d) and shall be interpreted in a manner
consistent therewith.

 

26

 

(d) Income and Loss described in clause (iv) of
the definition of Gross Asset Value shall be allocated in a manner consistent
with the manner that the adjustments to the Capital Accounts are required to be
made pursuant to Regulations Section 1.704-l(b)(2)(iv)(m).

 

(e) The allocations set forth in Section 5.2(a) through
Section 5.2(d) inclusive (the “Regulatory Allocations”)
are intended to comply with certain requirements of Section 1.704-l(b) and
1.704-2 of the Regulations. The Regulatory Allocations may not be consistent
with the manner in which the Unitholders intend to allocate Income and Loss of
the Company or to make distributions. Accordingly, notwithstanding the other
provisions of this Article V, but subject to the Regulatory
Allocations, items of Income and Loss of the Company shall be allocated among
the Unitholders so as to eliminate the effect of the Regulatory Allocations and
thereby cause the respective Capital Account balances of the Unitholders to be
in the amounts (or as close thereto as possible) they would have been if Income
and Loss had been allocated without reference to the Regulatory Allocations. In
general, the Unitholders anticipate that this will be accomplished by specially
allocating other Income and Loss among the Unitholders so that the net amount
of Regulatory Allocations and such special allocations to each such Unitholder
is zero.

 

(f) Income and Loss of the Company shall be
allocated in the manner required by proposed Regulations Section 1.704(b)-l(b)(4)(xii)(c) (or any successor guidance dealing
with so-called “forfeiture allocations”) from and after the time permitted by
applicable final or temporary guidance.

 

Section 5.3 Tax Allocations.

 

(a) The income, gains, losses and deductions of
the Company shall be allocated for federal, state and local income tax purposes
among the Unitholders in accordance with the allocation of such income, gains,
losses and deductions among the Unitholders for purposes of computing their
Capital Accounts; except that if any such allocation is not permitted by the
Code or other applicable law, then the Company’s subsequent income, gains,
losses and deductions for tax purposes shall be allocated among the Unitholders
so as to reflect as nearly as possible the allocation set forth herein in
computing their Capital Accounts.

 

(b) Items of Company taxable income, gain, loss
and deduction with respect to any property contributed to the capital of the
Company shall be allocated among the Unitholders in accordance with Section 704(c) of
the Code so as to take account of any variation between the adjusted basis of
such property to the Company for federal income tax purposes and its Gross
Asset Value, using the “remedial method” under Regulation Section 1.704-3(d),
unless otherwise agreed in writing by the Vestar Majority Holders.

 

(c) If the Gross Asset Value of any Company asset
is adjusted pursuant to the requirements of Regulations Section 1.704-l(b)(2)(iv)(e) or (f), subsequent allocations of items of taxable income, gain,
loss and deduction with respect

 

27

 

to
such asset shall take account of any variation between the adjusted basis of
such asset for federal income tax purposes and its Gross Asset Value in the
same manner as under Section 704(c) of the Code using such method or
methods as the Vestar Group Majority may direct.

 

(d) In addition to the consent rights set forth
in Section 6.10(b), the Vestar Group Majority shall have the sole
and exclusive right to determine the method used by the Company or any of its
Subsidiaries to make allocations pursuant to Section 704(c) of the
Code (including any so-called “reverse” Section 704(c) allocations).

 

(e) Tax credits, tax credit recapture and any
items related thereto shall be allocated to the Unitholders according to their
interests in such items as reasonably determined by the Board of Managers
taking into account the principles of Regulations Sections 1.704-1 (b)(4)(ii) and
1.704-1 T(b)(4)(xi).

 

(f) Allocations pursuant to this Section 5.3
are solely for the purposes of federal, state and local taxes and shall not
affect, or in any way be taken into account in computing, any Unitholder’s
Capital Account or share of Income, Loss, distributions or other Company items
pursuant to any provision of this Agreement.

 

Section 5.4
Unitholders’ Tax Reporting. The Unitholders acknowledge and are aware of
the income tax consequences of the allocations made pursuant to this Article V
and, except as may otherwise be required by applicable law or regulatory
requirements, hereby agree to be bound by the provisions of this Article V
in reporting their shares of Company income, gain, loss, deduction and credit
for federal, state and local income tax purposes.

 

Section 5.5
Indemnification and Reimbursement for Payments on Behalf of a Unitholder.
If the Company is required by law to make any payment to a Governmental Entity
that is specifically attributable to a Unitholder or a Unitholder’s status as
such (including federal withholding taxes, state or local personal property taxes
and state or local unincorporated business taxes), then such Unitholder shall
indemnify the Company in full for the entire amount paid (including interest,
penalties and related expenses). The Board of Managers may offset distributions
to which a Person is otherwise entitled under this Agreement against such
Person’s obligation to indemnify the Company under this Section 5.5.
A Unitholder’s obligation to indemnify the Company under this Section 5.5
shall survive termination, dissolution, liquidation and winding up of the
Company, and for purposes of this Section 5.5, the Company shall be
treated as continuing in existence. The Company may pursue and enforce all
rights and remedies it may have against each Unitholder under this Section 5.5,
including instituting a lawsuit to collect such indemnification, with interest
calculated at a rate equal to 10 percent (but not in excess of the highest rate
per annum permitted by law).

 

ARTICLE VI

MANAGEMENT

 

Section 6.1
The Board of Managers; Delegation of Authority and Duties.

 

(a) Members and Board of Managers. The
Members shall possess all rights and powers as provided in the Act and
otherwise by applicable law. Except as

 

28

 

otherwise
expressly provided for herein, the Members hereby consent to the exercise by
the Board of Managers of all such powers and rights conferred on them by the
Act with respect to the management and control of the Company. Notwithstanding
the foregoing and except as explicitly set forth in this Agreement, if a vote,
consent or approval of the Members is required by the Act or other applicable
law with respect to any act to be taken by the Company or matter considered by
the Board of Managers, each Member agrees that it shall be deemed to have
consented to or approved such act or voted on such matter in accordance with a
vote of the Board of Managers on such act or matter. Each Class A
Unitholder shall have one vote for each Class A Unit held by such
Unitholder. Holders of Preferred Units, Class B Units and Class C
Units shall not have the right to vote on any matter unless such right is
expressly provided herein. If a vote, consent or approval of the Members is
required by this Agreement, only the Class A Members shall be entitled to
vote, consent or approve unless a right to vote, consent or approve is
expressly provided herein to any other Member. Unless otherwise set forth in
this Agreement, any vote, consent or approval of any class of Units required by
this Agreement shall require a majority of the voting power of the applicable
Units. No Member, in its capacity as a Member, shall have any power to act for,
sign for or do any act that would bind the Company. The Members, acting through
the Board of Managers, shall devote such time and effort to the affairs of the
Company as they may deem appropriate for the oversight of the management and
affairs of the Company. Each Member acknowledges and agrees that no Member
shall, in its capacity as a Member, be bound to devote all of such Member’s business
time to the affairs of the Company, and that each Member and such Member’s
Affiliates do and will continue to engage for such Member’s own account and for
the account of others in other business ventures.

 

(b) Delegation by Board of Managers. The
Board of Managers shall have the power and authority to delegate to one or more
other Persons the Board of Managers’ rights and powers to manage and control
the business and affairs of the Company, including to delegate to agents and
employees of a Member, a Manager or the Company (including Officers), and to
delegate by a management agreement or another agreement with, or otherwise to,
other Persons. The Board of Managers may authorize any Person (including any
Member, Officer or Manager) to enter into and perform under any document on
behalf of the Company.

 

(c) Committees. With the consent of at
least one Manager designated by the Vestar Group Majority, the Board of
Managers may, from time to time, designate one or more committees (including
the Compensation Committee), each of which shall be comprised of at least two
Managers. Any such committee, to the extent provided in the enabling resolution
and until dissolved by the Board of Managers, shall have and may exercise any
or all of the authority of the Board of Managers. At every meeting of any such
committee, unless otherwise provided in the enabling resolution, the presence
of a majority of all the Managers thereof shall constitute a quorum, and the
affirmative vote of a majority of the Managers present shall be necessary for
the adoption of any resolution. The Board of Managers may dissolve any
committee at any time, unless otherwise provided in the Certificate or this
Agreement.

 

29

 

Section 6.2
Establishment of Board of Managers.

 

(a) Managers. There shall be established a
board of managers (the “Board of Managers”) composed of such number of
persons as is determined by the Vestar Group Majority consistent with Section 2.1
of the Securityholders Agreement, all of whom shall be individuals as
determined pursuant to the Securityholders Agreement (“Manager”) who
shall be elected by a majority vote of the holders of the Class A Units,
voting together as a single class, and each such Unitholder shall have one vote
for each Unit held by such Member. The size of the Board of Managers may from
time to time be changed with the prior written consent of the Vestar Group
Majority in a manner consistent with Section 2.1 of the Securityholders
Agreement. Each Manager shall be a “manager” (as such term is defined in the
Act) of the Company but, notwithstanding the foregoing, no Manager shall have
any rights or powers beyond the rights and powers granted to such Manager in
this Agreement. Any Manager may be removed from the Board of Managers at any
time by the holders of a majority of the Class A Units in a manner
consistent with Section 2.1 of the Securityholders Agreement. Each Manager
shall remain in office until his or her death, resignation or removal, and in
the event of death, resignation or removal of a Manager, the holders of a
majority of the total voting power of the outstanding Units shall fill the
vacancy created.

 

(b) Duties; Investment Opportunities;
Conflicts of Interest.

 

(i) A Manager shall be personally liable to the
Company and the other Members for any loss incurred by such Person for acts or
omissions in the management of the Company only in the case of gross
negligence, willful misconduct, bad faith or breach of fiduciary duty as
provided below by such Manager; but a Manager shall not be personally liable to
the Company or any Member for any other acts or omissions, including the
negligence, strict liability or other fault or responsibility (short of gross
negligence, willful misconduct, bad faith or breach of fiduciary duty as
provided below) by such Manager. The Board of Managers and any member or
committee thereof may consult with counsel and accountants in respect of
Company affairs and, provided the Board of Managers (or such member or
committee, as the case may be) acts in good faith reliance upon the advice or
opinion of such counsel or accountants, the Board of Managers (or such member
or committee, as the case may be) shall not be liable for any loss suffered by
the Members or the Company in reliance thereon. Notwithstanding any other
provision of this Agreement or any duty otherwise existing at law or in equity,
the parties hereby agree that the Managers, in their capacities as Managers,
shall, to the maximum extent permitted by law, including Section 18-1101 (c) of
the Act, owe no fiduciary duties to the Company, the Members or any other
Person bound by this Agreement; provided, however, that the
Managers shall act in accordance with the implied contractual covenant of good
faith and fair dealing. Any amendment or modification of the provisions of this
Section 6.2(b) shall not adversely affect any rights or
protections of a Manager at the time of such amendment or modification. Except
as stated in the preceding sentence and the other duties as may be expressly
set forth in this Agreement, a Manager shall not be subject to any duties in
the management of the Company. And, for the avoidance of doubt, in the event
that there is a Company Sale and the Board of Managers or any particular
Manager, in such capacity, takes any action to

 

30

 

implement,
undertake or facilitate such Company Sale at the request of Vestar, then such
action shall not be subject to the standards set forth in this Section 6.2(b),
but instead shall be considered actions taken to implement the contractual
agreements of the parties to this Agreement and not in a fiduciary capacity to
the Members.

 

(ii) In performing such Person’s duties, each of
the Managers and the officers of the Company shall be entitled to rely in good
faith on the provisions of this Agreement and on information, opinions, reports
or statements (including financial statements and information, opinions,
reports or statements as to the value or amount of the assets, liabilities,
profits or losses of the Company or any facts pertinent to the existence and
amount of assets from which distributions to Unitholders might properly be
paid), of the following other Persons or groups: (A) one or more officers
or employees of the Company or any of its Subsidiaries; (B) any attorney,
independent accountant or other Person employed or engaged by the Company or
any of its Subsidiaries; or (C) any other Person who has been selected
with reasonable care by or on behalf of the Company or any of its Subsidiaries,
in each case, as to matters which such relying Person reasonably believes to be
within such other Person’s professional or expert competence. The preceding
sentence shall in no way limit any Person’s right to rely on information to the
extent provided in Section 18-406 of the Act.

 

(iii) The Members expressly acknowledge that (A) Vestar
and its respective Affiliates are permitted to have, and may presently or in
the future have, investments or other business relationships with entities other
than through the Company or any of its Subsidiaries (an “Other Business”),
(B) Vestar and its respective Affiliates may have or may develop a
strategic relationship with an Other Business, (C) none of Vestar and its
respective Affiliates will be prohibited by virtue of its investment in the
Company or any of its Subsidiaries or, if applicable, its service on the Board
of Managers from pursuing and engaging in any such activities with Other
Businesses, (D) none of Vestar and its respective Affiliates shall be
obligated to inform the Company or any of its Subsidiaries of any such
opportunity, relationship or investment relating to Other Businesses, (E) the
other Members will not acquire or be entitled to any interest or participation
in any Other Business except as provided in any agreement with the Company or
Subsidiary as a result of the participation therein of Vestar or any of its
respective Affiliates, and (F) the involvement of any equityholder of a
Member or its Affiliates in any Other Business except as provided in any
agreement with the Company or Subsidiary will not constitute a conflict of
interest by such Persons with respect to the Company or its Members or any of
its Subsidiaries. Nothing in the preceding sentence shall limit the confidentiality
obligations of Section 9.4 or, other than as described in this Section 6.2(b)(iii) any
fiduciary obligations of the Managers.

 

(c) Absence. A Manager may designate a
Person to act as his or her substitute and in his or her place at any meeting
of the Board of Managers. Such Person shall have all power of the absent
Manager, and references herein to a “Manager” at a

 

31

 

meeting
shall be deemed to include his or her substitute. Notwithstanding anything in
this Agreement to the contrary, Managers, in their capacities as such, shall
not be deemed to be “members” (as such term is defined in the Act) of the
Company.

 

(d) No Individual Authority. No Manager
has the authority or power to act for or on behalf of the Company, to do any
act that would be binding on the Company or to make any expenditures or incur
any obligations on behalf of the Company or authorize any of the foregoing,
other than acts that are expressly authorized by the Board of Managers.

 

(e) Conflict. Each provision of this Section 6.2
is subject to the terms and provisions of the Securityholders Agreement, and to
the extent any such provisions apply, they are then to be construed as being
incorporated in this Agreement and made a part hereof.

 

(f) Compensation of Directors; Expense
Reimbursement. Managers that are also employees or officers of the Company
or any of its Subsidiaries shall not receive any stated salary for services in
their capacity as Managers; provided, however, that, subject to Section 6.10(b),
nothing herein contained shall be construed to preclude any Manager from
serving the Company or any Subsidiary in any other capacity and receiving
compensation (including Class B Units or Class C Units) therefor.
Managers that are not also employees or officers of the Company or any of its
Subsidiaries may receive equity based compensation and/or a stated salary for
their services as Managers, in each case, as is determined from time to time by
the Board of Managers. Managers shall be reimbursed for any reasonable
out-of-pocket expenses related to attendance at each regular or special meeting
of the Board of Managers (or any committee thereof), subject to the Company’s
requirements with respect to reporting and documentation of such expenses.

 

Section 6.3
Board of Managers Meetings.

 

(a) Quorum and Voting. A majority of the
total number of Managers (including at least one Manager designated by the
Vestar Group Majority) shall constitute a quorum for the transaction of
business of the Board of Managers and, except as otherwise provided in this
Agreement or Section 2.3 of the Securityholders Agreement, the act of a
majority of the Managers present at a meeting of the Board of Managers at which
a quorum is present shall be the act of the Board of Managers. A Manager who is
present at a meeting of the Board of Managers at which action on any matter is
taken shall be presumed to have assented to the action unless his dissent shall
be entered in the minutes of the meeting or unless he shall file his written
dissent to such action with the Person acting as secretary of the meeting
before the adjournment thereof or shall deliver such dissent to the Company
immediately after the adjournment of the meeting. Such right to dissent shall
not apply to a Manager who voted in favor of such action.

 

(b) Place and Waiver of Notice. Meetings
of the Board of Managers may be held at such place or places as shall be
determined from time to time by resolution of the Board of Managers. At all
meetings of the Board of Managers, business

 

32

 

shall
be transacted in such order as shall from time to time be determined by
resolution of the Board of Managers. Attendance of a Manager at a meeting shall
constitute a waiver of notice of such meeting, except where a Manager attends a
meeting for the express purpose of objecting to the transaction of any business
on the ground that the meeting is not lawfully called or convened.

 

(c) Regular Meetings. Regular meetings of
the Board of Managers may be held as from time to time shall be determined by
the Board of Managers. After there has been such determination, and notice
thereof has once been given to each Manager, regular meetings of the Board of
Managers may be held without further notice being given. Such notice need not
state the purpose or purposes of, nor the business to be transacted at, such
meeting, except as may otherwise be required by applicable law or provided for
in this Agreement.

 

(d) Special Meetings. Special meetings of
the Board of Managers may be called on at least 24 hours notice to each Manager
by any two Managers. Such notice need not state the purpose or purposes of, nor
the business to be transacted at, such meeting, except as may otherwise be
required by applicable law or provided for in this Agreement.

 

(e) Notice. Notice of any special meeting
of the Board of Managers or other committee may be given personally, by mail,
facsimile, courier or other means and, if other than personally, shall be
deemed given when written notice is delivered to the office of the Manager at
the address of the Manager in the books and records of the Company.

 

Section 6.4
Chairman. The Board of Managers shall designate a Manager to serve as
chairman. The chairman shall preside at all meetings of the Board of Managers.
If the chairman is absent at any meeting of the Board of Managers, a majority
of the Managers present shall designate another Manager to serve as interim
chairman for that meeting. The chairman shall have no independent authority or
power to act for or on behalf of the Company, to do any act that would be
binding on the Company or to make any expenditure or incur any obligations on
behalf of the Company or authorize any of the foregoing. The chairman shall not
have exclusive power to establish the agenda for any meeting. Any matter
proposed for consideration and seconded by at least one Manager other than the
proposing Manager shall be deemed properly raised for consideration at any
meeting.

 

Section 6.5
Approval or Ratification of Acts or Contracts. Any act or contract
approved or ratified by the Board of Managers shall be as valid and as binding
upon the Company and upon all the Members (in their capacity as Members) as if
it had been approved or ratified by each Member of the Company.

 

Section 6.6
Action by Written Consent. Any action permitted or required by the Act,
the Certificate or this Agreement to be taken at a meeting of the Board of
Managers or any committee designated by the Board of Managers may be taken
without a meeting if a consent in writing, setting forth the action to be
taken, is signed by a majority of the Managers or representatives of such other
committee, as the case may be, subject to Section 2.3 of the

 

33

 

Securityholders
Agreement. Such consent shall have the same force and effect as a vote at a
meeting and may be stated as such in any document or instrument filed with the
Secretary of State of the State of Delaware, and the execution of such consent
shall constitute attendance or presence in person at a meeting of the Board of
Managers or any such other committee, as the case may be.

 

Section 6.7
Meetings by Telephone Conference or Similar Measures. Subject to the
requirements of this Agreement for notice of meetings, the Managers, or
representatives of any other committee designated by the Board of Managers, may
participate in and hold a meeting of the Board of Managers or any such other
committee, as the case may be, by means of a conference telephone or similar
communications equipment by means of which all Persons participating in the
meeting can hear each other, and participation in such meeting shall constitute
attendance and presence in person at such meeting, except where a Person
participates in the meeting for the express purpose of objecting to the
transaction of any business on the ground that the meeting is not lawfully
called or convened.

 

Section 6.8
Officers.

 

(a) Designation and Appointment. The Board
of Managers may, from time to time, employ and retain Persons as may be
necessary or appropriate for the conduct of the Company’s business (subject to
the supervision and control of the Board of Managers), including employees,
agents and other Persons (any of whom may be a Member or Manager) who may be
designated as Officers of the Company, with such titles as and to the extent
authorized by the Board of Managers. Any number of offices may be held by the
same Person. In its discretion, the Board of Managers may choose not to fill
any office for any period as it may deem advisable. Officers need not be
residents of the State of Delaware or Members. Any Officers so designated shall
have such authority and perform such duties as the Board of Managers may from
time to time delegate to them. The Board of Managers may assign titles to
particular Officers. Each Officer shall hold office until his successor shall
be duly designated and shall qualify or until his death or until he shall
resign or shall have been removed in the manner hereinafter provided. The
salaries or other compensation, if any, of the Officers of the Company shall be
fixed from time to time by the Board of Managers.

 

(b) Resignation and Removal. Any Officer
may resign as such at any time. Such resignation shall be made in writing and
shall take effect at the time specified therein, or if no time is specified, at
the time of its receipt by the Board of Managers. The acceptance of a
resignation shall not be necessary to make it effective, unless expressly so
provided in the resignation. Any Officer may be removed as such, either with or
without cause at any time by the Board of Managers. Designation of an Officer
shall not of itself create any contractual or employment rights.

 

(c) Duties of Officers Generally. The
Officers, in the performance of their duties as such, shall owe to the Company
duties of loyalty and due care of the type owed by the officers of a
corporation to such corporation and its stockholders under the laws of the
State of Delaware.

 

34

 

Section 6.9
Management Matters.

 

(a) Transfer of Property. All property
owned by the Company shall be registered in the Company’s name, in the name of
a nominee or in “street name” as the Board of Managers may from time to time
determine. Any corporation, brokerage firm or transfer agent called upon to
Transfer any Securities to or from the name of the Company shall be entitled to
rely on instructions or assignments signed or purported to be signed by any
Officer or Manager without inquiry as to the authority of the Person signing or
purporting to sign such instructions or assignments or as to the validity of
any Transfer to or from the name of the Company. At the time of any such
Transfer, any such corporation, brokerage firm or transfer agent shall be
entitled to assume that (i) the Company is then in existence and (ii) that
this Agreement is in full force and effect and has not been amended, in each
case, unless such corporation, brokerage firm or transfer agent shall have
received written notice to the contrary.

 

(b) Existence and Good Standing. The Board
of Managers may take all action which may be necessary or appropriate (i) for
the continuation of the Company’s valid existence as a limited liability
company under the laws of the State of Delaware (and of each other jurisdiction
in which such existence is necessary to enable the Company to conduct the
business in which it is engaged) and (ii) for the maintenance,
preservation and operation of the business of the Company in accordance with
the provisions of this Agreement and applicable laws and regulations. The Board
of Managers may file or cause to be filed for recordation in the office of the
appropriate authorities of the State of Delaware, and in the proper office or
offices in each other jurisdiction in which the Company is formed or qualified,
such certificates (including certificates of limited liability companies and
fictitious name certificates) and other documents as are required by the
applicable statutes, rules or regulations of any such jurisdiction or as
are required to reflect the identity of the Members and the amounts of their
respective capital contributions.

 

(c) Investment Company Act. The Board of
Managers shall use its best efforts to assure that the Company shall not be subject
to registration as an investment company pursuant to the Investment Company Act
of 1940, as amended.

 

Section 6.10
Consent Rights.

 

(a) Consent Rights of the Managers. The
prior written consent of at least one Manager designated by the Vestar Group Majority
or any Vestar Manager (as defined in the Securityholders Agreement) shall be
required at any time for the Board of Managers, any such other comparable body
or any such committee (i) to adopt the annual budget of the Company and
its Subsidiaries, (ii) to adopt any annual incentive compensation plan and
(iii) to hire or terminate the Chief Executive Officer, the Chief
Financial Officer, the Chief Operating Officer (if any) or any President of the
Company or any of its Subsidiaries.

 

(b) Consent Rights of the Vestar Group
Majority Unitholders. Notwithstanding any other provision of this
Agreement, the Company and the Board of

 

35

 

Managers
shall not, and shall take all action possible to ensure that each Subsidiary of
the Company shall not, without the prior written consent of the Vestar Group
Majority Holders, do, or cause to be done, or agree to do or cause to be done,
any of the following:

 

(i) any transaction that results in any third
party or group of third parties acquiring (A) Equity Securities of the
Company possessing the voting power under normal circumstances to elect a
majority of the Managers (whether by merger, consolidation or sale or Transfer
of the Company’s Equity Securities) or (B) all or substantially all of the
Company’s and its Subsidiaries’ assets, determined on a consolidated basis
(each transaction described in clause (A) or (B), a “Change of Control”):

 

(ii) any merger or consolidation involving the
Company or any of its Subsidiaries, other than (A) a merger or
consolidation of any Subsidiary of the Company with and into the Company, or of
two or more Subsidiaries of the Company into one another, or (B) one that
qualifies as a Change of Control or (C) one constituting an acquisition that
does not require consent under subsection (iii) below;

 

(iii) any acquisition, including by merger or
consolidation, of any business, entity, asset or group of related assets, in
any one or a series of related transactions;

 

(iv) the sale, lease, license or other
disposition of, or permitting any Subsidiary to sell, lease, license or
otherwise dispose of, directly or indirectly, in any transaction or series of
related transactions, assets or any business group, unit or line of business of
the Company and/or its Subsidiaries having a Fair Market Value in any one or
more (A) related transactions in excess of $2.5 million in any 12-month
period or (B) unrelated transactions in excess of $5.0 million in any
12-month period;

 

(v) the incurrence by the Company and its
Subsidiaries of Indebtedness (other than intercompany Indebtedness and any
amounts borrowed by the Company and its Subsidiaries as part of the
transactions contemplated by the Transaction Documents), in the aggregate
principal amount, on a consolidated basis, exceeding $10 million;

 

(vi) the authorization, issuance or sale of, or
the granting of permission to any Subsidiary to authorize, any Equity
Securities or rights to acquire any Equity Securities other than issuance of
any additional Class B and Class C Units, but without causing the
total number of all outstanding Class B and Class C Units at any time
to exceed 13% of the aggregate number of Units (other than the Preferred
Units);

 

(vii) transactions with Affiliates (including the
entry into, termination of, or any changes, modifications or amendments to, any
employment or similar agreements between the Company and/or one or more of its

 

36

 

Subsidiaries,
on the one hand, and any senior executive employee of the Company or any of its
Subsidiaries, on the other hand) other than those transactions undertaken in
compliance with Section 2.4 of the Securityholders Agreement;

 

(viii) directly or indirectly declare or pay any
dividends or make any distributions upon any Units or other Equity Securities
of the Company or any of its Subsidiaries, other than Tax Distributions (Section 4.4);

 

(ix) redeem, purchase or otherwise acquire any
Units or other Equity Securities of the Company or any of its Subsidiaries,
other than the redemption or repurchase of Units by the Company pursuant to any
Management Grant Agreement;

 

(x) make, or permit any Subsidiary to make, any
loan or advance to, guarantee for the benefit of, or investment in, any Person
(other than a wholly-owned or controlled Subsidiary), in each case, in an
amount exceeding $5.0 million individually or $10.0 million in the aggregate;

 

(xi) (A) any material change in the business
of the Company or any Subsidiary (as in effect on the date hereof), (B) any
extension of or entering into a new line of business of the Company or any
Subsidiary or (C) engaging in acts making it impossible to carry on the
business of the Company or any Subsidiary;

 

(xii) make any capital expenditures (including
commitments with respect to capitalized leases, as is determined in accordance
with GAAP) exceeding the approved budget (as adopted pursuant to Section 6.10))
by $5.0 million in the aggregate on a consolidated basis during any 12-month
period;

 

(xiii) become subject to, or permit any of its
Subsidiaries to become subject to (including by way of amendment to or
modification of), any agreement or instrument which by its terms would (under
any circumstances) restrict the Company’s right or ability to perform the
provisions of any of the Transaction Documents; or waive compliance by any
other person of any obligation of such person under any Transaction Document;

 

(xiv) any amendment to the organizational
documents of the Company or any of its Subsidiaries, including the Certificate
and this Agreement;

 

(xv) the entry into, termination of, or any
material changes, modifications or amendments to, any material agreement to
which the Company or any Subsidiary is or will be a party or which otherwise is
or will be binding on the Company or any Subsidiary, including the
Securityholders Agreement and the Management Agreement;

 

(xvi) the declaration of a Bankruptcy (or
acquiescence with respect thereto), dissolution, liquidation, recapitalization
or reorganization in any form of transaction of the Company or its
Subsidiaries;

 

37

 

(xvii) any change of the Company’s or any of its
Subsidiaries’ independent auditors;

 

(xviii) agree to the creation or incurrence of
any Lien other than any Permitted Lien; or

 

(xix) any significant action affecting
allocations made by the Company for Capital Account or tax purposes, Capital
Account balances or any tax item of the Company or its Subsidiaries.

 

(c) Scope of Consent Rights. The Members
hereby acknowledge and agree that the determination of the Vestar Group
Majority Holders as to whether to consent to any of the actions described in Section 6.10(b) shall
be made (i) in the sole discretion of the Vestar Group Majority Holders
acting in their own best interests and (ii) without regard to any
fiduciary duty.

 

(d) Termination. The provisions set forth
in this Section 6.10 shall terminate upon the consummation of an
initial Public Offering.

 

Section 6.11
Securities in Subsidiaries. The Company shall vote, or cause to be
voted, all of the securities it holds in any direct or indirect Subsidiary of
the Company as directed by the Board of Managers, or as required by the
Securityholders Agreement.

 

Section 6.12
Liability of Unitholders.

 

(a) No Personal Liability. Except as
otherwise required by applicable law and as expressly set forth in this
Agreement, no Unitholder shall have any personal liability whatsoever in such
Person’s capacity as a Unitholder, whether to the Company, to any of the other
Unitholders, to the creditors of the Company or to any other third party, for
the debts, liabilities, commitments or any other obligations of the Company or
for any losses of the Company. Each Unitholder shall be liable only to make
such Unitholder’s Capital Contribution to the Company, if applicable, and the
other payments provided for expressly herein.

 

(b) Return of Distributions. In accordance
with the Act and the laws of the State of Delaware, a member of a limited
liability company may, under certain circumstances, be required to return
amounts previously distributed to such member. It is the intent of the Members
that no distribution to any Member pursuant to Article IV shall be
deemed a return of money or other property paid or distributed in violation of
the Act. The payment of any such money or distribution of any such property to
a Member shall be deemed to be a compromise within the meaning of the Act, and
the Member receiving any such money or property shall not be required to return
to any Person any such money or property. However, if any court of competent
jurisdiction holds that, notwithstanding the provisions of this Agreement, any
Member is obligated to make any such payment, such obligation shall be the
obligation of such Member and not of any Manager or other Member.

 

38

 

Section 6.13
Indemnification by the Company. Subject to the limitations and
conditions provided in this Section 6.13, each Person who was or is
made a party or is threatened to be made a party to or is involved in any
threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or arbitral (each a “Proceeding”), or any
appeal in such a Proceeding or any inquiry or investigation that could lead to
such a Proceeding, by reason of the fact that he, she or it, or a Person of
which he, she or it is the legal representative, is or was a Unitholder,
Officer or Manager shall be indemnified by the Company to the fullest extent
permitted by applicable law, as the same exists or may hereafter be amended
(but, in the case of any such amendment, only to the extent that such amendment
permits the Company to provide broader indemnification rights than such law
permitted the Company to provide prior to such amendment) against all
judgments, penalties (including excise and similar taxes and punitive damages),
fines, settlements and reasonable expenses (including reasonable attorneys’
fees and expenses) actually incurred by such Person in connection with such
Proceeding, appeal, inquiry or investigation, if such Person acted in Good
Faith. Reasonable expenses incurred by a Person of the type entitled to be
indemnified under this Section 6.13 who was, is or is threatened to
be made a named defendant or respondent in a Proceeding shall be paid by the
Company in advance of the final disposition of the Proceeding upon receipt of
an undertaking by or on behalf of such Person to repay such amount if it shall
ultimately be determined that he or she is not entitled to be indemnified by
the Company. Indemnification under this Section 6.13 shall continue
as to a Person who has ceased to serve in the capacity which initially entitled
such Person to indemnity hereunder. The rights granted pursuant to this Section 6.13
shall be deemed contract rights, and no amendment, modification or repeal of
this Section 6.13 shall have the effect of limiting or denying any
such rights with respect to actions taken or Proceedings, appeals, inquiries or
investigations arising prior to any amendment, modification or repeal. It is
expressly acknowledged that the indemnification provided in this Section 6.13
could involve indemnification for negligence or under theories of strict
liability.

 

Section 6.14
Investment Representations of Unitholders. Each Unitholder hereby
represents, warrants and acknowledges to the Company that: (a) such
Unitholder has such knowledge and experience in financial and business matters
and is capable of evaluating the merits and risks of an investment in the
Company and is making an informed investment decision with respect thereto; (b) such
Unitholder is acquiring interests in the Company for investment only and not
with a view to, or for resale in connection with, any distribution to the
public or public offering thereof; and (c) the execution, delivery and
performance of this Agreement have been duly authorized by such Unitholder.

 

ARTICLE VII

WITHDRAWAL; DISSOLUTION; TRANSFER OF MEMBERSHIP INTERESTS;

ADMISSION OF NEW MEMBERS

 

Section 7.1
Unitholder Withdrawal. No Unitholder shall have the power or right to
withdraw or otherwise resign or be expelled from the Company prior to the
dissolution and winding up of the Company, except pursuant to a Transfer
permitted under this Agreement of all of such Unitholder’s Units to an
Assignee, a Member or the Company.

 

39

 

Section 7.2
Dissolution.

 

(a) Events. Subject to Section 6.10,
the Company shall be dissolved and its affairs shall be wound up on the first
to occur of (i) the majority vote of the Board of Managers and the consent
of the Vestar Majority Holders, or (ii) the entry of a decree of judicial
dissolution of the Company under Section 18-802 of the Act.

 

(b) Actions Upon Dissolution. When the
Company is dissolved, the business and property of the Company shall be wound
up and liquidated by the Board of Managers or, in the event of the
unavailability of the Board of Managers or if the Board of Managers so
determine, such Member or other liquidating trustee as shall be named by the
Board of Managers.

 

(c) Priority. A reasonable time shall be
allowed for the orderly winding up of the business and affairs of the Company
and the liquidation of its assets pursuant to Section 7.2 to
minimize any losses otherwise attendant upon such winding up. Notwithstanding
the generality of the foregoing, within 120 calendar days after the effective
date of dissolution of the Company, the assets of the Company shall be
distributed in the following manner and order: (i) all debts and
obligations of the Company, if any, shall first be paid, discharged or provided
for by adequate reserves; and (ii) the balance shall be distributed to the
Unitholders in accordance with Section 4.1.

 

(d) Cancellation of Certificate. On
completion of the distribution of Company assets as provided herein, the
Company is terminated, and shall file a certificate of cancellation with the
Secretary of State of the State of Delaware, cancel any other filings made and
take such other actions as may be necessary to terminate the Company.

 

(e) Return of Capital. The liquidators
shall not be personally liable for the return of Capital Contributions or any
portion thereof to the Members (it being understood that any such return shall
be made solely from Company assets).

 

(f) Hart-Scott-Rodino. Notwithstanding any
other provision in this Agreement, in the event the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the “HSR Act”), is applicable to
any Member by reason of the fact that any assets of the Company will be
distributed to such Member in connection with the dissolution of the Company,
the dissolution of the Company shall not be consummated until such time as the
applicable waiting periods (and extensions thereof) under the HSR Act have
expired or otherwise been terminated with respect to each such Member.

 

Section 7.3
Transfer by Unitholders. Any Member who shall Transfer any Units in the
Company shall cease to be a Member of the Company with respect to such Units
and shall no longer have any rights or privileges of a Member with respect to
such Units. Any Member or Assignee who acquires in any manner whatsoever any
Units, irrespective of whether such Person has accepted and adopted in writing
the terms and provisions of this Agreement, shall be deemed by the acceptance
of the benefits of the acquisition thereof to have agreed to be subject to and
bound by all of the terms and conditions of this Agreement that any predecessor
in such Units or other interest in the Company was subject to or by which such
predecessor was bound. No Member shall cease to be a Member upon the collateral
assignment of, or the

 

40

 

pledging
or granting of a security interest in, its entire interest in the Company. Any
Transfer and any related admission of a Person as a Member in compliance with
the provisions of the Securityholders Agreement and this Agreement shall be
deemed effective on such date that the Transferee or successor in interest
complies with the requirements of the Securityholders Agreement and this
Agreement.

 

Section 7.4
Admission or Substitution of New Members.

 

(a) Admission. The Board of Managers shall
have the right, subject to Section 7.3. to admit as a Substituted
Member or an Additional Member any Person who acquires an interest in the
Company, or any part thereof, from a Member or from the Company; provided
that the Board of Managers shall admit as a Substituted Member, subject to Section 7.4(b),
any Transferee who acquires an interest in the Company pursuant to an Exempt
Employee Transfer, an Exempt TCW Transfer, an Exempt NYLIM Transfer or an
Exempt Individual Transfer. Concurrently with the admission of a Substituted
Member or an Additional Member, the Board of Managers shall forthwith (i) amend
Schedule B hereto to reflect the name and address of such Substituted
Member or Additional Member and to eliminate or modify, as applicable, the name
and address of the Transferring Member with regard to the Transferred Units and
(ii) cause any necessary papers to be filed and recorded and notice to be
given wherever and to the extent required showing the substitution of a Transferee
as a Substituted Member in place of the Transferring Member, or the admission
of an Additional Member, in each case, at the expense, including payment of any
professional and filing fees incurred, of such Substituted Member or Additional
Member, unless otherwise determined by the Board of Managers.

 

(b) Conditions and Limitations. The
admission of any Person as a Substituted Member or an Additional Member shall
be conditioned upon (i) such Person’s written acceptance and adoption of
all the terms and provisions of this Agreement, either by (A) execution
and delivery of a counterpart signature page to this Agreement
countersigned by a Manager on behalf of the Company or (B) any other
writing evidencing the intent of such Person to become a Substituted Member or
an Additional Member and such writing is accepted by the Board of Managers on
behalf of the Company and (ii) (at the request of the Board of Managers)
such Person’s execution and delivery of a counterpart to the Securityholders
Agreement.

 

(c) Prohibited Transfers. Other than
pursuant to a Company Sale, any Transfer of a Unit or an Economic Interest
shall not be permitted (and, if attempted, shall be void ab initio)
if, in the determination of the Board of Managers, (i) such a
Transfer would cause the Company to become ineligible for safe harbor treatment
under Section 7704 of the Code and Regulations Section 1.7704-l(h) or
otherwise would pose a material risk that the Company would be a “publicly
traded partnership” as defined in Section 7704 of the Code, or (ii) such
Transfer would result in 50 percent or more of the Company’s total “partnership
interests” having been “sold or exchanged” in any 12-month period (within the
meaning of Section 708(b)(l)(B) of the Code) and the resulting
termination of the Company pursuant to Section 708(b)(l)(B) would, in
the

 

41

 

determination
of the Board of Managers, have a more than immaterial adverse effect on the
Company or the Members.

 

(d) Effect of Transfer to Substituted Member.
Following the Transfer of any Unit that is permitted under this Section 7.4,
the Transferee of such Unit shall be treated as having made all of the Capital
Contributions in respect of, and received all of the distributions received in
respect of, such Unit, shall succeed to the Capital Account balance associated
with such Unit, shall receive allocations and distributions under Article IV,
Article V and Section 7.2 in respect of such Unit and
otherwise shall become a Substituted Member entitled to all the rights of a
Member with respect to such Unit.

 

Section 7.5
Compliance with Law. Notwithstanding any other provision hereof to the
contrary, no sale or other disposition of an interest in the Company may be
made except in compliance with all federal, state and other applicable laws,
including federal and state securities laws. Nothing in this Section 7.5
shall be construed to limit or otherwise affect any of the provisions of the
Securityholders Agreement or the Management Grant Agreements, and to the extent
any such provisions apply, they are then to be construed as being incorporated
in this Agreement and made a part hereof.

 

ARTICLE VIII

BOOKS AND RECORDS; FINANCIAL STATEMENTS AND OTHER INFORMATION;

TAX MATTERS

 

Section 8.1
Books and Records; Management Interviews.

 

(a) Books and Records. The Company shall
keep at its principal executive office (i) correct and complete books and
records of account (which, in the case of financial records, shall be kept in
accordance with GAAP), (ii) minutes of the proceedings of meetings of the
Members, the Board of Managers and any committee of the Board of Managers, (iii) a
current list of the Managers, directors and officers of the Company and its
Subsidiaries and their respective residence addresses, and (iv) a record
containing the names and addresses of all Members, the total number and class
of Units held by each Member, and the dates when they respectively became the
owners of record thereof. Any of the foregoing books, minutes or records may be
in written form or in any other form capable of being converted into written
form within a reasonable time.

 

(b) Inspection of Property. The Company
shall permit any representative designated by the Vestar Majority Holders or by
any Member than owns in excess of 1.5% of the aggregate number of the total
Preferred Units and the Class A Units taken together, upon reasonable
notice and during normal business hours and at such other times as such Persons
may reasonably request, for any purpose reasonably related to such Member’s
interest as a member of the Company, to (i) visit and inspect any of the
properties of the Company and its Subsidiaries, (ii) examine any books,
minutes and records of the Company and its Subsidiaries (including business and
financial records) and make copies thereof or extracts therefrom, and (iii) discuss
the affairs, finances and accounts of the Company or any of its Subsidiaries
with the directors, officers, key employees and independent accountants of the
Company and its Subsidiaries, in each

 

42

 

case,
under such conditions and restrictions (including a confidentiality undertaking
or agreement) as the Board of Managers may reasonably prescribe.

 

Section 8.2
Financial Statements and Other Information.

 

(a) The Company shall, and shall cause each of
its Subsidiaries to, deliver to each Preferred Member and each Class A
Member, for so long as such Member (X) holds more than 1.5% of the
aggregate number of the Preferred Units and the Class A Units taken
together, the items described in this clause (a) or (Y) is an active
employee of the Company, the items described in subclauses (i) - (iii) of
this clause (a):

 

(i) as soon as available, but in any event within
30 calendar days after the end of each calendar month in each Fiscal Year,
unaudited statements of income and cash flows of RTS and each of its
Subsidiaries for such monthly period and for the period from the beginning of
the Fiscal Year to the end of such month, and unaudited balance sheets of RTS
and each of its Subsidiaries as of the end of such monthly period, setting
forth, in each case, comparisons to the annual budget for such Fiscal Year and
to the corresponding period in the preceding Fiscal Year, and all such
statements shall be prepared in accordance with GAAP, subject to the absence of
footnote disclosures and to normal year-end adjustments for recurring accruals;

 

(ii) as soon as available, but in any event
within 45 calendar days after each Fiscal Quarter during each Fiscal Year, unaudited
statements of income and cash flows of RTS and each of its Subsidiaries for
such quarterly period and for the period from the beginning of the Fiscal Year
to the end of such Fiscal Quarter, and unaudited balance sheets of RTS and each
of its Subsidiaries as of the end of such quarterly period, setting forth, in
each case, comparisons to the annual budget for such Fiscal Year and to the
corresponding period in the preceding Fiscal Year, and all such statements
shall be prepared in accordance with GAAP, subject to the absence of footnote
disclosures and to normal year-end adjustments for recurring accruals, and
shall be certified by the CEO and the CFO. In addition, such financial
statements shall be accompanied by a brief written summary prepared by the CEO
and the CFO which summarizes performance highlights, lowlights, variances from
the annual budget for such Fiscal Year and the prior year, and an outlook for
the ensuing period;

 

(iii) as soon as available, but in any event
within 90 calendar days after the end of each Fiscal Year, statements of income
and cash flows of RTS and each of its Subsidiaries for such Fiscal Year, and
balance sheets of RTS and each of its Subsidiaries as of the end of such Fiscal
Year, setting forth, in each case, comparisons to the annual budget for such
Fiscal Year and to the preceding Fiscal Year, all prepared in accordance with
GAAP, and accompanied by an opinion, unqualified as to scope or compliance with
GAAP, of a nationally recognized independent accounting firm reasonably
acceptable to the Vestar Majority Holders, and certified by the CEO and the
CFO;

 

43

 

(iv) at such time as any draft of the annual
business plan and budget is provided to the Board of Managers for its consideration,
a copy of such draft, and, as soon as practicable before the end of each Fiscal
Year, a copy of the annual budget approved by the Board of Managers, including
projected income statement, cash flow and balance sheet, on a monthly basis for
the ensuing Fiscal Year, together with underlying assumptions and a brief
qualitative description of the Company’s plan by the CEO and the CFO in support
of such budget;

 

(v) promptly, but in any event within 10 calendar
days, after the discovery of any default under any material agreement to which
the Company or any of its Subsidiaries is a party, any condition or event that
could reasonably be expected to result in any material liability under any
federal, state or local statute or regulation relating to public health and
safety, worker health and safety or pollution or protection of the environment
or any other material adverse change, event or circumstance affecting the
Company or any Subsidiary (including the filing of any material litigation
against the Company or any Subsidiary or the existence of any dispute with any
Person that involves any likelihood of such litigation being commenced);

 

(vi) promptly upon receipt thereof, any
additional reports, management letters or other detailed information concerning
material aspects of the Company’s or such Subsidiary’s operations or financial
affairs given to the Company or any Subsidiary by its independent accountants
(and not otherwise contained in other materials provided hereunder);

 

(vii) within 10 calendar days after generation
thereof, copies of any internal valuation memoranda or analyses;

 

(viii) within 10 calendar days after generation
thereof, a copy of the monthly management reporting package delivered to the
Board of Managers;

 

(ix) prior to the transmission thereof to the
public, copies of all press releases and other written statements made
available generally by the Company or any of its Subsidiaries to the public
concerning material developments in the Company’s and its Subsidiaries’
businesses; and

 

(x) with reasonable promptness, such other
information and financial data concerning the Company and its Subsidiaries as
any Person entitled to receive information under this Section 8.2(a) may
reasonably request.

 

(b) The Unitholders shall be supplied with all
other Company information necessary to enable each Unitholder to prepare its
federal, state and local income tax returns.

 

(c) All determinations, valuations and other
matters of judgment required to be made for accounting purposes under this Agreement
shall be made in Good Faith by the Board of Managers and shall be conclusive
and binding on all Unitholders, their Successors in Interest and any other
Person, and to the fullest extent permitted by

 

44

 

law,
no such Person shall have the right to an accounting or an appraisal of the
assets of the Company or any successor thereto.

 

Section 8.3
Fiscal Year; Taxable Year. Each of the Fiscal Year and the taxable year
of the Company shall end on December 31 of each calendar year; provided
that the taxable year of the Company shall end on a different date if necessary
to comply with Section 706 of the Code.

 

Section 8.4
Certain Tax Matters.

 

(a) Preparation of Returns. The Board of
Managers shall cause to be prepared all federal, state and local tax returns of
the Company for each year for which such returns are required to be filed and
shall cause such returns to be timely filed. Except as other provided herein,
the Board of Managers shall determine the appropriate treatment of each item of
income, gain, loss, deduction and credit of the Company and the accounting
methods and conventions under the tax laws of the United States of America, the
several states and other relevant jurisdictions as to the treatment of any such
item or any other method or procedure related to the preparation of such tax
returns. Except as specifically provided otherwise in this Agreement, the Board
of Managers may cause the Company to make or refrain from making any and all
elections permitted by such tax laws.

 

(b) Consistent Treatment. Each Unitholder
agrees that it shall not, except as otherwise required by applicable law or
regulatory requirements, (i) treat, on its individual income tax returns,
any item of income, gain, loss, deduction or credit relating to its interest in
the Company in a manner inconsistent with the treatment of such item by the
Company as reflected on the Form K-l or other information statement
furnished by the Company to such Unitholder for use in preparing its income tax
returns or (ii) file any claim for refund relating to any such item based
on, or which would result in, such inconsistent treatment.

 

(c) Duties of the Tax Matters Member. In
respect of an income tax audit of any tax return of the Company, the filing of
any amended return or claim for refund in connection with any item of income,
gain, loss, deduction or credit reflected on any tax return of the Company, or
any administrative or judicial proceedings arising out of or in connection with
any such audit, amended return, claim for refund or denial of such claim, (A) the
Board of Managers shall direct the Tax Matters Member to act for, and such
action shall be final and binding upon, the Company and all Unitholders, except
to the extent a Unitholder shall properly elect to be excluded from such
proceeding pursuant to the Code, (B) all expenses incurred by the Tax
Matters Member in connection therewith (including attorneys’, accountants’ and
other experts’ fees and disbursements) shall be expenses of, and payable by,
the Company, (C) no Unitholder other than the Tax Matters Member shall
have the right to (1) participate in the audit of any Company tax return, (2) file
any amended return or claim for refund in connection with any item of income,
gain, loss, deduction or credit (other than items which are not partnership
items within the meaning of Section 6231(a)(4) of the Code or which
cease to be partnership items under Section 623l(b)) of the Code reflected
on any tax return of the Company,

 

45

 

(3) participate
in any administrative or judicial proceedings conducted by the Company or the
Tax Matters Member arising out of or in connection with any such audit, amended
return, claim for refund or denial of such claim, or (4) appeal, challenge
or otherwise protest any adverse findings in any such audit conducted by the
Company or the Tax Matters Member or with respect to any such amended return or
claim for refund filed by the Company or the Tax Matters Member or in any such
administrative or judicial proceedings conducted by the Company or the Tax
Matters Member and (D) the Tax Matters Member shall keep the Unitholders
reasonably apprised of the status of any such proceeding. Notwithstanding the
previous sentence, if a petition for a readjustment to any partnership item
included in a final partnership administrative adjustment is filed with a
District Court or the Court of Claims and the IRS has elected to assess income
tax against a Member with respect to that final partnership administrative
adjustment (rather than suspending assessments until the District Court or
Court of Claims proceedings become final), such Member shall be permitted to
file a claim for refund within such period of time as to avoid application of
any statute of limitations that would otherwise prevent the Member from having
any claim based on the final outcome of that review.

 

(d) Tax Matters Member. The Company and
each Member hereby designate Vestar V as the initial “tax matters partner” for
purposes of Section 6231(a)(7) of the Code (the “Tax Matters
Member”). The Board of Managers may remove or replace the Tax Matters
Member at any time and from time to time.

 

(e) Certain Filings. Upon the Transfer of
an interest in the Company (within the meaning of the Code), a sale of Company
assets or a liquidation of the Company, the Unitholders shall provide the Board
of Managers with information and shall make tax filings as reasonably requested
by the Board of Managers and required under applicable law.

 

ARTICLE IX

MISCELLANEOUS

 

Section 9.1
Schedules. Without in any way limiting the provisions of Section 8.2,
a Manager may from time to time execute on behalf of the Company and deliver to
the Unitholders schedules that set forth the then current Capital Account
balances of each Unitholder and any other matters deemed appropriate by the
Board of Managers or required by applicable law. Such schedules shall be for
information purposes only and shall not be deemed to be part of this Agreement
for any purpose whatsoever.

 

Section 9.2
Governing Law. THIS AGREEMENT IS GOVERNED BY AND SHALL BE CONSTRUED IN
ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE, EXCLUDING ANY
CONFLICT-OF-LAWS RULE OR PRINCIPLE THAT MIGHT REFER THE GOVERNANCE OR THE
CONSTRUCTION OF THIS AGREEMENT TO THE LAW OF ANOTHER JURISDICTION. In the event
of a direct conflict between the provisions of this Agreement and any provision
of the Certificate or any mandatory provision of the Act, the applicable
provision of the Certificate or the Act shall control.

 

46

 

Section 9.3
Successors and Assigns. This Agreement shall be binding upon and shall
inure to the benefit of the parties hereto and their respective Successors in
Interest; provided that no Person claiming by, through or under a Member
(whether as such Member’s Successor in Interest or otherwise), as distinct from
such Member itself, shall have any rights as, or in respect to, a Member
(including the right to approve or vote on any matter or to notice thereof).

 

Section 9.4
Confidentiality. By executing this Agreement, each Member expressly
agrees to maintain, for so long as such Person is a Member and at all times
thereafter, the confidentiality of, and not to disclose to any Person other than
the Company, another Member or a Person designated by the Company or any of
their respective financial planners, accountants, attorneys or other advisors,
any information relating to the business, financial structure, financial
position or financial results, clients or affairs of the Company, or any
Subsidiary of the Company that shall not be generally known to the public,
except as otherwise required by applicable law or by any regulatory or
self-regulatory organization having jurisdiction and except in the case of any
Member who is employed by any entity controlled by the Company in the ordinary
course of its duties; provided, however, that to the extent
consistent with applicable law, a Member may provide its customary reports to
its stockholders, limited partners, members or other owners, as the case may
be, regarding its investment in the Company. Notwithstanding the provisions of
this Section 9.4 to the contrary, in the event that any Member
desires to undertake any Transfer of its Membership Interest permitted by the
Securityholders Agreement, such Member may, upon the execution of a
confidentiality agreement (in form reasonably acceptable to the Company’s legal
counsel) by the Company and any bona fide potential Transferee, disclose to
such potential Transferee (unless such potential Transferee is a direct
competitor of the Company or its Affiliates) information of the sort otherwise
restricted by this Section 9.4 if such Member reasonably believes
such disclosure is necessary for the purpose of Transferring such Membership
Interest to the bona fide potential Transferee.

 

Section 9.5
Amendments. Subject to Section 6.10, the Board of Managers
may, to the fullest extent allowable under Delaware law, amend or modify this
Agreement; provided that if an amendment or modification (i) changes
the order of priority of distributions to any class of Units relative to any
other class of then outstanding Units, then such class of Members, by majority
vote, must approve such amendment or modification or (ii) changes the
rights of the holders of the same class of Units to share ratably in
distributions of such class, then the Members so differently treated must
approve such amendment or modification. For the avoidance of doubt the Board of
Managers may amend this Agreement without the consent of any class of Members
in order to provide for the creation and/or issuance of, with the consent of
the Vestar Majority Holders, any other class of units or other securities
(whether of an existing or new class), and to make any such other amendments as
it deems necessary or desirable to reflect such additional issuances and to add
parties to this Agreement as contemplated by this Agreement; provided  further
that no amendment shall be effective without the consent of each Member that
would be adversely affected by such amendment if such amendment (a) modifies
the limited liability of a Member, or (b) amends this Section 9.5.

 

Section 9.6
Notices. Whenever notice is required or permitted by this Agreement to
be given, such notice shall be in writing and shall be given to any Member at
such

 

47

 

Member’s
address or facsimile number shown in the Company’s books and records, or, if
given to the Company, at the following address:

 

Radiation
Therapy Investments, LLC

c/o
Vestar Capital Partners V, L.P.

245
Park Avenue

41st Floor

New
York, NY 10167

Attention:
James L. Elrod, Erin Russell and General Counsel

Facsimile:
(212) 808-4922

 

and

 

Radiation
Therapy Services, Inc.

2234
Colonial Boulevard

Fort
Myers, FL 33907

Attention:
Dr. Dosoretz

Facsimile:
(239) 931-7380

 

with
a copy (which shall not constitute notice to the Company) to:

 

Kirkland &
Ellis LLP

Citigroup
Center

153
East 53rd Street

New
York, NY 10022

Attention:
Michael Movsovich, Esq.

Facsimile:
(212) 446-6460

 

and

 

Shumaker,
Loop & Kendrick, LLP

101
East Kennedy Boulevard

Suite 2800

Tampa,
Florida 33602

Attn:
Darrell C. Smith, Esq.

Facsimile:
(813) 229-1660

 

Each
proper notice shall be effective upon any of the following: (a) personal
delivery to the recipient, (b) when sent by facsimile to the recipient
(with confirmation of receipt), (c) one Business Day after being sent to
the recipient by reputable overnight courier service (charges prepaid) or (d) three
Business Days after being deposited in the mails (first class or airmail
postage prepaid).

 

Section 9.7
Counterparts. This Agreement may be executed simultaneously in two or
more separate counterparts, any one of which need not contain the signatures of
more

 

48

 

than
one party, but each of which shall be an original and all of which together
shall constitute one and the same agreement binding on all the parties hereto.

 

Section 9.8
Power of Attorney. Each Member hereby irrevocably appoints each Manager
as such Member’s true and lawful representative and attorney-in-fact, each
acting alone, in such Member’s name, place and stead, (a) to make,
execute, sign and file all instruments, documents and certificates which, from
time to time, may be required to set forth any amendment to this Agreement or
which may be required by this Agreement or by the laws of the United States of
America, the State of Delaware or any other state in which the Company shall
determine to do business, or any political subdivision or agency thereof and (b) to
execute, implement and continue the valid and subsisting existence of the
Company or to qualify and continue the Company as a foreign limited liability
company in all jurisdictions in which the Company may conduct business. No
Manager, as representative and attorney-in-fact, however, shall have any
rights, powers or authority to amend or modify this Agreement when acting in
such capacity, except as expressly provided herein. Such power of attorney is
coupled with an interest and shall survive and continue in full force and
effect notwithstanding the subsequent withdrawal from the Company of any Member
for any reason and shall survive and shall not be affected by the disability or
incapacity of such Member.

 

Section 9.9
Entire Agreement. This Agreement, and the other documents and agreements
referred to herein or entered into concurrently herewith embody the entire
agreement and understanding of the parties hereto in respect of the subject
matter contained herein; provided that such other agreements and
documents shall not be deemed to be a part of, a modification of or an
amendment to this Agreement. There are no restrictions, promises,
representations, warranties, covenants or undertakings, other than those
expressly set forth or referred to herein. This Agreement supersedes all prior
agreements and understandings between the parties with respect to such subject
matter. Notwithstanding any other provision in this Agreement, wherever a
conflict exists between this Agreement and the Securityholders Agreement, the
provisions of the Securityholders Agreement shall control, but solely to the
extent of such conflict.

 

Section 9.10
Arbitration.

 

(a) Any dispute with regard to this Agreement
that is not resolved by mutual agreement, other than as provided in Section 9.10(b),
shall be resolved by binding arbitration before the American Arbitration
Association (“AAA”) in New York City pursuant to the rules of AAA. The
arbitration shall be governed by the United States Arbitration Act, 9 U.S.C.
§§1-16 and shall be conducted in accordance with the rules and procedures
of AAA. Any judgment upon the reward rendered by the arbitrator may be entered
in any court having jurisdiction thereof. The arbitrator’s decision shall set
forth a reasoned basis for any award of damages or findings of liability. The
arbitrator shall not have the power to award damages in excess of actual
compensatory damages and shall not multiply actual damages or award punitive
damages, and each party hereby irrevocably waives any claim to such damages.
The costs of AAA and the arbitrator shall be borne by the Company. Each party
shall bear its own costs (including, without limitation, legal fees and fees of
any experts) and out-of-pocket expenses.

 

49

 

(b) The parties hereby agree and stipulate that
in the event of any breach or violation of this Agreement by any other party
hereto, either threatened or actual, the non-breaching parties’ rights shall
include, in addition to any and all other rights available to any such
non-breaching party at law or in equity, the right to seek and obtain any and
all injunctive relief or restraining orders available to it in courts of proper
jurisdiction, so as to prohibit, bar, and restrain any and all such breaches or
violations by any other party hereto. Each of the parties hereto further agrees
that no bond need be filed in connection with any request by any other party
hereto for a temporary restraining order or for temporary or preliminary
injunctive relief.

 

Section 9.11
Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT HEREBY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM,
DEMAND, ACTION, OR CAUSE OF ACTION (A) ARISING UNDER THIS AGREEMENT OR (B) IN
ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES
HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN
EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT,
TORT, EQUITY OR OTHERWISE.

 

Section 9.12
Severability. Whenever possible, each provision of this Agreement shall
be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be invalid, illegal or
unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability shall not affect
any other provision or any other jurisdiction, but this Agreement shall be
reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provision had never been contained herein.

 

Section 9.13
Creditors. None of the provisions of this Agreement shall be for the
benefit of or enforceable by any creditors of the Company or any of its
Affiliates, and no creditor who makes a loan to the Company or any of its
Affiliates may have or acquire (except pursuant to the terms of a separate
agreement executed by the Company in favor of such creditor) at any time as a
result of making the loan any direct or indirect interest in Company profits,
losses, distributions, capital or property other than as a secured creditor.

 

Section 9.14
Waiver. No failure by any party to insist upon the strict performance of
any covenant, duty, agreement or condition of this Agreement or to exercise any
right or remedy consequent upon a breach thereof shall constitute a waiver of
any such breach or any other covenant, duty, agreement or condition.

 

Section 9.15
Further Action. The parties agree to execute and deliver all documents,
provide all information and take or refrain from taking such actions as may be
necessary or appropriate to achieve the purposes of this Agreement.

 

Section 9.16
Delivery by Facsimile or Email. This Agreement, the agreements referred
to herein, and each other agreement or instrument entered into in connection
herewith or therewith or contemplated hereby or thereby, and any amendments
hereto or thereto, to the extent signed and delivered by means of a facsimile
machine or email with scan or facsimile

 

50

 

attachment,
shall be treated in all manner and respects as an original agreement or
instrument and shall be considered to have the same binding legal effect as if
it were the original signed version thereof delivered in person. At the request
of any party hereto or to any such agreement or instrument, each other party
hereto or thereto shall re-execute original forms thereof and deliver them to
all other parties. No party hereto or to any such agreement or instrument shall
raise the use of a facsimile machine or email to deliver a signature or the
fact that any signature or agreement or instrument was transmitted or
communicated through the use of a facsimile machine or email as a defense to
the formation or enforceability of a contract, and each such party forever
waives any such defense.

 

[END OF PAGE]

[SIGNATURE PAGES FOLLOW]

 

51

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first
written above.

 

	
   

  	
  RADIATION THERAPY INVESTMENTS, LLC

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/
  Erin L. Russell

  
	
   

  	
   

  	
  Name:
  Erin L. Russell 

  Title:
  Vice President

  

 

[Signature Page to LLC Agreement]

 

 

	
   

  	
  TCW/CRESCENT MEZZANINE PARTNERS V, L.P.

  
	
   

  	
   

  
	
   

  	
  By: TCW/Crescent Mezzanine Management V, LLC

  
	
   

  	
  Its: Investment Manager

  
	
   

  	
   

  
	
   

  	
  By: TCW Asset Management Company

  
	
   

  	
  Its: Sub-Advisor

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  TCW/CRESCENT MEZZANINE PARTNERS VB, L.P.

  
	
   

  	
   

  
	
   

  	
  By: TCW/Crescent Mezzanine Management V, LLC

  
	
   

  	
  Its: Investment Manager

  
	
   

  	
   

  
	
   

  	
  By: TCW Asset Management Company

  
	
   

  	
  Its: Sub-Advisor

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  

 

[Signature Page to LLC Agreement]

 

 

	
   

  	
  TCW/CRESCENT MEZZANINE PARTNERS VC, L.P.

  
	
   

  	
   

  
	
   

  	
  By: TCW/Crescent Mezzanine Management V, LLC

  
	
   

  	
  Its: Investment Advisor

  
	
   

  	
   

  
	
   

  	
  By: TCW Asset Management Company

  
	
   

  	
  Its: Sub-Advisor

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  MAC EQUITY HOLDING, LLC

  
	
   

  	
   

  
	
   

  	
  By: MAC Capital, Ltd.

  
	
   

  	
  Its: Sole Member

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By: TCW Advisors, Inc., as attorney-in-fact

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Julia K. Haramis

  
	
   

  	
   

  	
   

  	
  Name:
  Julia K. Haramis 

  Title:
  Vice President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Scott E. Feldman

  
	
   

  	
   

  	
   

  	
  Name:
  Scott E. Feldman 

  Title:
  Vice President

  

 

[Signature Page to LLC Agreement]

 

 

	
   

  	
   

  	
  NEW YORK LIFE INVESTMENT MANAGEMENT MEZZANINE PARTNERS II,
  LP

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: NYLIM Mezzanine Partners II GenPar, LP 

  
	
   

  	
   

  	
  Its: General Partner

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: NYLIM Mezzanine Partners II GenPar GP, LLC

  
	
   

  	
   

  	
  Its: General Partner

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: 

  	
  /s/
  Authorized Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  Steven M. Benevento 

  Title:
  Executive Vice President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  NYLM MEZZANINE PARTNERS II PARALLEL FUND, LP 

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: NYLIM Mezzanine Partners II GenPar, LP 

  
	
   

  	
   

  	
  Its: General Partner

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: NYLIM Mezzanine Partners II GenPar GP, LLC

  
	
   

  	
   

  	
  Its: General Partner

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: 

  	
  /s/
  Authorized
  Signatory

  
	
   

  	
   

  	
   

  	
  Name:
  Steven M. Benevento 

  Title:
  Executive Vice President

  

 

[Signature Page to LLC Agreement]

 

 

SCHEDULE A

RADIATION THERAPY INVESTMENTS, LLC 

SCHEDULE OF UNITS

 

(as of March 25, 2008)

 

	
  Members

  	
   

  	
  Preferred Units

  	
   

  	
  Class A Units

  	
   

  	
  Class B

  Units

  	
   

  	
  Class C

  Units

  	
   

  	
  Aggregate

  Capital

  Contributions

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar Capital Partners V, L.P.

  	
   

  	
  224,728.4227

  	
   

  	
  4,260,078.2606

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  267,329,205.28

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar Capital Partners V-A, L.P.

  	
   

  	
  61,805.5188

  	
   

  	
  1,171,620.1453

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  73,521,720.30

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar Executive V, L.P.

  	
   

  	
  3,732.5095

  	
   

  	
  70,755.5469

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  4,440,064.94

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar Holdings V, L.P.

  	
   

  	
  12,365.0257

  	
   

  	
  234,398.3758

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  14,709,009.48

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar Total

  	
   

  	
  302,631.4767

  	
   

  	
  5,736,852.3286

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  360,000,000.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Vestar/ Radiation Therapy Investments, LLC

  	
   

  	
  121,893.2337

  	
   

  	
  2,310,676.6324

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  145,000,000.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  TCW/Crescent Mezzanine Partners V, L.P.  

  	
   

  	
  6,189.8643

  	
   

  	
  117,338.5452

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  7,363,249.71

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  TCW/Crescent Mezzanine Partners VB, L.P.

  	
   

  	
  998.7779

  	
   

  	
  18,933.3952

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  1,188,111.86

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  TCW/Crescent Mezzanine Partners VC, L.P.

  	
   

  	
  2,430.7155

  	
   

  	
  46,078.0086

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  2,891,495.57

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  MAC Capital, Ltd./MAC Equity Holdings, LLC

  	
   

  	
  468.3582

  	
   

  	
  8,878.4619

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  557,142.86

  	
   

  

 

 

	
  Members

  	
   

  	
  Preferred Units

  	
   

  	
  Class A Units

  	
   

  	
  Class B

  Units

  	
   

  	
  Class C

  Units

  	
   

  	
  Aggregate

  Capital

  Contributions

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  New York Life Investment Management Mezzanine
  Partners II, LP

  	
   

  	
  2,024.1801

  	
   

  	
  38,371.4961

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  2,407,895.10

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  NYLIM Mezzanine Partners II Parallel Fund, LP

  	
   

  	
  497.7488

  	
   

  	
  9,435.6066

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  592,104.90

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  TCW Total

  	
   

  	
  12,609.6449

  	
   

  	
  239,035.5137

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  15,000,000.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Daniel E. Dosoretz

  	
   

  	
  37,828.9514

  	
   

  	
  717,106.8598

  	
   

  	
  315,757.5000

  	
   

  	
  423,433.8715

  	
   

  	
  $

  	
  45,100,131.07

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  James Rubenstein

  	
   

  	
  18,704.2960

  	
   

  	
  354,569.1461

  	
   

  	
  12,630.3000

  	
   

  	
  32,664.8987

  	
   

  	
  $

  	
  22,254,778.32

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Howard Sheridan

  	
   

  	
  9,457.2379

  	
   

  	
  179,276.7149

  	
   

  	
  4,210.1000

  	
   

  	
  10,888.2996

  	
   

  	
  $

  	
  11,251,601.94

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Michael Katin

  	
   

  	
  13,450.2963

  	
   

  	
  254,971.3740

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  16,000,010.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Norton Travis

  	
   

  	
  840.6430

  	
   

  	
  15,935.7009

  	
   

  	
  42,101.0000

  	
   

  	
  108,882.9955

  	
   

  	
  $

  	
  1,015,969.40

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  David Watson

  	
   

  	
  126.0964

  	
   

  	
  2,390.3551

  	
   

  	
  12,630.3000

  	
   

  	
  32,664.8987

  	
   

  	
  $

  	
  154,790.82

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Madlyn Dornaus

  	
   

  	
  546.4179

  	
   

  	
  10,358.2056

  	
   

  	
  4,210.1000

  	
   

  	
  10,888.2996

  	
   

  	
  $

  	
  651,596.94

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Daniel Galmarini

  	
   

  	
  2,521.9101

  	
   

  	
  47,806.7442

  	
   

  	
  63,151.5000

  	
   

  	
  163,324.4933

  	
   

  	
  $

  	
  3,023,931.60

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Bruce Nakfoor

  	
   

  	
  2,101.6054

  	
   

  	
  39,839.2124

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  2,499,997.50

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Eduardo Fernandez and Angelica Guckes, tenants by
  the entireties

  	
   

  	
   840.6640  

  	
   

  	
   15,936.0993  

  	
   

  	
   8,420.2000  

  	
   

  	
   21,776.5991  

  	
   

  	
   $1,003,218.88

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Connie Mantz

  	
   

  	
  420.3215

  	
   

  	
  7,967.8505

  	
   

  	
  8,420.2000

  	
   

  	
  21,776.5991

  	
   

  	
  $

  	
  503,193.88

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  James Orr

  	
   

  	
  1,260.9645

  	
   

  	
  23,903.5514

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  1,500,000.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Hugo Myslicki

  	
   

  	
  92.8911

  	
   

  	
  1,760.8950

  	
   

  	
  6,315.1500

  	
   

  	
  16,332.4493

  	
   

  	
  $

  	
  112,895.41

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Steve Patrice

  	
   

  	
  840.6640

  	
   

  	
  15,936.0993

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  1,000,025.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Quinten Black

  	
   

  	
  109.2836

  	
   

  	
  2,071.6411

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  130,000.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  John Miksa

  	
   

  	
  126.1133

  	
   

  	
  2,390.6739

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  150,020.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Keith Miller

  	
   

  	
  210.1607

  	
   

  	
  3,983.9252

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
   250,000.00

  	
   

  

 

 

	
  Members

  	
   

  	
  Preferred Units

  	
   

  	
  Class A Units

  	
   

  	
  Class B

  Units

  	
   

  	
  Class C

  Units

  	
   

  	
  Aggregate

  Capital

  Contributions

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Larry Silverman

  	
   

  	
  68.3022

  	
   

  	
  1,294.7757

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  $

  	
  81,250.00

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Ricardo Andisco

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  16,840.4000

  	
   

  	
  43,553.1982

  	
   

  	
  $

  	
  6,387.76

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  James Eaton

  	
   

  	
  420.3215

  	
   

  	
  7,967.8505

  	
   

  	
  4,210.1000

  	
   

  	
  10,888.2996

  	
   

  	
  $

  	
  501,596.94

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Andrew Woods

  	
   

  	
  420.3215

  	
   

  	
  7,967.8505

  	
   

  	
  4,210.1000

  	
   

  	
  10,888.2996

  	
   

  	
  $

  	
  501,596.94

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Margarita Suarez

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  2,105.0500

  	
   

  	
  5,444.1498

  	
   

  	
  $

  	
  798.47

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Management Total

  	
   

  	
  90,387.4622

  	
   

  	
  1,713,435.5253

  	
   

  	
  505,212.0000

  	
   

  	
  913,407.3514

  	
   

  	
  $

  	
  107,693,790.87

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Reserve

  	
   

  	
  0.0000

  	
   

  	
  0.0000

  	
   

  	
  21,050.5000

  	
   

  	
  54,441.4978

  	
   

  	
  $

  	
  0

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Total

  	
   

  	
  527,521.8175

  	
   

  	
  10,000,000.0000

  	
   

  	
  526,262.5000

  	
   

  	
  967,848.8492

  	
   

  	
  $

  	
  627,693,790.87

  	
   

  

 

 

SCHEDULE B 

SCHEDULE OF MEMBERS

 

(as of March 25, 2008)

 

	
  Name of Member

  	
   

  	
  Address of Member

  
	
   

  	
   

  	
   

  
	
  VESTAR
  CAPITAL PARTNERS V, L.P.

  	
   

  	
  c/o
  Vestar Capital Partners 

  245 Park Avenue, 41st Floor 

  New York, NY 10167 

  Attn: James L. Elrod, Erin Russell and General Counsel 

  Facsimile: (212) 808-4922

  
	
   

  	
   

  	
   

  
	
  VESTAR
  CAPITAL PARTNERS V-A, L.P.

  	
   

  	
  c/o
  Vestar Capital Partners

  245 Park Avenue, 41st Floor 

  New York, NY 10167 

  Attn: James L. Elrod, Erin Russell and General Counsel 

  Facsimile: (212) 808-4922

  
	
   

  	
   

  	
   

  
	
  VESTAR
  EXECUTIVE V, L.P.

  	
   

  	
  c/o
  Vestar Capital Partners 

  245 Park Avenue, 41st Floor 

  New York, NY 10167 

  Attn: James L. Elrod, Erin Russell and General Counsel 

  Facsimile: (212) 808-4922

  
	
   

  	
   

  	
   

  
	
  VESTAR
  HOLDINGS V, LP.

  	
   

  	
  c/o
  Vestar Capital Partners 

  245 Park Avenue, 41st Floor 

  New York, NY 10167 

  Attn: James L. Elrod, Erin Russell and General Counsel

  Facsimile: (212) 808-4922

  
	
   

  	
   

  	
   

  
	
  VESTAR/RADIATION
  THERAPY INVESTMENTS, LLC

  	
   

  	
  c/o
  Vestar Capital Partners 

  245 Park Avenue, 41st Floor 

  New York, NY 10167 

  Attn: James L. Elrod, Erin Russell and General Counsel

  Facsimile: (212) 808-4922

  
	
   

  	
   

  	
   

  
	
  TCW/CRESCENT
  MEZZANINE PARTNERS V, L.P.

  	
   

  	
  11100
  Santa Monica Blvd., Suite 2050 

  Los Angeles, CA 90025

  
	
   

  	
   

  	
   

  
	
  TCW/CRESCENT
  MEZZANINE PARTNERS VB, L.P.

  	
   

  	
  11100
  Santa Monica Blvd., Suite 2050 

  Los Angeles, CA 90025

  
	
   

  	
   

  	
   

  
	
  TCW/CRESCENT
  MEZZANINE PARTNERS VC, L.P.

  	
   

  	
  11100
  Santa Monica Blvd., Suite 2050 

  Los Angeles, CA 90025

  
	
   

  	
   

  	
   

  
	
  NEW
  YORK LIFE INVESTMENT MANAGEMENT MEZZANINE PARTNERS II, L.P.

  	
   

  	
  51
  Madison Avenue 

  16th Floor 

  New York, New York 10010

  
	
   

  	
   

  	
   

  
	
  NYLIM
  MEZZANINE PARTNERS II PARALLEL FUND, L.P.

  	
   

  	
  51
  Madison Avenue 

  16th Floor 

  New York, New York 10010

  

 

 

	
  ANDISCO, RICARDO

  	
   

  	
  6916
  Erin Marie Ct. 

  Fort Myers, FL 33919

  
	
   

  	
   

  	
   

  
	
  BLACK, QUINTEN C.

  	
   

  	
  816
  Quill Gordon Ct. 

  Biltmore Lake, NC 28715

  
	
   

  	
   

  	
   

  
	
  DORNAUS, MADLYN

  	
   

  	
  18930
  Knoll Landing Dr. 

  Fort Meyers, FL. 33908

  
	
   

  	
   

  	
   

  
	
  DOSORETZ, DANIEL E.

  	
   

  	
  13221
  Ponderosa Way 

  Fort Meyers, FL. 33907

  
	
   

  	
   

  	
   

  
	
  EATON, JAMES

  	
   

  	
  P.O. Box
  1713 

  Tallahassee, Fl. 32301

  
	
   

  	
   

  	
   

  
	
  FERNANDEZ, EDUARDO

  	
   

  	
  4351-NE
  22 Avenue 

  Fort Lauderdale, Fl. 33308

  
	
   

  	
   

  	
   

  
	
  GALMARINI, DANIEL H.

  	
   

  	
  7051
  Pelican Colony Blvd. #1903 

  Bonita Springs, FL. 34134

  
	
   

  	
   

  	
   

  
	
  KATIN, MICHAEL J.

  	
   

  	
  2234
  Colonial Blvd. 

  Fort Meyers, FL. 33907

  
	
   

  	
   

  	
   

  
	
  MANTZ, CONSTANTINE A.

  	
   

  	
  1676
  Morning Glory Court 

  Fort Meyers, FL. 33901

  
	
   

  	
   

  	
   

  
	
  MIKSA, JOHN W.

  	
   

  	
  2071
  SE 28th St. 

  Cape Coral, FL. 33904

  
	
   

  	
   

  	
   

  
	
  MILLER, KEITH L.

  	
   

  	
  12731
  Terebella Way 

  Fort Meyers, FL. 33912

  
	
   

  	
   

  	
   

  
	
  MYSLICKI, HUGO H.

  	
   

  	
  9660
  Falconer Way 

  Estero, FL. 33928

  
	
   

  	
   

  	
   

  
	
  NAKFOOR, BRUCE

  	
   

  	
  340
  Colony Drive 

  Naples, FL. 34108

  
	
   

  	
   

  	
   

  
	
  ORR, JAMES W.

  	
   

  	
  21
  George Town 

  Fort Meyers, FL.

  
	
   

  	
   

  	
   

  
	
  PATRICE, STEPHEN J.

  	
   

  	
  245
  Osprey Point Drive 

  Osprey, FL. 34229

  
	
   

  	
   

  	
   

  
	
  RUBENSTEIN, JAMES

  	
   

  	
  13301
  Ponderosa Way
  Fort Meyers, FL. 33907

  
	
   

  	
   

  	
   

  
	
  SHERIDAN, HOWARD M.

  	
   

  	
  842
  Cal Cove Drive 

  Fort Meyers, FL. 33919

  
	
   

  	
   

  	
   

  
	
  SILVERMAN, LARRY

  	
   

  	
  7691
  Donald Ross Rd W 

  Sarasota, FL. 34240

  
	
   

  	
   

  	
   

  
	
  SUAREZ, MARGARITA

  	
   

  	
  7710
  Ahoy Avenue 

  Naples, FL 34109

  
	
   

  	
   

  	
   

  
	
  TRAVIS, NORTON L.

  	
   

  	
  350
  East 57th Street - Apt. 9A 

  New York, NY. 10022

  
	
   

  	
   

  	
   

  
	
  WATSON, DAVID N.T.

  	
   

  	
  7385
  Stonegate Dr. 

  Naples, FL. 34109

  
	
   

  	
   

  	
   

  
	
  WOODS, ANDREW

  	
   

  	
  12
  Brierleigh Court 

  Lutherville, MD. 21093Exhibit 10.91

 

EXECUTION VERSION

 

 

GUARANTY AND COLLATERAL AGREEMENT

 

dated as of

 

February 21, 2008

 

among

 

RADIATION THERAPY SERVICES HOLDINGS, INC.,

 

RADIATION THERAPY SERVICES, INC.
  (as successor to RTS MERGERCO, INC.),

 

as Borrower

 

THE SUBSIDIARIES OF RADIATION THERAPY SERVICES, INC. 

FROM TIME TO TIME PARTY HERETO

 

and

 

WACHOVIA BANK, NATIONAL ASSOCIATION

 

as Collateral Agent

 

 

 

TABLE OF CONTENTS

 

	
   

  	
   

  	
   

  	
   

  	
  Page

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE I

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  DEFINITIONS

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 1.01.

  	
   

  	
  Credit
  Agreement

  	
   

  	
  1

  
	
  Section 1.02.

  	
   

  	
  Other
  Defined Terms

  	
   

  	
  1

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE II

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  GUARANTEE

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 2.01.

  	
   

  	
  Guarantee

  	
   

  	
  4

  
	
  Section 2.02.

  	
   

  	
  Guarantee
  of Payment

  	
   

  	
  4

  
	
  Section 2.03.

  	
   

  	
  No
  Limitations

  	
   

  	
  5

  
	
  Section 2.04.

  	
   

  	
  Reinstatement

  	
   

  	
  6

  
	
  Section 2.05.

  	
   

  	
  Agreement
  To Pay; Subrogation

  	
   

  	
  6

  
	
  Section 2.06.

  	
   

  	
  Information

  	
   

  	
  6

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE III

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  PLEDGE OF SECURITIES

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 3.01.

  	
   

  	
  Pledge

  	
   

  	
  6

  
	
  Section 3.02.

  	
   

  	
  Delivery
  of the Pledged Collateral

  	
   

  	
  7

  
	
  Section 3.03.

  	
   

  	
  Representations,
  Warranties and Covenants

  	
   

  	
  8

  
	
  Section 3.04.

  	
   

  	
  Certification
  of Limited Liability Company and Limited Partnership Interests

  	
   

  	
  9

  
	
  Section 3.05.

  	
   

  	
  Registration
  in Nominee Name; Denominations

  	
   

  	
  9

  
	
  Section 3.06.

  	
   

  	
  Voting
  Rights; Dividends and Interest

  	
   

  	
  10

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE IV

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  SECURITY INTERESTS IN PERSONAL PROPERTY

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 4.01.

  	
   

  	
  Security
  Interest

  	
   

  	
  11

  
	
  Section 4.02.

  	
   

  	
  Representations
  and Warranties

  	
   

  	
  13

  
	
  Section 4.03.

  	
   

  	
  Covenants

  	
   

  	
  14

  
	
  Section 4.04.

  	
   

  	
  Other
  Actions

  	
   

  	
  15

  
	
  Section 4.05.

  	
   

  	
  Covenants
  Regarding Patent, Trademark and Copyright Collateral

  	
   

  	
  16

  

 

i

 

	
   

  	
   

  	
   

  	
   

  	
  Page

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE V

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  REMEDIES

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 5.01.

  	
   

  	
  Remedies
  upon Default

  	
   

  	
  18

  
	
  Section 5.02.

  	
   

  	
  Application
  of Proceeds

  	
   

  	
  19

  
	
  Section 5.03.

  	
   

  	
  Grant
  of License To Use Intellectual Property

  	
   

  	
  20

  
	
  Section 5.04.

  	
   

  	
  Securities
  Act

  	
   

  	
  20

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE VI

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  INDEMNITY, SUBROGATION AND SUBORDINATION

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 6.01.

  	
   

  	
  Indemnity
  and Subrogation

  	
   

  	
  21

  
	
  Section 6.02.

  	
   

  	
  Contribution
  and Subrogation

  	
   

  	
  21

  
	
  Section 6.03.

  	
   

  	
  Subordination

  	
   

  	
  22

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ARTICLE VII

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  MISCELLANEOUS

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Section 7.01.

  	
   

  	
  Notices

  	
   

  	
  22

  
	
  Section 7.02.

  	
   

  	
  Waivers;
  Amendment

  	
   

  	
  22

  
	
  Section 7.03.

  	
   

  	
  Collateral
  Agent’s Fees and Expenses

  	
   

  	
  23

  
	
  Section 7.04.

  	
   

  	
  Successors
  and Assigns

  	
   

  	
  23

  
	
  Section 7.05.

  	
   

  	
  Survival
  of Agreement

  	
   

  	
  23

  
	
  Section 7.06.

  	
   

  	
  Counterparts;
  Effectiveness; Several Agreement

  	
   

  	
  23

  
	
  Section 7.07.

  	
   

  	
  Severability

  	
   

  	
  24

  
	
  Section 7.08.

  	
   

  	
  Right
  of Set-Off

  	
   

  	
  24

  
	
  Section 7.09.

  	
   

  	
  Governing
  Law; Jurisdiction; Consent to Service of Process

  	
   

  	
  24

  
	
  Section 7.10.

  	
   

  	
  WAIVER
  OF JURY TRIAL

  	
   

  	
  25

  
	
  Section 7.11.

  	
   

  	
  Headings

  	
   

  	
  25

  
	
  Section 7.12.

  	
   

  	
  Security
  Interest Absolute

  	
   

  	
  25

  
	
  Section 7.13.

  	
   

  	
  Termination
  or Release

  	
   

  	
  26

  
	
  Section 7.14.

  	
   

  	
  Additional
  Subsidiaries

  	
   

  	
  26

  
	
  Section 7.15.

  	
   

  	
  Collateral
  Agent Appointed Attorney-in-Fact

  	
   

  	
  26

  
	
  Section 7.16.

  	
   

  	
  Further
  Assurances

  	
   

  	
  27

  

 

ii

 

	
  Schedules

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Schedule I

  	
   

  	
  Subsidiary
  Guarantors

  
	
  Schedule II

  	
   

  	
  Pledged
  Stock; Debt Securities

  
	
  Schedule III

  	
   

  	
  Intellectual
  Property

  
	
  Schedule IV

  	
   

  	
  Commercial
  Tort Claims

  
	
   

  	
   

  	
   

  
	
  Exhibits

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Exhibit I

  	
   

  	
  Form of
  Supplement

  
	
  Exhibit II

  	
   

  	
  Form of
  Copyright Security Agreement

  
	
  Exhibit III

  	
   

  	
  Form of
  Patent Security Agreement

  
	
  Exhibit IV

  	
   

  	
  Form of
  Trademark Security Agreement

  

 

iii

 

GUARANTEE
AND COLLATERAL AGREEMENT (this “Agreement”) dated as of February 21,
2008, among RADIATION THERAPY SERVICES HOLDINGS, INC., a Delaware
corporation (“Parent”), RTS MERGERCO, INC., a Florida corporation
that is a wholly owned subsidiary of Parent (to be merged with and into the
Company (as hereinafter defined), “MergerSub”), RADIATION THERAPY
SERVICES, INC., a Florida corporation (“Borrower”), Subsidiaries of
Borrower from time to time party hereto (the “Subsidiary Guarantors”)
and WACHOVIA BANK, NATIONAL ASSOCIATION, as collateral agent (the “Collateral
Agent”) for the Secured Parties. The Subsidiary Guarantors, together with
Parent, are referred to herein as the “Guarantors”, and the Subsidiary
Guarantors, together with MergerSub and Borrower, are referred to herein as the
“Grantors.”

 

Reference
is made to the Credit Agreement dated as of February 21, 2008 (as amended,
supplemented or otherwise modified from time to time, the “Credit Agreement”),
among Parent, Borrower, the Lenders party thereto, Wachovia Bank, National
Association, as administrative agent (the “Administrative Agent”) for
the Secured Parties and as Collateral Agent and the other financial
institutions party thereto. The Lenders have agreed to extend credit to
Borrower subject to the terms and conditions set forth in the Credit Agreement.
The obligations of the Lenders to extend such credit are conditioned upon,
among other things, the execution and delivery of this Agreement. Parent,
Borrower and the Subsidiary Guarantors will derive substantial benefits from
the extension of credit to Borrower pursuant to the Credit Agreement and are
willing to execute and deliver this Agreement in order to induce the Lenders to
extend such credit. Accordingly, the parties hereto agree as follows:

 

ARTICLE I

 

Definitions

 

Section 1.01.
Credit Agreement.

 

(a) Capitalized
terms used in this Agreement and not otherwise defined in this Agreement have
the meanings specified in the Credit Agreement. All terms defined in the New
York UCC (as defined in this Agreement) and not defined in this Agreement have
the meanings specified therein.

 

(b) The
rules of construction specified in Section 1.2 of the Credit
Agreement also apply to this Agreement, mutatis mutandis.

 

Section 1.02.
Other Defined Terms. As used in this Agreement, the following terms have
the meanings specified below:

 

“Article 9
Collateral” has the meaning assigned to such term in Section 4.01.

 

“Collateral” means Article 9
Collateral and Pledged Collateral. 

 

 

“Contributing
Party” shall have the meaning assigned to such term in Section 6.02.

 

“Copyright
License” means any written agreement, now or hereafter in effect, granting
any right to any third party under any U.S. Copyright now or hereafter owned by
any Grantor or that such Grantor otherwise has the right to license, or
granting any right to any Grantor under any Copyright now or hereafter owned by
any third party, and all rights of any Grantor under any such agreement.

 

“Copyright
Security Agreement” means an agreement substantially in the form annexed
hereto as Exhibit II.

 

“Copyrights”
means all of the following now owned or hereafter acquired by any Grantor: (a) all
copyright rights in any work subject to the copyright laws of the United
States, whether as author, assignee, transferee or otherwise and (b) all
registrations and applications for registration of any such copyright in the
United States, including registrations, recordings, supplemental registrations
and pending applications for registration in the United States Copyright
Office, including those listed on Schedule III.

 

“Credit
Agreement” has the meaning assigned to such term in the preliminary
statement in this Agreement.

 

“Federal
Securities Laws” has the meaning assigned to such term in Section 5.04.

 

“General
Intangibles” means all “General Intangibles” of any Grantor as defined in Section 9-102(42)
of the New York UCC.

 

“Grantors”
has the meaning assigned to such term in the preliminary statement in this
Agreement.

 

“Guarantors”
has the meaning assigned to such term in the preliminary statement in this
Agreement.

 

“Instrument”
has the meaning specified in Article 9 of the New York UCC.

 

“Intellectual
Property” means all intellectual property of any Grantor of every kind and
nature now owned or hereafter acquired by any Grantor, including inventions,
designs, Patents, Copyrights, Trademarks, trade secrets, confidential or
proprietary technical and business information, know-how or other data or
information to the extent protectable by applicable law, software and databases
and related documentation.

 

“Investment
Property” means a security, whether certificated or uncertificated,
Security Entitlement, Securities Account, Commodity Contract or Commodity
Account.

 

“License”
means any Patent License, Trademark License or Copyright License.

 

“New
York UCC” means the Uniform Commercial Code as from time to time in effect
in the State of New York.

 

2

 

“Patent
License” means any written agreement, now or hereafter in effect, granting
to any third party any right to make, use or sell any invention on which a U.S.
Patent, now or hereafter owned by any Grantor or that any Grantor otherwise has
the right to license, is in existence, or granting to any Grantor any right to
make, use or sell any invention on which a U.S. Patent, now or hereafter owned
by any third party, is in existence, and all rights of any Grantor under any
such agreement.

 

“Patent
Security Agreement” means an agreement substantially in the form annexed
hereto as Exhibit III.

 

“Patents”
means all of the following now owned or hereafter acquired by any Grantor: (a) all
letters patent of the United States, all issuances and recordings thereof, and
all applications for letters patent of the United States, including issuances,
recordings and pending applications in the United States Patent and Trademark
Office, including those listed on Schedule III, and (b) all reissues,
continuations, divisions, continuations-in-part, renewals or extensions
thereof, including the right to make, use and/or sell the inventions disclosed
or claimed therein.

 

“Pledged
Collateral” has the meaning assigned to such term in Section 3.01.

 

“Pledged
Notes” has the meaning assigned to such term in Section 3.01.

 

“Pledged
Securities” means any promissory notes, stock certificates or other
securities now or hereafter included in the Pledged Collateral, including all
certificates, instruments or other documents representing or evidencing any
Pledged Collateral.

 

“Pledged
Stock” has the meaning assigned to such term in Section 3.01.

 

“Proceeds”
has the meaning specified in Section 9-102 of the New York UCC.

 

“Requirements
of Law” shall mean, collectively, any and all requirements of any
Governmental Authority including any and all laws, judgments, orders, decrees,
ordinances, rules, regulations, statutes or case law.

 

“Secured
Obligations” means collectively, (a) the Obligations, (b) the due
and punctual payment and performance in full of all obligations of each Loan
Party to the applicable Qualified Counterparty under each Swap Agreement
entered into with any Qualified Counterparty and (c) the due and punctual
payment and performance of all Obligations of the Loan Parties (including
overdrafts and related liabilities) to the applicable Cash Management Bank
under each Cash Management Agreement.

 

“Security
Interest” has the meaning assigned to such term in Section 4.01.

 

“Subsidiary
Guarantors” means (a) the Subsidiaries identified on Schedule I and (b) each
other Subsidiary that becomes a party to this Agreement as a Subsidiary Guarantor
through the execution of an agreement substantially in the form annexed hereto
as Exhibit I, after the Closing Date.

 

3

 

“Trademark
License” means any written agreement, now or hereafter in effect, granting
to any third party any right to use any U.S. Trademark now or hereafter owned
by any Grantor or that any Grantor otherwise has the right to license, or
granting to any Grantor any right to use any trademark now or hereafter owned
by any third party, and all rights of any Grantor under any such agreement.

 

“Trademark
Security Agreement” means an agreement substantially in the form annexed
hereto as Exhibit IV.

 

“Trademarks”
means all of the following now owned or hereafter acquired by any Grantor: (a) all
trademarks, service marks, trade names, domain names, corporate names, company
names, business names, fictitious business names, trade styles, trade dress,
logos, designs and other source or business identifiers, now existing or
hereafter adopted or acquired, all registrations and recordings thereof, and
all registration and recording applications filed in connection therewith,
including registrations and registration applications in the United States
Patent and Trademark Office or any similar offices in any State of the United
States or any political subdivision thereof, and all renewals thereof,
including those listed on Schedule III, and (b) all goodwill associated
therewith or symbolized thereby.

 

ARTICLE II

 

Guarantee

 

Section 2.01.
Guarantee.

 

(a) Each
Guarantor unconditionally guarantees, jointly with the other Guarantors and
severally, as a primary obligor and not merely as a surety, the due and
punctual payment and performance in full when due of the Secured Obligations.
Each Guarantor further agrees that the Secured Obligations may be extended or
renewed, in whole or in part, or amended or modified, without notice to or
further assent from it, and that it will remain bound upon its guarantee
notwithstanding any extension, renewal, amendment or modification of the
Secured Obligations. To the extent permitted by applicable law, each Guarantor
waives, presentment to, demand of payment from and protest to Borrower or any
other Loan Party of the Secured Obligations and also waives notice of
acceptance of its guarantee and notice of protest for nonpayment.

 

(b) Anything
herein or in any other Loan Document to the contrary notwithstanding, the
maximum liability of each Guarantor hereunder and under the other Loan
Documents shall in no event exceed the amount which can be guaranteed by such
Guarantor under applicable federal and state laws relating to fraudulent
conveyances or transfers, or any applicable laws relating to corporate law or
the insolvency of debtors (after giving effect to the right of contribution
established in Section 6.02).

 

Section 2.02.
Guarantee of Payment. Each Guarantor further agrees that its guarantee
hereunder constitutes a guarantee of payment when due and not of collection,
and, to the extent permitted by applicable law, waives any right to require
that any resort be had by the Collateral Agent or any other Secured Party to
any security held for the payment of the Secured

 

4

 

Obligations
or to any balance of any Deposit Account or credit on the books of the
Collateral Agent or any other Secured Party in favor of Borrower or any other
Person.

 

Section 2.03.
No Limitations.

 

(a) Except
for termination of a Guarantor’s obligations hereunder as expressly provided in
Section 7.13, and except to the extent the Secured Obligations have been
paid in cash, the obligations of each Guarantor hereunder shall not be subject
to any reduction, limitation, impairment or termination for any reason,
including any claim of waiver, release, surrender, alteration or compromise,
and shall not be subject to any defense or set-off, counterclaim, recoupment or
termination whatsoever (other than defense of payment or performance) by reason
of the invalidity, illegality or unenforceability of the Secured Obligations or
otherwise. Without limiting the generality of the foregoing, the obligations of
each Guarantor hereunder shall not be discharged or impaired or otherwise
affected by (i) the failure of the Collateral Agent or any other Secured
Party to assert any claim or demand or to enforce any right or remedy under the
provisions of any Loan Document or otherwise; (ii) any rescission, waiver,
amendment or modification of, or any release from any of the terms or
provisions of, any Loan Document or any other agreement, including with respect
to any other Guarantor under this Agreement; (iii) the release of,
impairment of or failure to perfect any Lien held by the Collateral Agent or
any other Secured Party for the payment and performance of the Secured
Obligations or any of them; (iv) any default, failure or delay, willful or
otherwise, in the performance of the Secured Obligations; or (v) any other
act or omission that may or might in any manner or to any extent vary the risk
of any Guarantor or otherwise operate as a discharge of any Guarantor as a
matter of law or equity (other than the payment in full in cash of the Secured
Obligations (other than contingent indemnification obligations)). To the extent
not prohibited under the Credit Agreement, each Guarantor expressly authorizes
the Collateral Agent during the continuance of an Event of Default in
accordance with the terms hereof and the Credit Agreement (i) to take and
hold security for the payment and performance of the Secured Obligations, (ii) to
exchange, waive or release any or all such security (with or without
consideration), (iii) to enforce or apply such security and direct the
order and manner of any sale thereof in its sole discretion or (iv) to
release or substitute any one or more other guarantors or obligors upon or in
respect of the Secured Obligations, all without affecting the obligations of
any Guarantor hereunder.

 

(b) To
the fullest extent permitted by applicable law, each Guarantor waives any
defense based on or arising out of any defense of Borrower or any other Loan
Party or the unenforceability of the Secured Obligations or any part thereof
from any cause, or the cessation from any cause of the liability of Borrower or
any other Loan Party, other than defense of performance or payment in full in cash
of all the Secured Obligations. To the extent not prohibited under the Credit
Agreement, the Collateral Agent may, at its election, foreclose on any security
held by one or more of them by one or more judicial or nonjudicial sales,
accept an assignment of any such security in lieu of foreclosure, compromise or
adjust any part of the Secured Obligations, make any other accommodation with
Borrower or any other Loan Party or exercise any other right or remedy
available to them against Borrower or any other Loan Party, without affecting
or impairing in any way the liability of any Guarantor hereunder except to the
extent the Secured Obligations have been fully paid in full in cash. To the
fullest extent permitted by applicable law, each Guarantor waives any defense
arising out of any such election even though such election operates, pursuant
to applicable law, to impair or to extinguish any

 

5

 

right
of reimbursement or subrogation or other right or remedy of such Guarantor
against Borrower or any other Loan Party, as applicable, or any security.

 

Section 2.04.
Reinstatement. Each of the Guarantors agrees that its guarantee
hereunder shall continue to be effective or be reinstated, as applicable, if
and to the extent at any time payment, or any part thereof, of any Secured
Obligation is rescinded or must otherwise be restored by the Collateral Agent
or any other Secured Party upon the bankruptcy or reorganization of Borrower,
any other Loan Party or otherwise.

 

Section 2.05.
Agreement To Pay; Subrogation. In furtherance of the foregoing and not
in limitation of any other right that the Collateral Agent or any other Secured
Party has at law or in equity against any Guarantor by virtue hereof, upon the
failure of Borrower or any other Loan Party to pay any Secured Obligation when
and as the same shall become due, whether at maturity, by acceleration, after
notice of prepayment or otherwise, each Guarantor hereby promises to and will
forthwith pay, or cause to be paid, to the Collateral Agent for distribution to
the applicable Secured Parties in cash the amount of such unpaid Secured
Obligation. Upon payment by any Guarantor of any sums to the Collateral Agent
as provided above, all rights of such Guarantor against Borrower or any other
Loan Party arising as a result thereof by way of right of subrogation,
contribution, reimbursement, indemnity or otherwise shall in all respects be
subject to Article VI.

 

Section 2.06.
Information. Each Guarantor assumes all responsibility for being and
keeping itself informed of Borrower’s and each other Loan Party’s financial
condition and assets and of all other circumstances bearing upon the risk of
nonpayment of the Secured Obligations and the nature, scope and extent of the
risks that such Guarantor assumes and incurs hereunder and agrees that none of
the Collateral Agent or the other Secured Parties will have any duty to advise
such Guarantor of information known to it or any of them regarding such
circumstances or risks.

 

ARTICLE III

 

Pledge of Securities

 

Section 3.01.
Pledge. As security for the payment or performance, as applicable, in
full of the Secured Obligations, each Grantor hereby grants to the Collateral
Agent and its permitted successors and assigns, for the benefit of the Secured
Parties, a security interest in, all of such Grantor’s right, title and
interest in, to and under (a) the Capital Stock of each Domestic
Subsidiary and each first-tier Foreign Subsidiary owned by it and listed on
Schedule II, and any other Capital Stock issued by any Domestic Subsidiary or
first-tier Foreign Subsidiary and obtained in the future by such Grantor and,
to the extent certificated, the certificates representing securities in all
such Capital Stock (the “Pledged Stock”), provided that the
Pledged Stock shall not include more than 65% of the outstanding Capital Stock
of any such Foreign Subsidiary; (b)(i) the debt securities or promissory
notes listed opposite the name of such Grantor on Schedule II, (ii) any
debt securities or promissory notes in excess of $2,000,000 issued after the
Closing Date to such Grantor by Borrower and each Subsidiary (collectively, the
“Pledged Notes”); (c) subject to Section 3.06, all payments of
dividends and other property from time to

 

6

 

 

time
received, receivable or otherwise distributed in respect of, in exchange for or
upon the conversion of, the securities referred to in clauses (a) and (b) above;
(d) subject to Section 3.06, all rights and privileges of such
Grantor with respect to the securities and other property referred to in
clauses (a) and(b); (e) subject to Section 3.06, all rights and
privileges of such Grantor with respect to the Pledged Stock and the Pledged
Notes; and (f) all Proceeds of any of the foregoing (the items referred to
in clauses (a) through (f) above being collectively referred to as
the “Pledged Collateral”). Notwithstanding the foregoing, (A) Pledged
Stock shall not include (v) Capital Stock of Immaterial Subsidiaries (w) Capital
Stock of Unrestricted Subsidiaries, (x) Capital Stock of Insurance
Subsidiaries, (y) Capital Stock of a Non Wholly-Owned Subsidiary to the
extent prohibited by (or requiring consent (other than consent of any Grantor)
pursuant to) such Non Wholly-Owned Subsidiary’s organizational document and
related agreements, or (z) any other Capital Stock if granting a security
interest in such Capital Stock is prohibited by (or requiring consent (other
than consent of any Grantor) pursuant to) applicable law or to the extent that
granting a security interest in such Capital Stock is prohibited by a
shareholder, joint-venture or similar agreement, except to the extent that the
provision of such shareholder, joint-venture or similar agreement giving rise
to such prohibition is ineffective under applicable law, and (B) Pledged
Collateral shall not include any assets as to which the Administrative Agent
and the Borrower have reasonably determined in writing that the burden or cost
of obtaining a security interest in such assets outweighs the benefit to the
Secured Parties of the security to be afforded thereby and the Grantors shall
not be required to perfect a security interest in any item of Pledged
Collateral as to which the Administrative Agent and the Borrower have
reasonably determined in writing that the burden or cost of perfecting a
security interest in such Pledged Collateral outweighs the benefit to the
Secured Parties of the security to be afforded thereby.

 

TO
HAVE AND TO HOLD the Pledged Collateral, together with all right, title,
interest, powers, privileges and preferences pertaining or incidental thereto,
unto the Collateral Agent, its successors and assigns, for the ratable benefit
of the Secured Parties, forever, subject, however, to the terms,
covenants and conditions hereinafter set forth.

 

Section 3.02.
Delivery of the Pledged Collateral.

 

(a) Each
Grantor represents and warrants that all certificates, agreements or
instruments representing or evidencing the Pledged Collateral (except as set
forth in this Section 3.02) in existence on the date hereof have been
delivered to the Collateral Agent in suitable form for transfer by delivery or
accompanied by duly executed instruments of transfer or assignment in blank.
Each Grantor agrees promptly to deliver or cause to be delivered to the Collateral
Agent any and all certificated Pledged Securities acquired after the Closing
Date.

 

(b) Each
Grantor will cause any Indebtedness for borrowed money in excess of
$2,000,000.00 owed to such Grantor by any Person to be evidenced by a duly
executed promissory note to be pledged and delivered to the Collateral Agent
pursuant to the terms hereof.

 

(c) Upon
delivery thereof to the Collateral Agent, (i) any certificated Pledged
Securities shall be accompanied by undated stock powers duly executed in blank
or other undated instruments of transfer reasonably satisfactory to the
Collateral Agent and (ii) all other property comprising part of the
Pledged Collateral shall be accompanied by proper instruments of assignment
reasonably satisfactory to the Collateral Agent duly executed by the applicable

 

7

 

Grantor.
Each delivery of Pledged Securities shall be accompanied by a schedule
describing such Pledged Securities, which schedule shall be attached hereto as
a supplement to Schedule II and made a part hereof, provided that
failure to attach any such schedule hereto shall not affect the validity of
such pledge of such Pledged Securities. Each schedule so delivered shall
supplement any prior schedules so delivered.

 

Section 3.03.
Representations, Warranties and Covenants. The Grantors jointly and
severally represent, warrant and covenant to and with the Collateral Agent, for
the benefit of the Secured Parties, as and to the extent required under Section 5.2
of the Credit Agreement that:

 

(a) Schedule II correctly sets forth (i) the
percentage of the issued and outstanding shares, membership interests,
partnership interests, units or other comparable measure of each class of the
Capital Stock held by any Grantor and (ii) all of debt securities and
promissory notes owned by each Grantor in excess of $2,000,000;

 

(b) the Pledged Stock and Pledged Notes have
been duly and validly authorized and issued by the issuers thereof and (i) in
the case of Pledged Stock, are fully paid and nonassessable and (ii) in
the case of Pledged Notes, are legal, valid and binding obligations of the
issuers thereof;

 

(c) except for the security interests granted
hereunder, each of the Grantors (i) is and, subject to any transfers made
in compliance with the Credit Agreement, will continue to be the direct owner,
beneficially and of record, of the Pledged Securities indicated on Schedule II
as owned by such Grantor, (ii) holds the same free and clear of all Liens,
other than Liens created by any Loan Document and Liens permitted by Section 7.3
of the Credit Agreement and (iii) will not create or permit to exist any
Lien on, the Pledged Collateral, other than Liens created by any Loan Document,
Liens permitted by Section 7.3 of the Credit Agreement and transfers made
in compliance with the Credit Agreement; provided that nothing in this
Agreement shall prevent any Grantor from discontinuing the operation or
maintenance of any of its assets or properties if such discontinuance is
permitted by the Credit Agreement;

 

(d) except for restrictions and limitations
imposed by (i) the Loan Documents, (ii) securities laws generally or (iii) customary
provisions in joint venture agreements relating to purchase options, rights of
first refusal, tag, drag, call or similar rights of a third party that owns
Capital Stock in such joint venture, the Pledged Collateral is and will
continue to be freely transferable and assignable;

 

(e) each of the Grantors has the corporate or
other organizational power and authority to pledge the Pledged Collateral
pledged by it hereunder in the manner hereby done or contemplated;

 

(f) no consent or approval of any Governmental
Authority, any securities exchange or any other Person is necessary to the
validity of the pledge effected hereby (other than (x) as such as have
been obtained and are in full force and effect, (y) filings necessary to
perfect the security interest or (z) the failure of which to obtain could
not

 

8

 

reasonably
be expected, individually or in the aggregate, to have a Material Adverse
Effect); and

 

(g) subject to clauses (c) and (d) of
this Section 3.03, by virtue of the execution and delivery by the Grantors
of this Agreement, when any certificated Pledged Securities are delivered to
the Collateral Agent in accordance with this Agreement, the Collateral Agent
will obtain, for the benefit of the Secured Parties, a legal, valid and
perfected lien under U.S. law upon and security interest in such certificated
Pledged Securities as security for the payment and performance of the Secured
Obligations.

 

Section 3.04.
Certification of Limited Liability Company and Limited Partnership Interests.

 

(a) Each
Grantor acknowledges and agrees that, to the extent any membership interest in
any limited liability company or partnership interest in any limited
partnership acquired by such Grantor after the Effective Date and constituting
Pledged Securities herein shall be a “security” within the meaning of Article 8
of the New York UCC and shall be governed by Article 8 of the New York
UCC, such Grantor shall, to the extent permitted by applicable law, use
commercially reasonable efforts to cause the issuer thereof to issue the
corresponding certificates.

 

(b) Each
Grantor further acknowledges and agrees that (i) the interests in any
limited liability company or limited partnership controlled by such Grantor and
required to be pledged hereunder that are not represented by a certificate are
not “securities” within the meaning of Article 8 of the New York UCC and (ii) such
Grantor shall at no time elect to treat any such interest as a “security”
within the meaning of Article 8 of the New York UCC or cause the issuer
thereof to issue any certificate representing such interest, unless such Grantor
provides prompt written notification to the Collateral Agent of such election
and promptly (but in no case later than 15 Business Days) pledges any such
certificate to the Collateral Agent pursuant to the terms hereof; provided,
however, that this Section 3.04 shall not apply to any Capital
Stock in limited liability companies or limited partnerships which may not be
pledged, assigned or otherwise encumbered pursuant to applicable Federal, state
or local laws, rules or regulations related to the practice of medicine or
the healthcare industry generally or customary provisions in joint venture
agreements (including consent rights (other than consent rights of any
Grantor)).

 

Section 3.05.
Registration in Nominee Name; Denominations. The Collateral Agent, on
behalf of the Secured Parties, shall have the right (in its sole and absolute
discretion, but subject to the terms and provisions of the Credit Agreement and
Article V herein) to hold the Pledged Securities in the name of the
applicable Grantor, endorsed or assigned in blank or in favor of the Collateral
Agent or, upon the occurrence and during the continuation of an Event of
Default and written notice to the applicable Grantor, and subject to the rights
and remedies set forth in Section 8 of the Credit Agreement and Article V
herein, in its own name as pledgee or the name of its nominee (as pledgee or as
sub-agent). The Collateral Agent shall at all times upon the occurrence and
during the continuation of an Event of Default but subject to the terms and provisions
of the Credit Agreement and Article V herein have the right to exchange
the certificates representing Pledged Securities for certificates of smaller or
larger denominations for any purpose consistent with this Agreement.

 

9

 

Section 3.06.
Voting Rights; Dividends and Interest.

 

(a) Unless
and until an Event of Default shall have occurred and be continuing and prior
written notice thereof shall have been given by the Collateral Agent to the
relevant Grantor of the Collateral Agent’s intent to exercise its corresponding
rights pursuant to Section 3.06(b):

 

(i) Each Grantor shall be entitled to exercise
any and all voting and other consensual rights and powers inuring to an owner
of Pledged Securities or any part thereof for any purpose.

 

(ii) The Collateral Agent shall execute and
deliver to each Grantor, or cause to be executed and delivered to such Grantor,
all such proxies, powers of attorney and other instruments as such Grantor may
reasonably request for the purpose of enabling such Grantor to exercise the
voting and other consensual rights and powers it is entitled to exercise
pursuant to subparagraph (i) above.

 

(iii) Each Grantor shall be entitled to receive
and retain any and all dividends, interest, principal and other distributions
paid on or distributed in respect of the Pledged Securities to the extent and
only to the extent that such dividends, interest, principal and other
distributions are permitted by, and otherwise paid or distributed in accordance
with, the terms and conditions of the Credit Agreement, the other Loan
Documents and applicable laws, provided that any noncash (w) dividends,
(x) interest, (y) principal or (z) other distributions that
would constitute Pledged Stock or Pledged Notes, whether resulting from a
subdivision, combination or reclassification of the outstanding Capital Stock
of the issuer of any Pledged Securities or received in exchange for Pledged
Securities or any part thereof, or in redemption thereof, or as a result of any
merger, consolidation, acquisition or other exchange of assets to which such
issuer may be a party or otherwise, shall be and become part of the Pledged
Collateral, and, if received by any Grantor, shall not be commingled by such
Grantor with any of its other funds or property but shall be held separate and
apart therefrom, shall be held in trust for the benefit of the Collateral Agent
and the other Secured Parties and shall be forthwith delivered to the
Collateral Agent in the same form as so received (with any necessary
endorsement as described in Section 3.03(c) or otherwise).

 

(b) Upon
the occurrence and during the continuation of an Event of Default and prior
written notice from the Collateral Agent to the Grantor, all rights of any
Grantor to dividends or other distributions that such Grantor is authorized to
receive pursuant to paragraph (a)(iii) of this Section 3.06 shall
cease, all such rights shall thereupon become vested in the Collateral Agent,
which shall have the sole and exclusive right and authority to receive and
retain such dividends or other distributions. All dividends or other
distributions received by any Grantor contrary to the provisions of this Section 3.06
shall be held in trust for the benefit of the Collateral Agent and the other
Secured Parties, shall be segregated from other property or funds of such
Grantor and shall be forthwith delivered to the Collateral Agent upon demand in
the same form as so received (with any necessary endorsement). Any and all
money and other property paid over to or received by the Collateral Agent
pursuant to the provisions of this paragraph (b) shall be retained by the
Collateral Agent in an account to be established by the

 

10

 

Collateral
Agent upon receipt of such money or other property and shall be applied in
accordance with the provisions of Section 5.02.

 

(c) Upon
the occurrence and during the continuation of an Event of Default and prior
written notice from the Collateral Agent to the Grantor, all rights of any
Grantor to exercise the voting and other consensual rights and powers it is
entitled to exercise pursuant to paragraph (a)(i) of this Section 3.06,
and the obligations of the Collateral Agent under paragraph (a)(ii) of
this Section 3.06, shall cease, and all such rights thereupon become
vested in the Collateral Agent, which shall have the sole and exclusive right
and authority to exercise such voting and other consensual rights and powers.

 

(d) Any
notice given by the Collateral Agent to the Grantors suspending their rights
under paragraph (a), (b) or (c) of this Section 3.06 (i) may
be given by telephone if promptly confirmed in writing, (ii) may be given
to one or more of the Grantors at the same or different times and (iii) may
suspend the rights of the Grantors under paragraph (a)(i) or paragraph (a)(iii) of
this Section 3.06 in part without suspending all such rights (as specified
by the Collateral Agent in its sole and absolute discretion) and without
waiving or otherwise affecting the Collateral Agent’s rights to give additional
notices from time to time suspending other rights so long as an Event of
Default has occurred and is continuing.

 

ARTICLE IV

 

Security Interests in Personal Property

 

Section 4.01.
Security Interest.

 

(a) As
security for the payment or performance, as applicable, in full of the Secured
Obligations, each Grantor hereby grants to the Collateral Agent and its
successors and assigns, for the ratable benefit of the Secured Parties, a
security interest (the “Security Interest”) in all right, title or
interest in or to any and all of the following assets and properties now owned
or at any time hereafter acquired by such Grantor or in which such Grantor now
has or at any time in the future may acquire any right, title or interest
(collectively, the “Article 9 Collateral”):

 

(i)                        all Accounts;

 

(ii)                     all Chattel Paper;

 

(iii)                  all Commercial Tort Claims listed on Schedule
IV hereto;

 

(iv)                 all Documents;

 

(v)                    all Goods, including all
Equipment, Inventory and Fixtures;

 

(vi)                 all General Intangibles (including
Intellectual Property and Licenses);

 

(vii)              all Instruments;

 

11

 

(viii)           all Investment Property;

 

(ix)                   all Letter-of-Credit Rights;

 

(x)                      all books and records
pertaining to the Article 9 Collateral; and

 

(xi)                     to the extent not otherwise
included, all Proceeds and products of any and all of the foregoing and all
collateral security, supporting obligations and guarantees given by any Person
with respect to any of the foregoing.

 

Notwithstanding
the foregoing, (A) the Article 9 Collateral shall not include, and no
Security Interest shall be deemed granted in (i) any Equipment that is
subject to a purchase money lien or capital lease permitted under the Credit
Agreement to the extent the documents relating to such purchase money lien or
capital lease would not permit such Equipment to be subject to the Security
Interests created hereby, (ii) any property, any pledges and security
interest or equity in Unrestricted Subsidiaries to the extent that the grant of
a security interest therein is prohibited by any Requirements of Law of any
Governmental Authority, (iii) any contract, license, agreement, or permit
to the extent that such grant of a security interest therein constitutes a breach
or default under or results in termination of any such contract, license,
agreement, or permit or any rights of the applicable Grantor therein pursuant
to the terms thereof, (iv) any Investment Property or Pledged Securities
(other than Capital Stock of a Wholly Owned Subsidiary), to the extent that
granting a security interest in such Investment Property or Pledged Securities
is prohibited by a shareholder, joint-venture or similar agreement, except, in
each case of clauses (ii), (iii) and (iv) above, to the extent that
such Requirement of Law or the provision of such contract, license, agreement,
permit or shareholder or similar agreement giving rise to such prohibition,
breach, default or termination is ineffective under applicable law, (v) any
United States intent-to-use trademark application to the extent and for so long
as creation by a Grantor of a security interest therein would impair the
validity or enforceability of such intent-to-use trademark application, (vi) assets
to the extent a Security Interest in such assets would result in adverse tax
consequences as determined by the Borrower in writing delivered to the
Collateral Agent, (vii) any leasehold interest related to real estate and (viii) motor
vehicles and other assets subject to certificates of title; and (B) and
the Article 9 Collateral shall not include any assets as to which the
Administrative Agent and the Borrower have reasonably determined in writing
that the burden or cost of obtaining a security interest in such assets
outweighs the benefit to the Secured Parties of the security to be afforded
thereby and the Grantors shall not be required to perfect a security interest
in any item of Article 9 Collateral as to which the Administrative Agent
and the Borrower have reasonably determined in writing that the burden or cost
of perfecting a security interest in such Article 9 Collateral outweighs
the benefit to the Secured Parties of the security to be afforded thereby. For
the avoidance of doubt, with respect to Intellectual Property, the grant of a
Security Interest herein shall not be deemed an assignment of Intellectual
Property to the Collateral Agent.

 

(b) Each
Grantor hereby irrevocably authorizes the Collateral Agent at any time and from
time to time to file in any relevant jurisdiction any initial financing
statements with respect to the Collateral or any part thereof and amendments
thereto that (i) indicate the Collateral as “all assets” of such Grantor
or such description as the Collateral Agent may determine and (ii) contain
the information required by Article 9 of the Uniform Commercial

 

12

 

Code
of each applicable jurisdiction for the filing of any financing statement or
amendment, including whether such Grantor is an organization, the type of
organization and any organizational identification number issued to such
Grantor. Each Grantor agrees to provide such information to the Collateral
Agent promptly upon the Collateral Agent’s written request.

 

Each
Grantor also ratifies its authorization for the Collateral Agent to file in any
relevant jurisdiction any initial financing statements (including fixture
filings, as applicable) or other appropriate filings, recordings or
registrations or amendments thereto if filed prior to the date hereof.

 

The
Collateral Agent is further authorized to file with the United States Patent
and Trademark Office or United States Copyright Office (or any successor office
or any similar office in any other country) such documents as may be necessary
for the purpose of perfecting, confirming, continuing, enforcing or protecting
the Security Interest granted by each Grantor, including the Copyright Security
Agreement, the Patent Security Agreement and the Trademark Security Agreement,
and naming any Grantor or the Grantors as debtors and the Collateral Agent as
secured party.

 

(c) The
Security Interest is granted as security only and shall not subject the
Collateral Agent or any other Secured Party to, or in any way alter or modify,
any obligation or liability of any Grantor with respect to or arising out of
the Article 9 Collateral.

 

(d) Notwithstanding
anything herein to the contrary, in no event shall any Grantor be required to (x) perfect
a security interest in (A) any foreign Intellectual Property or (B) in
any goods covered by a certificate of title, or (y) deliver (A) control
agreements, (B) landlord waivers, (C) bailee letters, (D) other
similar third-party documents, or (E) foreign security documents.

 

Section 4.02.
Representations and Warranties. The Grantors jointly and severally
represent and warrant to the Collateral Agent and the other Secured Parties, as
and to the extent required under Section 5.2 of the Credit Agreement that:

 

(a) Each Grantor has corporate or other
organizational power and authority to grant to the Collateral Agent, for the
benefit of the Secured Parties, the Security Interest in such Article 9
Collateral pursuant hereto and to execute, deliver and perform its obligations
in accordance with the terms in this Agreement, without the consent or approval
of any other Person other than any consent or approval that has been obtained.

 

(b) The Security Interest constitutes (i) a
valid security interest under U.S. law in all the Article 9 Collateral
securing the payment and performance of the Secured Obligations, (ii) subject
to the filings in each governmental, municipal or other office specified in
Schedule II, a perfected first priority security interest in all Article 9
Collateral in which a security interest under U.S. law may be perfected by
filing, recording or registering (A) a financing statement or analogous
document in the United States (or any political subdivision thereof) and its
territories and possessions pursuant to the Uniform Commercial Code or other
applicable U.S. law and (B) a Patent Security Agreement, a Trademark
Security Agreement or a Copyright Security Agreement with the United

 

13

 

States
Patent and Trademark Office and the United States Copyright Office, as applicable;
provided, however, that additional filings may be required in the United States
Patent and Trademark Office and/or United States Copyright Office to perfect
the Collateral Agent’s security interest in any Intellectual Property acquired
after the date hereof. The Security Interest is and shall be prior to any other
Lien on any of the Article 9 Collateral, other than Liens that are
permitted by the Credit Agreement.

 

(c) The Article 9 Collateral is and shall
be owned by the Grantors free and clear of any Lien, except for Liens permitted
pursuant to Section 7.3 of the Credit Agreement. Except with respect to
Liens permitted pursuant to Section 7.3 of the Credit Agreement, none of
the Grantors has filed or consented to the filing of (i) any financing
statement or analogous document under the Uniform Commercial Code or any other
applicable laws covering any Article 9 Collateral, (ii) any
assignment in which any Grantor assigns any Collateral or any security
agreement or similar instrument covering any Article 9 Collateral with the
United States Patent and Trademark Office or the United States Copyright Office
or (iii) any assignment in which any Grantor assigns any Article 9
Collateral or any security agreement or similar instrument covering any Article 9
Collateral with any foreign governmental, municipal or other office, which
financing statement or analogous document, assignment, security agreement or
similar instrument is still in effect, except, in each case, such as have been
(or will be) filed by the Collateral Agent hereunder and except for Liens
permitted pursuant to Section 7.3 of the Credit Agreement. For the
avoidance of doubt, licenses of Intellectual Property shall not constitute “Liens.”

 

(d) As of the date hereof, each Grantor hereby
represents and warrants that it holds no Commercial Tort Claims with a value in
excess of $2,000,000.00 other than those listed in Schedule IV.

 

Section 4.03.
Covenants.

 

(a) Each
Grantor agrees to maintain, at its own cost and expense, such complete and
accurate records with respect to the Article 9 Collateral owned by it as
is consistent with its reasonable business judgment.

 

(b) Each
Grantor shall, at its own expense, take any and all commercially reasonable
actions to defend title to the Article 9 Collateral (other than Article 9
Collateral that is deemed by such Grantor to be immaterial to the conduct of
its business) against all Persons and to defend the Security Interest of the
Collateral Agent in the Article 9 Collateral and the priority thereof
against any Lien not expressly permitted pursuant to Section 7.3 of the
Credit Agreement. Nothing in this Agreement shall prevent any Grantor from
discontinuing the operation or maintenance of any of its assets or properties
if such discontinuance is (x) in the judgment of its board or directors,
desirable in the conduct of its business and (y) permitted by the Credit
Agreement.

 

(c) Each
Grantor agrees, at its own expense, to execute, acknowledge, deliver and cause
to be duly filed all such further instruments and documents and take all such
actions as the Collateral Agent may from time to time reasonably request in
writing to preserve, protect and

 

14

 

perfect
the Security Interest and the rights and remedies created hereby, including the
payment of any fees and taxes required in connection with the execution and
delivery of this Agreement, the granting of the Security Interest and the
filing of any financing statements (including fixture filings) or other
documents (including execution of agreements in the form of Exhibits IV, V and
VI and filing such agreements with the United States Patent and Trademark
Office or United States Copyright Office, as applicable) in connection herewith
or therewith.

 

(d) At
its option, the Collateral Agent may discharge past due Taxes, assessments,
charges, fees or Liens at any time levied or placed on the Article 9
Collateral and not permitted pursuant to Section 7.3 of the Credit
Agreement, and may pay for the maintenance and preservation (including policies
of insurance) of the Article 9 Collateral to the extent any Grantor fails
to do so as required by the Credit Agreement or this Agreement, and each
Grantor jointly and severally agrees to reimburse the Collateral Agent on
demand for any payment made or any expense incurred by the Collateral Agent
pursuant to the foregoing authorization, provided that nothing in this
paragraph shall be interpreted as excusing any Grantor from the performance of,
or imposing any obligation on the Collateral Agent or any Secured Party to cure
or perform, any covenants or other promises of any Grantor with respect to
Taxes, assessments, charges, fees, Liens and maintenance as set forth in this
Agreement or in the other Loan Documents.

 

(e) None
of the Grantors shall grant any Liens in respect of the Article 9
Collateral, except as permitted by the Credit Agreement.

 

(f) The
Grantors, at their own expense, shall maintain or cause to be maintained
insurance covering physical loss or damage to the Inventory and Equipment in
accordance with the requirements set forth in Section 6.5 of the Credit
Agreement. Each Grantor appoints the Collateral Agent (and all officers,
employees or agents designated by the Collateral Agent) as such Grantor’s true
and lawful agent (and attorney-in-fact), upon the occurrence and during the
continuation of an Event of Default, for the purpose of making, settling and
adjusting claims in respect of Article 9 Collateral under policies of
insurance, endorsing the name of such Grantor on any check, draft, instrument
or other item of payment for the proceeds of such policies of insurance and for
making all determinations and decisions with respect thereto.

 

(g) Each
Grantor shall maintain, in form and manner consistent with its reasonable
business judgment, records of its Chattel Paper and its books, records and
documents evidencing or pertaining thereto.

 

Section 4.04.
Other Actions. In order to insure the attachment, perfection and
priority of, and the ability of the Collateral Agent to enforce, the Security
Interest, each Grantor agrees, in each case at such Grantor’s own expense, to
take the following actions with respect to the following Article 9
Collateral:

 

(a) Instruments
and Tangible Chattel Paper. Each Grantor represents and warrants that each
Instrument and each item of Tangible Chattel Paper, other than any of the
foregoing issued in the ordinary course of business, with a value in excess of
$2,000,000 in existence on the date hereof has been properly endorsed, assigned
and delivered to the Collateral Agent, accompanied by instruments of transfer
or assignment duly executed in blank. If any Grantor shall at any time hold or
acquire any Instruments or Chattel Paper with a value in excess

 

15

 

of
$2,000,000 or any such Instrument or Tangible Chattel Paper with a value that
when taken together with the value of any Instrument or Tangible Chattel Paper
not previously endorsed, assigned and delivered to the Collateral Agent exceeds
$2,000,000, such Grantor shall forthwith endorse, assign and deliver the same
to the Collateral Agent, accompanied by undated instruments of transfer or
assignment duly executed in blank reasonably acceptable to the Collateral
Agent.

 

(c) Commercial
Tort Claims. If any Grantor shall at any time hold or acquire a Commercial
Tort Claim in excess of $2,000,000, such Grantor shall immediately notify the
Collateral Agent in writing signed by such Grantor of the brief details thereof
and grant to the Collateral Agent in such writing a security interest therein
and in the Proceeds thereof, all upon the terms of this Agreement, with such
writing to be in form and substance reasonably satisfactory to the Collateral
Agent.

 

Section 4.05.
Covenants Regarding Patent, Trademark and Copyright Collateral.

 

(a) Each
Grantor agrees that it will not do any act or omit to do any act whereby it is
reasonably foreseeable any Patent owned or exclusively licensed by such Grantor
that is material to the conduct of such Grantor’s business and included in the Article 9
Collateral would become invalidated or dedicated to the public, (except at the
end of its statutory term) and agrees that it shall continue to mark any
products covered by a Patent owned or exclusively licensed by such Grantor with
the relevant patent number as necessary and sufficient in its reasonable
business judgment to establish and preserve its material rights under
applicable patent laws.

 

(b) Except
as could reasonably not be expected to result in a Material Adverse Effect,
each Grantor (either itself or through its licensees or its sublicensees) will,
for each registered Trademark owned by such Grantor, material to the conduct of
such Grantor’s business and included in the Article 9 Collateral, (i) maintain
(at least as done in the past) such Trademark in full force free from any claim
of abandonment or invalidity for non-use, (ii) use commercially reasonable
efforts to maintain substantially the same (or better) quality of products and
services offered under such Trademark, (iii) display such Trademark with
notice of Federal or foreign registration (or, if such Trademark is
unregistered, display such Trademark with notice as required for unregistered
Trademarks) to the extent necessary and sufficient in its reasonable business
judgment to establish and preserve its maximum rights under applicable law and (iv) not
knowingly use or knowingly permit the use of such Trademark in any violation of
any third party rights.

 

(c) Except
as could not reasonably be expected to result in a Material Adverse Effect,
each Grantor (either itself or through its licensees or sublicensees) will, for
each work covered by a Copyright owned by such Grantor, material to the conduct
of such Grantor’s business and included in the Article 9 Collateral,
continue to publish, reproduce, display, adopt and distribute the work with
appropriate copyright notice as necessary and sufficient in its reasonable
judgment to establish and preserve its material rights under applicable
copyright laws, except at the end of its statutory term.

 

(d) Except
as could not reasonably be expected to result in a Material Adverse Effect,
each Grantor shall notify the Collateral Agent as soon as reasonably
practicable (but in

 

16

 

 

any
event within 30 Business Days) if it knows that any Patent, Trademark or
Copyright owned or exclusively licensed by such Grantor and material to the
conduct of its business could reasonably be expected to become abandoned, lost
or dedicated to the public (except at the end of its statutory term), or of any
materially adverse determination or development (including the institution of,
or any such determination or development in, any proceeding in the United
States Patent and Trademark Office, United States Copyright Office or any
court) regarding such Grantor’s ownership of any material Patent, Trademark or
Copyright (other than, for the avoidance of doubt, office actions that arise in
the ordinary course of prosecution of any pending applications for patenting or
registering any Intellectual Property or that are immaterial in the reasonable
business judgment of Borrower).

 

(e)    Whenever any Grantor, either itself or
through any agent, employee, licensee or designee, shall file an application
with respect to any Patent, Trademark or Copyright (or for the registration of
any Trademark or Copyright) with the United States Patent and Trademark Office,
United States Copyright Office or any office or agency in any political
subdivision of the United States, such Grantor shall (i) report such
filing to the Collateral Agent concurrently with the delivery of the financial
statements referred to in Section 6.1(a) or 6.1(b) in the Credit
Agreement and (ii) at such time execute and deliver a Copyright Security
Agreement, a Patent Security Agreement or a Trademark Security Agreement with
respect to any such Copyrights, Patents or Trademarks, as applicable and, at
the request of the Collateral Agent, any and all other agreements, instruments,
documents and papers as the Collateral Agent may reasonably request to evidence
the Collateral Agent’s security interest in such applied for or registered
Patent, Trademark or Copyright.

 

(f)     Except as could not reasonably be expected
to result in a Material Adverse Effect, each Grantor will take all commercially
reasonable necessary steps that are consistent with the practice in any
proceeding before the United States Patent and Trademark Office, United States
Copyright Office or any office or agency in any political subdivision of the
United States, to the extent necessary in its reasonable business judgment, to
maintain and prosecute each registration or application that is material to the
conduct of such Grantor’s business relating to the Patents, Trademarks and/or
Copyrights owned by such Grantor (and to obtain the relevant grant or
registration) and to maintain each issued Patent and each registration of the
Trademarks and Copyrights that is owned by Grantor and material to the conduct
of any Grantor’s business, including timely filings of applications for
renewal, affidavits of use, affidavits of incontestability and payment of
maintenance fees except as such Grantor may otherwise decide in its reasonable
business judgment, and, if consistent with good business judgment, to initiate
opposition, interference and cancellation proceedings against third parties.

 

(g)    Except as could not reasonably be expected
to result in a Material Adverse Effect, in the event that any Grantor knows
that any Article 9 Collateral consisting of a material Patent, Trademark
or Copyright owned or exclusively licensed by such Grantor and material to the
conduct of any Grantor’s business has been infringed, misappropriated or
diluted by a third party, such Grantor shall take such actions as Grantor shall
reasonably deem appropriate under the circumstances to protect such material
Intellectual Property and (ii) if such Intellectual Property is of
material economic value to such Grantor, notify the Collateral Agent as soon as
reasonably practicable after it learns thereof and, if consistent with such
Grantor’s reasonable business judgment, sue for infringement, misappropriation
or dilution, to seek injunctive relief where

 

17

 

appropriate
and to recover any and all damages for such infringement, misappropriation or
dilution (and take any actions required by applicable law prior to instituting
such suit), and take such other actions as are appropriate under the
circumstances to protect such Article 9 Collateral. Nothing in this
Agreement shall prevent any Grantor from discontinuing the use or maintenance
of any Article 9 Collateral consisting of a Patent, Trademark or
Copyright, or require any Grantor to pursue any claim of infringement,
misappropriation or dilution, if (x) such Grantor so determines in its
good business judgment and (y) it is not prohibited by the Credit
Agreement.

 

(h)    Upon and during the continuation of an Event
of Default, each Grantor shall, at the reasonable request of the Collateral
Agent, use its commercially reasonable efforts to obtain all requisite consents
or approvals by the licensor of each material Copyright License, Patent License
or Trademark License to effect the assignment of all such Grantor’s right,
title and interest thereunder to the Collateral Agent or its designee.

 

ARTICLE V

 

Remedies

 

Section 5.01.
Remedies upon Default. Upon the occurrence and during the continuation
of an Event of Default, it is agreed that the Collateral Agent shall have the
right to take any of or all the following actions at the same or different
times: (a) with respect to any Article 9 Collateral consisting of
Intellectual Property, on demand, to cause the Security Interest to become an
assignment, transfer and conveyance of any of or all such Article 9
Collateral by the applicable Grantors to the Collateral Agent, for the ratable
benefit of the Secured Parties, or to license or sublicense, whether general,
special or otherwise, and whether on an exclusive or nonexclusive basis, any
such Article 9 Collateral throughout the world on such terms and
conditions and in such manner as the Collateral Agent shall determine (other
than (i) in violation of any then-existing licensing arrangements to the
extent that waivers cannot be obtained or (ii) if such action would result
in the invalidity, unenforceability, abandonment, cancellation or voiding of
such intellectual property), and (b) with or without legal process and
with or without prior notice or demand for performance, to take possession of
the Article 9 Collateral and without liability for trespass to enter any
premises where the Article 9 Collateral may be located for the purpose of
taking possession of or removing the Article 9 Collateral and, generally,
to exercise any and all rights afforded to a secured party under the Uniform
Commercial Code or other applicable law. Without limiting the generality of the
foregoing, each Grantor agrees that the Collateral Agent shall have the right,
subject to the mandatory requirements of applicable law, to sell or otherwise
dispose of all or any part of the Collateral at a public or private sale or at
any broker’s board or on any securities exchange, for cash, upon credit or for
future delivery as the Collateral Agent shall deem appropriate. Each such
purchaser at any sale of Collateral shall hold the property sold absolutely,
free from any claim or right on the part of any Grantor, and each Grantor
hereby waives (to the extent permitted by law) all rights of redemption, stay
and appraisal that such Grantor now has or may at any time in the future have
under any rule of law or statute now existing or hereafter enacted.

 

The
Collateral Agent shall give the applicable Grantors not less than 10 days’
written notice (which each Grantor agrees is reasonable notice within the meaning
of Section 9-611

 

18

 

of
the New York UCC or its equivalent in other jurisdictions) of the Collateral
Agent’s intention to make any sale of Collateral. Any such notice shall (i) in
the case of a public sale, state the time and place for such sale, (ii) in
the case of a private sale, state the day after which such sale may be
consummated and (iii) in the case of a sale at a broker’s board or on a
securities exchange, shall state the board or exchange at which such sale is to
be made and the day on which the Collateral, or portion thereof, will first be
offered for sale at such board or exchange. Any such public sale shall be held
at such time or times within ordinary business hours and at such place or places
as the Collateral Agent may fix and state in the notice of such sale. At any
such sale, the Collateral, or portion thereof, to be sold may be sold in one
lot as an entirety or in separate parcels, as the Collateral Agent may
determine in its sole and absolute discretion. The Collateral Agent shall not
be obligated to make any sale of any Collateral if it shall determine not to do
so, regardless of the fact that notice of sale of such Collateral shall have
been given. The Collateral Agent may, without notice or publication, adjourn
any public or private sale or cause the same to be adjourned from time to time
by announcement at the time and place fixed for sale, and such sale may,
without further notice, be made at the time and place to which the same was so
adjourned. In case any sale of all or any part of the Collateral is made on
credit or for future delivery, the Collateral so sold may be retained by the
Collateral Agent until the sale price is paid by the purchaser or purchasers
thereof, but the Collateral Agent and the other Secured Parties shall not incur
any liability in case any such purchaser or purchasers shall fail to take up
and pay for the Collateral so sold and, in case of any such failure, such
Collateral may be sold again upon like notice. At any public (or, to the extent
permitted by law, private) sale made pursuant to this Agreement, any Secured
Party may bid for or purchase, free (to the extent permitted by law) from any
right of redemption, stay, valuation or appraisal on the part of any Grantor
(all said rights being also hereby waived and released to the extent permitted
by law), the Collateral or any part thereof offered for sale and may make
payment on account thereof by using any claim then due and payable to such
Secured Party from any Grantor as a credit against the purchase price, and such
Secured Party may, upon compliance with the terms of sale, hold, retain and
dispose of such property without further accountability to any Grantor
therefor. For purposes hereof, a written agreement to purchase the Collateral
or any portion thereof shall be treated as a sale thereof; the Collateral Agent
shall be free to carry out such sale pursuant to such agreement and no Grantor
shall be entitled to the return of the Collateral or any portion thereof
subject thereto, notwithstanding the fact that after the Collateral Agent shall
have entered into such an agreement, all Events of Default shall have been
remedied and the Obligations paid in full. As an alternative to exercising the
power of sale herein conferred upon it, the Collateral Agent may proceed by a
suit or suits at law or in equity to foreclose this Agreement and to sell the
Collateral or any portion thereof pursuant to a judgment or decree of a court
or courts having competent jurisdiction or pursuant to a proceeding by a
court-appointed receiver. Any sale pursuant to the provisions of this Section 5.01
shall be deemed to conform to the commercially reasonable standards as provided
in Section 9-610(b) of the New York UCC or its equivalent in other
jurisdictions.

 

Section 5.02.
Application of Proceeds. The Collateral Agent shall apply the proceeds
of any collection or sale of Collateral pursuant to this Article V,
including any Collateral consisting of cash, as follows:

 

FIRST, to the payment of all costs and expenses
incurred by the Collateral Agent and the Administrative Agent in connection
with such collection or sale or otherwise in

 

19

 

connection
with this Agreement, any other Loan Document or any of the Secured Obligations,
including all court costs and the fees and expenses of its agents and legal
counsel, the repayment of all advances made by the Collateral Agent hereunder
or under any other Loan Document on behalf of any Grantor and any other costs
or expenses incurred in connection with the exercise of any right or remedy
hereunder or under any other Loan Document;

 

SECOND, to the payment in full of the Secured
Obligations (the amounts so applied to be distributed among the Secured Parties
pro rata in accordance with the amounts of the Secured Obligations owed to them
on the date of any such distribution); and

 

THIRD,
to the Grantors, their successors or assigns, or as a court of competent
jurisdiction may otherwise direct.

 

The
Collateral Agent shall have sole and absolute discretion as to the time of
application of any such proceeds, moneys or balances in accordance with this
Agreement. Upon any sale of Collateral by the Collateral Agent (including
pursuant to a power of sale granted by statute or under a judicial proceeding),
the receipt of the Collateral Agent or of the officer making the sale shall be
a sufficient discharge to the purchaser or purchasers of the Collateral so sold
and such purchaser or purchasers shall not be obligated to see to the
application of any part of the purchase money paid over to the Collateral Agent
or such officer or be answerable in any way for the misapplication thereof.

 

Section 5.03.
Grant of License To Use Intellectual Property. For the purpose of enabling
the Collateral Agent to exercise rights and remedies under this Agreement at
such time as the Collateral Agent shall be lawfully entitled to exercise such
rights and remedies, each Grantor hereby grants to the Collateral Agent a
nonexclusive license (exercisable without payment of royalty or other
compensation to the Grantors) to use, license or sublicense, subject to
reasonable quality control in favor of such Grantor, any of the Article 9
Collateral consisting of Intellectual Property now owned or hereafter acquired
by such Grantor, and wherever the same may be located, and including in such
license reasonable access to all media in which any of the licensed items may
be recorded or stored and to all computer software and programs used for the
compilation or printout thereof. The use of the foregoing licenses shall be
effective at the option of the Collateral Agent, only upon the occurrence and
during the continuation of an Event of Default.

 

Section 5.04.
Securities Act. Each Grantor understands that compliance with the
Securities Act of 1933, as now or hereafter in effect, or any similar statute
hereafter enacted analogous in purpose or effect (such Act and any such similar
statute as from time to time in effect being called the “Federal Securities
Laws”) with respect to any disposition of the Pledged Collateral permitted
hereunder might limit the course of conduct of the Collateral Agent if the
Collateral Agent were to attempt to dispose of all or any part of the Pledged
Collateral, and might also limit the extent to which or the manner in which any
subsequent transferee of any Pledged Collateral could dispose of the same.
Similarly, there may be other legal restrictions or limitations affecting the
Collateral Agent in any attempt to dispose of all or part of the Pledged
Collateral under applicable Blue Sky or other state securities laws or similar
laws analogous in purpose or effect. Each Grantor recognizes that in light of
such restrictions and limitations the

 

20

 

Collateral
Agent may, with respect to any sale of the Pledged Collateral, limit the
prospective purchasers to a limited number of investors who will agree, among
other things, to acquire such Pledged Collateral for their own account, for
investment, and not with a view to the distribution or resale thereof. Each
Grantor acknowledges and agrees that in light of such restrictions and
limitations, the Collateral Agent, in its sole and absolute discretion (a) may
proceed to make such a sale whether or not a registration statement for the
purpose of registering such Pledged Collateral or part thereof shall have been
filed under the Federal Securities Laws and (b) may approach and negotiate
with a single potential purchaser to effect such sale. Each Grantor
acknowledges and agrees that any such sale might result in prices and other
terms less favorable to the seller than if such sale were a public sale without
such restrictions. In the event of any such sale, the Collateral Agent shall
incur no responsibility or liability for selling all or any part of the Pledged
Collateral at a price that the Collateral Agent, in its sole and absolute
discretion, may in good faith deem reasonable under the circumstances,
notwithstanding the possibility that a substantially higher price might have
been realized if the sale were deferred until after registration as aforesaid
or if more than a single purchaser were approached. The provisions of this Section 5.04
will apply notwithstanding the existence of a public or private market upon
which the quotations or sales prices may exceed substantially the price at
which the Collateral Agent sells.

 

ARTICLE VI

 

Indemnity, Subrogation and Subordination

 

Section 6.01.
Indemnity and Subrogation. In addition to all such rights of indemnity
and subrogation as the Guarantors may have under applicable law (but subject to
Section 6.03), Borrower agrees that (a) in the event a payment of any
Secured Obligation shall be made by any Guarantor under this Agreement,
Borrower shall indemnify such Guarantor for the full amount of such payment and
such Guarantor shall be subrogated to the rights of the Person to whom such
payment shall have been made to the extent of such payment and (b) in the
event any assets of any Grantor shall be sold pursuant to this Agreement or any
other Security Document to satisfy in whole or in part any Secured Obligation
owed to any Secured Party, Borrower shall indemnify such Grantor in an amount
equal to the fair value of the assets so sold.

 

Section 6.02.
Contribution and Subrogation. Each Guarantor and Grantor (a “Contributing
Party”) agrees (subject to Section 6.03) that, to the extent any other
Guarantor hereunder shall have paid (or shall be deemed to have paid, as a
result of a sale of the Collateral owned by it in accordance with Sections 5.01
or 5.03 herein) more than its proportionate share of any payment hereunder in
respect of any Obligation owed to any Secured Party and such other Guarantor or
Grantor (the “Claiming Party”) shall not have been fully indemnified by
Borrower as provided in Section 6.01, the Claiming Party shall be entitled
to seek and receive contribution from the Contributing Parties which have not
paid their respective share of such payment. Any Contributing Party making any
payment to a Claiming Party pursuant to this Section 6.02 shall be
subrogated to the rights of such Claiming Party under Section 6.01 to the
extent of such payment.

 

21

 

Section 6.03.
Subordination. Notwithstanding any provision in this Agreement to the
contrary, all rights of the Guarantors and Grantors under Sections 6.01 and
6.02 and all other rights of indemnity, contribution or subrogation under
applicable law or otherwise shall be fully subordinated to the payment in full
in cash of the Secured Obligations (other than indemnification obligations not
then due). No failure on the part of Borrower or any Guarantor or Grantor to
make the payments required by Sections 6.01 and 6.02 (or any other payments
required under applicable law or otherwise) shall in any respect limit the
obligations and liabilities of any Guarantor or Grantor with respect to its
Secured Obligations hereunder, and each Guarantor and Grantor shall remain
liable for the full amount of the Secured Obligations of such Guarantor or
Grantor hereunder.

 

ARTICLE VII

 

Miscellaneous

 

Section 7.01.
Notices. All communications and notices hereunder shall (except as
otherwise expressly permitted in this Agreement) be in writing and given as
provided in Section 10.2 of the Credit Agreement, provided that any
communication or notice hereunder from the Collateral Agent to any Loan Party
upon the occurrence and during the continuation of an Event of Default may be
given by telephone if promptly confirmed in writing. All communications and
notices hereunder to any Guarantor shall be given to it in care of Borrower as
provided in Section 10.2 of the Credit Agreement.

 

Section 7.02.
Waivers; Amendment.

 

(a)    No failure or
delay by any Secured Party in exercising any right or power hereunder or under
any other Loan Document shall operate as a waiver thereof, nor shall any single
or partial exercise of any such right or power, or any abandonment or
discontinuance of steps to enforce such a right or power, preclude any other or
further exercise thereof or the exercise of any other right or power. The
rights and remedies of the Secured Parties hereunder and under the other Loan
Documents are cumulative and are not exclusive of any rights or remedies that
they would otherwise have. No waiver of any provision in this Agreement or
consent to any departure by any Loan Party therefrom shall in any event be
effective unless the same shall be permitted by paragraph (b) of this Section 7.02,
and then such waiver or consent shall be effective only in the specific
instance and for the purpose for which given. Without limiting the generality
of the foregoing, the making of a Loan or issuance of a Letter of Credit shall
not be construed as a waiver of any Default, regardless of whether any Secured
Party may have had notice or knowledge of such Default at the time. No notice
or demand on any Loan Party in any case shall entitle any Loan Party to any
other or further notice or demand in similar or other circumstances.

 

(b)    Neither this
Agreement nor any provision hereof may be waived, amended or modified except
pursuant to an agreement or agreements in writing entered into by the
Collateral Agent and the Loan Party or Loan Parties with respect to which such
waiver, amendment or modification is to apply, subject to any consent required
in accordance with Section 10.1 of the Credit Agreement; provided further,
that no consent shall be required in

 

22

 

connection
with any automatic termination or release in accordance with Section 7.13,
except for any consent required by Section 7.13(c), if any.

 

Section 7.03.
Collateral Agent’s Fees and Expenses. The parties hereto agree that the
Collateral Agent shall be entitled to reimbursement of its reasonable out-of-pocket
costs and expenses incurred hereunder as provided in Section 10.5 of the
Credit Agreement.

 

Section 7.04.
Successors and Assigns. Whenever in this Agreement any of the parties
hereto is referred to, such reference shall be deemed to include the permitted
successors and assigns of such party; and all covenants, promises and
agreements by or on behalf of any Guarantor, Grantor or the Collateral Agent
that are contained in this Agreement shall bind and inure to the benefit of
their respective successors and assigns and shall inure to the benefit of the
other Secured Parties and their respective successors and assigns.

 

Section 7.05.
Survival of Agreement. All covenants, agreements, representations and
warranties made by the Loan Parties in the Loan Documents and in the
certificates or other instruments prepared or delivered in connection with or
pursuant to this Agreement or any other Loan Document shall be considered to
have been relied upon by the Lenders and shall survive the execution and
delivery of the Loan Documents and the making of any Loans and issuance of any
Letters of Credit, regardless of any investigation made by any Lender or on its
behalf and notwithstanding that the Administrative Agent, the Collateral Agent,
the Issuing Bank or any Lender may have had notice or knowledge of any Default
or incorrect representation or warranty at the time any credit is extended
under the Credit Agreement, and shall continue in full force and effect as long
as the principal of or any accrued interest on any Loan or any fee or any other
amount payable under any Loan Document is outstanding and unpaid or any Letter
of Credit is outstanding and so long as the Commitments have not expired or
terminated.

 

Section 7.06.
Counterparts; Effectiveness; Several Agreement. This Agreement may be
executed in counterparts, each of which shall constitute an original but all of
which, when taken together, shall constitute single contract. Delivery of an
executed signature page to this Agreement by facsimile transmission or
Adobe PDF e-mail shall be as effective as delivery of a manually signed
counterpart of this Agreement. This Agreement shall become effective as to any
Loan Party when a counterpart hereof executed on behalf of such Loan Party
shall have been delivered to the Collateral Agent and a counterpart hereof
shall have been executed on behalf of the Collateral Agent, and thereafter
shall be binding upon such Loan Party and the Collateral Agent and their
respective permitted successors and assigns, and shall inure to the benefit of
such Loan Party, the Collateral Agent, the Collateral Agent and the other
Secured Parties and their respective successors and assigns, except that no
Loan Party shall have the right to assign or transfer its rights or obligations
hereunder or any interest in this Agreement or in the Collateral (and any such
assignment or transfer shall be void) except as contemplated by this Agreement
or the Credit Agreement. This Agreement shall be construed as a separate
agreement with respect to each Loan Party and may be amended, modified,
supplemented, waived or released with respect to any Loan Party without the
approval of any other Loan Party and without affecting the obligations of any
other Loan Party hereunder.

 

23

 

Section 7.07.
Severability. Any provision in this Agreement held to be invalid,
illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be
ineffective to the extent of such invalidity, illegality or unenforceability
without affecting the validity, legality and enforceability of the remaining
provisions hereof; the invalidity of a particular provision in a particular
jurisdiction shall not invalidate such provision in any other jurisdiction. The
parties shall endeavor in good-faith negotiations to replace the invalid,
illegal or unenforceable provisions with valid provisions the economic effect
of which comes as close as possible to that of the invalid, illegal or
unenforceable provisions.

 

Section 7.08.
Right of Set-Off. In addition to any rights and remedies of the Lenders
provided by law, each Lender shall have the right after the occurrence and
during the continuance of an Event of Default, without prior notice to Parent
or the Borrower, any such notice being expressly waived by Parent and the
Borrower to the extent permitted by applicable law, upon any amount becoming
overdue and payable by Parent or the Borrower hereunder (whether at the stated
maturity, by acceleration or otherwise), to set off and appropriate and apply against
such amount any and all deposits (general or special, time or demand,
provisional or final other than payroll, tax or trust accounts), in any
currency, and any other credits, indebtedness or claims, in any currency, in
each case whether direct or indirect, absolute or contingent, matured or
unmatured, at any time held or owing by such Lender or any branch or agency
thereof to or for the credit or the account of Parent or the Borrower, as the
case may be. Each Lender agrees promptly to notify the Borrower and the
Administrative Agent after any such setoff and application made by such Lender,
provided that the failure to give
such notice shall not affect the validity of such setoff and application.

 

Section 7.09.
Governing Law; Jurisdiction; Consent to Service of Process.

 

(a)    This Agreement
shall be governed by and construed in accordance with, the law of the State of
New York without regard to principles of conflicts of law to the extent that
the application of the laws of another jurisdiction will be required thereby.

 

(b)    Each of the
parties hereto hereby irrevocably and unconditionally submits, for itself and
its property, to the nonexclusive jurisdiction of the Supreme Court of the
State of New York sitting in New York County and of the United States District
Court of the Southern District of New York, and any appellate court from any
thereof, in any action or proceeding arising out of or relating to this
Agreement or any other Loan Document, or for recognition or enforcement of any
judgment, and each of the parties hereto hereby irrevocably and unconditionally
agrees that all claims in respect of any such action or proceeding may be heard
and determined in such New York State or, to the extent permitted by law, in
such Federal court. Nothing in this Agreement or any other Loan Document shall
affect any right that the Collateral Agent, the Issuing Bank, any Lender or any
Loan Party may otherwise have to bring any action or proceeding relating to
this Agreement or any other Loan Document in the courts of any jurisdiction.

 

(c)    Each of the
Loan Parties hereby irrevocably and unconditionally waives, to the fullest
extent it may legally and effectively do so, any objection that it may now or
hereafter have to the laying of venue of any suit, action or proceeding arising
out of or relating to this Agreement or any other Loan Document in any court
referred to in paragraph (b) of this Section 7.09. Each of the
parties hereto hereby irrevocably waives, to the fullest extent

 

24

 

permitted
by law, the defense of an inconvenient forum to the maintenance of such action
or proceeding in any such court.

 

(d)    Each party to
this Agreement irrevocably consents to service of process in the manner
provided for notices in Section 7.01. Nothing in this Agreement or any
other Loan Document will affect the right of any party to this Agreement to
serve process in any other manner permitted by law.

 

Section 7.10.
WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY
(WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES
THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT
IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7.10.

 

Section 7.11.
Headings. Article and Section headings and the Table of
Contents used in this Agreement are for convenience of reference only, are not
part of this Agreement and are not to affect the construction of, or to be
taken into consideration in interpreting, this Agreement.

 

Section 7.12.
Security Interest Absolute. All rights of the Collateral Agent
hereunder, the Security Interest, the grant of a security interest in the
Pledged Collateral and all obligations of each Grantor and Guarantor hereunder
shall be absolute and unconditional irrespective of (a) any lack of
validity or enforceability of the Credit Agreement, any other Loan Document,
any agreement with respect to any of the Secured Obligations or any other
agreement or instrument relating to any of the foregoing, (b) any change
in the time, manner or place of payment of, or in any other term of, all or any
of the Secured Obligations, or any other amendment or waiver of or any consent
to any departure from the Credit Agreement, any other Loan Document or any
other agreement or instrument, (c) any exchange, release or non-perfection
of any Lien on other collateral, or any release or amendment or waiver of or
consent under or departure from any guarantee, securing or guaranteeing all or
any of the Secured Obligations (except as provided herein or in any other Loan
Document), or (d) any other circumstance that might otherwise constitute a
defense (other than defense of payment or performance) available to, or a
discharge of, any Grantor or Guarantor in respect of the Secured Obligations or
this Agreement. Each of the Grantors agrees that its obligations hereunder and
the security interest created hereunder shall continue to be effective or be
reinstated, as applicable, if at any time payment, or any part thereof, of all
or any part of the Secured Obligations is rescinded or must otherwise be
restored by the Secured Party upon the bankruptcy or reorganization of any
Grantor or otherwise.

 

25

 

Section 7.13.
Termination or Release.

 

(a)    This Agreement
and the Guarantees made in this Agreement shall terminate and the Security
Interest and all other security interests granted hereby shall be automatically
released when all the Obligations have been paid in full in cash (other than
indemnities and other contingent liabilities not then due that expressly
survive repayment of the Loans and termination of the Facility), the L/C
Obligations have been terminated (or have been cash collateralized or
backstopped by back to back letters of credit in each case pursuant to arrangements
reasonably satisfactory to the Issuing Bank) and the Lenders have no further
Commitment to lend or issue Letters of Credit under the Credit Agreement.

 

(b)    A Person which
was a Loan Party immediately prior to the consummation of any transaction permitted
by the Credit Agreement shall automatically be released from its obligations
hereunder and the Security Interest in the Collateral of such Person shall be
automatically released upon the consummation of any transaction permitted by
the Credit Agreement as a result of which such Person ceases to be a Loan
Party.

 

(c)    Upon any sale
or other transfer (including a windup or dissolution) by any Grantor of any
Collateral that is permitted under the Credit Agreement (other than any such
transfer to another Grantor), or upon the effectiveness of any written consent
to the release of the security interest granted hereby in any Collateral
pursuant to Section 10.1 of the Credit Agreement, the security interest in
such Collateral shall be automatically released.

 

(d)    In connection
with any termination or release of any Security Interest created hereunder, the
Collateral Agent shall execute and deliver to any Person, at such Person’s
expense, all documents that such Person shall reasonably request to evidence
such termination or release of its obligations or the Security Interests in its
Collateral. Any execution and delivery of documents pursuant to this Section 7.13
shall be without recourse to or warranty by the Collateral Agent.

 

Section 7.14.
Additional Subsidiaries. Pursuant to Section 6.9 of the Credit
Agreement, each Subsidiary of Borrower that was not in existence or not a
Subsidiary on the date of the Credit Agreement and required pursuant to Section 6.9
of the Credit Agreement to enter in this Agreement as a Subsidiary Guarantor
upon becoming such a Subsidiary shall do so (in accordance with Section 6.9
of the Credit Agreement). Upon execution and delivery by the Collateral Agent
and such Subsidiary of an instrument in the form of Exhibit I hereto, such
Subsidiary shall become a Subsidiary Guarantor and Grantor hereunder with the
same force and effect as if originally named as a Subsidiary Guarantor in this
Agreement. The execution and delivery of any such instrument shall not require
the consent of any other Loan Party hereunder. The rights and obligations of
each Loan Party hereunder shall remain in full force and effect notwithstanding
the addition of any new Loan Party as a party to this Agreement.

 

Section 7.15.
Collateral Agent Appointed Attorney-in-Fact. Each Grantor hereby
appoints the Collateral Agent the attorney-in-fact of such Grantor for the
purpose of carrying out the provisions of this Agreement and taking any action
and executing any instrument that the Collateral Agent may deem necessary to accomplish
the purposes hereof, which appointment is irrevocable and coupled with an
interest. Without limiting the generality

 

26

 

of
the foregoing, the Collateral Agent shall have the right, upon the occurrence
and during the continuation of an Event of Default, with full power of
substitution either in the Collateral Agent’s name or in the name of such
Grantor (a) to commence and prosecute any and all suits, actions or
proceedings at law or in equity in any court of competent jurisdiction to
collect or otherwise realize on all or any of the Collateral or to enforce any
rights in respect of any Collateral; (b) to settle, compromise, compound,
adjust or defend any actions, suits or proceedings relating to all or any of
the Collateral; and (c) to use, sell, assign, transfer, pledge, make any
agreement with respect to or otherwise deal with all or any of the Collateral,
and to do all other acts and things necessary to carry out the purposes of this
Agreement, as fully and completely as though the Collateral Agent were the
absolute owner of the Collateral for all purposes, provided that nothing
in this Agreement contained shall be construed as requiring or obligating the
Collateral Agent to make any commitment or to make any inquiry as to the nature
or sufficiency of any payment received by the Collateral Agent, or to present
or file any claim or notice, or to take any action with respect to the
Collateral or any part thereof or the moneys due or to become due in respect
thereof or any property covered thereby; provided further that the
Collateral Agent agrees that it will not exercise any rights under the power of
attorney provided for in this Section 7.15 unless an Event of Default
shall have occurred and be continuing. The Collateral Agent and the other
Secured Parties shall be accountable only for amounts actually received as a
result of the exercise of the powers granted to them in this Agreement, and
neither they nor their officers, directors, employees or agents shall be
responsible to any Grantor for any act or failure to act hereunder, except for
their own gross negligence or willful misconduct.

 

Section 7.16.
Further Assurances. Notwithstanding anything to the contrary herein, the
parties hereto agree to comply with the requirements set forth in Section 6.10
of the Credit Agreement.

 

Section 7.17.
Waivers, Etc. Each Qualified Counterparty and each Cash Management
Bank (in its capacity as such, and to the extent such Person is a Secured
Party), by becoming a Secured Party, shall be deemed to make the waivers,
appointments, exculpations, acknowledgments, agreements and delegations in
favor of the Collateral Agent that the Lenders make in Section 9 of the
Credit Agreement.

 

 

[Signature Pages to Follow]

 

27

 

IN
WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the
day and year first above written.

 

	
   

  	
   

  	
  RADIATION
  THERAPY SERVICES HOLDINGS, INC.,

  as a Grantor and a Guarantor

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Erin L. Russell

  
	
   

  	
   

  	
   

  	
  Name:

  	
  Erin
  L. Russell

  
	
   

  	
   

  	
   

  	
  Title:

  	
   

  

 

 

	
   

  	
   

  	
  RTS
  MERGERCO, INC.,

  as Borrower and a Grantor

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Erin L. Russell

  
	
   

  	
   

  	
   

  	
  Name:

  	
  Erin
  L. Russell

  
	
   

  	
   

  	
   

  	
  Title:

  	
   

  

 

 

	
   

  	
   

  	
  RADIATION
  THERAPY SERVICES, INC., 

  as Borrower and a Grantor

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  David Watson

  
	
   

  	
   

  	
   

  	
  Name:

  	
  David
  Watson

  
	
   

  	
   

  	
   

  	
  Title:

  	
  Executive
  Vice President and Chief Financial Officer

  

 

 

[Guaranty and Collateral Agreement]

 

 

	
   

  	
   

  	
  21ST
  CENTURY ONCOLOGY MANAGEMENT SERVICES, INC.

  21ST
  CENTURY ONCOLOGY OF ALABAMA, INC.

  21ST
  CENTURY ONCOLOGY OF ARIZONA, INC.

  21ST
  CENTURY ONCOLOGY OF HARFORD COUNTY MARYLAND, LLC

  21ST
  CENTURY ONCOLOGY OF JACKSONVILLE, INC.

  21ST
  CENTURY ONCOLOGY OF NEW JERSEY, INC.

  21ST
  CENTURY ONCOLOGY OF PRINCE GEORGES COUNTY, MARYLAND, LLC

  21ST
  CENTURY ONCOLOGY OF SOUTH CAROLINA, LLC

  21ST
  CENTURY ONCOLOGY, INC.

  AMERICAN
  CONSOLIDATED TECHNOLOGIES, L.L.C.

  ARIZONA
  RADIATION THERAPY MANAGEMENT SERVICES, INC.

  BERLIN
  RADIATION THERAPY TREATMENT CENTER, LLC

  CALIFORNIA
  RADIATION THERAPY MANAGEMENT SERVICES, INC.

  DEVOTO
  CONSTRUCTION OF SOUTHWEST FLORIDA, INC.

  FINANCIAL
  SERVICES OF SOUTHWEST FLORIDA, LLC

  MARYLAND
  RADIATION THERAPY MANAGEMENT SERVICES, INC.

  MICHIGAN
  RADIATION THERAPY MANAGEMENT SERVICES, INC.

  NEVADA
  RADIATION THERAPY MANAGEMENT SERVICES, INCORPORATED

  NEW
  YORK RADIATION THERAPY MANAGEMENT SERVICES, INCORPORATED

  NORTH
  CAROLINA RADIATION THERAPY MANAGEMENT SERVICES, INC.

  RADIATION
  THERAPY SERVICES INTERNATIONAL, INC.

  WEST
  VIRGINIA RADIATION THERAPY SERVICES, INC. 

  as Subsidiary Guarantors and Grantors

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  David Watson

  
	
   

  	
   

  	
   

  	
  Name:

  	
  David
  Watson 

  
	
   

  	
   

  	
   

  	
  Title:

  	
  Vice
  President

  

 

 

[Guaranty and Collateral Agreement]

 

 

	
   

  	
   

  	
  WACHOVIA
  BANK, NATIONAL ASSOCIATION, 

  as Collateral Agent

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/
  Kurt Brechnitz

  
	
   

  	
   

  	
   

  	
  Name:

  	
  Kurt
  Brechnitz

  
	
   

  	
   

  	
   

  	
  Title:

  	
  Managing
  Director

  

 

 

[Guaranty and Collateral Agreement]

 

 

SCHEDULES

 

TO THE

 

GUARANTY AND COLLATERAL AGREEMENT

 

dated as of

 

February 21, 2008

 

among

 

RADIATION THERAPY SERVICES HOLDINGS, INC.,

 

RADIATION THERAPY SERVICES, INC. 

(as successor to RTS MERGERCO, INC.),

 

as Borrower

 

THE SUBSIDIARIES OF RADIATION THERAPY SERVICES, INC.

FROM TIME TO TIME PARTY HERETO

 

and

 

WACHOVIA BANK, NATIONAL ASSOCIATION

 

as
Collateral Agent

 

 

SCHEDULE I

 

SUBSIDIARY GUARANTORS

 

21st
Century Oncology of Alabama, Inc.

Arizona
Radiation Therapy Management Services, Inc.

California
Radiation Therapy Management Services, Inc.

21st
Century Oncology of Jacksonville, Inc.

21st
Century Oncology, Inc.

21st
Century Oncology of Harford County Maryland, LLC

Berlin
Radiation Therapy Treatment Center, LLC

American
Consolidated Technologies, LLC

Nevada
Radiation Therapy Management Services, Incorporated

21st
Century Oncology of New Jersey, Inc.

New
York Radiation Therapy Management Services, Inc.

North
Carolina Radiation Therapy Management Services, Inc.

West
Virginia Radiation Therapy Services, Inc.

21st
Century Oncology of Arizona, Inc.

Devoto
Construction of Southwest Florida, Inc.

Financial
Services of Southwest Florida, LLC

Radiation
Therapy Services International, Inc.

21st
Century Oncology Management Services, Inc.

Maryland
Radiation Therapy Management Services, Inc.

21st
Century Oncology of Prince Georges County, Maryland, LLC

Michigan
Radiation Therapy Management Services, Inc.

21st
Century Oncology of South Carolina, LLC

 

2

 

SCHEDULE II

 

PLEDGED STOCK; PLEDGED NOTES

 

	
  Name of Entity

  	
   

  	
  Record Owner

  	
   

  	
  Certificate No.

  	
   

  	
  No. Shares/Interest

  	
   

  	
  Percent Pledged

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  RTS Mergerco, Inc.

  	
   

  	
  Radiation Therapy
  Services, Holdings, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation Therapy
  Services, Holdings, Inc.

  	
   

  	
  Radiation Therapy
  Investments, LLC 1

  	
   

  	
  1

  	
   

  	
  1000

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  Radiation Therapy Services
  Holdings, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  Alabama, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Arizona Radiation Therapy
  Management Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  California Radiation
  Therapy Management Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  Jacksonville, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  3

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Devoto Construction of
  Southwest Florida, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Financial Services of
  Southwest Florida, LLC

  	
   

  	
  Radiation Therapy
  Services, Inc. (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  6

  	
   

  	
  500

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century
  Oncology, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc. (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  6

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation Therapy Services
  International, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  3

  	
   

  	
  10

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology
  Management Services, Inc.

  	
   

  	
  21st Century
  Oncology, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Maryland Radiation Therapy
  Management Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  Harford County Maryland, LLC

  	
   

  	
  Maryland Radiation Therapy
  Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  

 

3

 

	
  Name of Entity

  	
   

  	
  Record Owner

  	
   

  	
  Certificate No.

  	
   

  	
  No. Shares/Interest

  	
   

  	
  Percent Pledged

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  Prince Georges County, Maryland, LLC

  	
   

  	
  Maryland Radiation Therapy
  Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Berlin Radiation Therapy
  Treatment Center, LLC.

  	
   

  	
  Maryland Radiation Therapy
  Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Michigan Radiation Therapy
  Management Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  American Consolidated
  Technologies, L.L.C.

  	
   

  	
  Michigan Radiation Therapy
  Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Nevada Radiation Therapy
  Management Services, Incorporated

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  7

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  New Jersey, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  New York Radiation Therapy
  Management Services, Incorporated

  	
   

  	
  Radiation Therapy Services, Inc.
  (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  7

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  North Carolina Radiation
  Therapy Management Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Century Oncology of
  South Carolina, LLC.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  West Virginia Radiation
  Therapy Services, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st Oncology of
  Arizona, Inc.

  	
   

  	
  Radiation Therapy
  Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  

 

PLEDGED NOTES

 

None.

 

4

 

SCHEDULE III

 

INTELLECTUAL PROPERTY

 

1.                          Company
Intellectual Property

 

(a)        Trademarks:

 

	
  Mark

  	
   

  	
  Country

  	
   

  	
  Status

  	
   

  	
  App.

  No./

  Reg.

  No.

  	
   

  	
  App.

  Date/

  Reg.

  Date

  	
   

  	
  Goods/Services

  	
   

  	
  Owner

  	
   

  
	
  21ST
  CENTURY ONCOLOGY

  	
   

  	
  U.S. State (Alabama)

  	
   

  	
  Registered

  	
   

  	
  109244

  	
   

  	
  7/7/04

  	
   

  	
  (Int. Cl. 35) Advertising
  and business.

  	
   

  	
  21st Century Oncology of AL, Inc.
  Alabama Corporation 2234 Colonial Blvd. Fort Myers, FL 33907

  	
   

  

 

(b)       Copyrights:

 

	
  Title

  	
   

  	
  Status

  	
   

  	
  App. No./

  Reg. No.

  	
   

  	
  App.

  Date/

  Reg.

  Date

  	
   

  	
  Owner

  	
   

  
	
  Corporate compliance manual.

  	
   

  	
  Registered

  	
   

  	
  TXu860539

  	
   

  	
  6/12/98

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  
	
  PROCAT-protocol office assistant for clinical
  trail software.

  	
   

  	
  Registered

  	
   

  	
  TXu728845

  	
   

  	
  8/2/99

  	
   

  	
  21st
  Century Oncology, Inc.

  	
   

  

 

(c)        Domain Names:

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
  21stcenturyoncology.biz

  	
   

  	
  Margarita
  Suarez

  	
   

  	
  3/22/09

  
	
   

  	
   

  	
  c/o
  Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncology.com

  	
   

  	
  RTSI

  	
   

  	
  12/15/08

  
	
   

  	
   

  	
  Radiation
  Therapy Regional Ctr.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncology.info

  	
   

  	
  Margarita
  Suarez

  	
   

  	
  3/23/09

  
	
   

  	
   

  	
  c/o
  Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  

 

 

5

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
  21stcenturyoncology.net

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  3/23/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncologyinc.biz

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/4/17

  
	
   

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncologyinc.com

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncologyinc.info

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  c/o Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  21stcenturyoncologyinc.net

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  c/o Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  owan.com

  	
   

  	
  RTSI

  	
   

  	
  7/22/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  owan.net

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  11/13/10

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  radiationtherapyservices.com

  	
   

  	
  RTSI

  	
   

  	
  7/18/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  radtherapyassoc.com

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  4/15/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  twenty-first-century.com

  	
   

  	
  Twenty First Century Oncology

  	
   

  	
  9/28/09

  
	
   

  	
   

  	
  1850 Boyscout Dr.

  	
   

  	
   

  
	
   

  	
   

  	
  Number 101A

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  radiationtherapyservicesinc.biz

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/4/17

  
	
   

  	
   

  	
  c/o Radiation Therapy Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
  radiationtherapyservicesinc.com

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  radiationtherapyservicesinc.info

  	
   

  	
  Radiation Therapy 

  	
   

  	
  1/5/17

  

 

6

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  radiationtherapyservicesinc.net

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  21stcenturyoncology.us

  	
   

  	
  Radiation Therapy Services, Inc.

  	
   

  	
  3/22/17

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  glogutstein.com

  	
   

  	
  ATTN:

  	
   

  	
  9/30/16

  
	
   

  	
   

  	
  GLOGUTSTEIN.COM

  	
   

  	
   

  
	
   

  	
   

  	
  c/o/ Network Solutions

  	
   

  	
   

  
	
  goldbergersurgery.com

  	
   

  	
  RTSI

  	
   

  	
  9/17/16

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  mrmgmt.com

  	
   

  	
  RTSI

  	
   

  	
  4/13/16

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  dolphinmedical-az.com

  	
   

  	
  RTSI

  	
   

  	
  7/18/11

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  advmedsvc.org

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  tvgynonc.com

  	
   

  	
  RTSI

  	
   

  	
  4/1/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  prostateseeds.org

  	
   

  	
  RTSI

  	
   

  	
  3/12/11

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  imaginginitiatives.com

  	
   

  	
  RTSI

  	
   

  	
  7/14/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  prostatecancercenters.com

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  greenbeltcancercenter.com

  	
   

  	
  RTSI

  	
   

  	
  7/24/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  

 

7

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
  southwestfloridaurology.com

  	
   

  	
  RTSI

  	
   

  	
  1/29/12

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  swfua.com

  	
   

  	
  RTSI

  	
   

  	
  1/29/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  advmedsvc.net

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  rtsx.com

  	
   

  	
  RTSI

  	
   

  	
  5/2/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  riversideoncologycenter.com

  	
   

  	
  RTSI

  	
   

  	
  12/20/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  prostateseeds.net

  	
   

  	
  RTSI

  	
   

  	
  3/12/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  flagynonc.com

  	
   

  	
  RTSI

  	
   

  	
  6/8/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  rtsx2.com

  	
   

  	
  RTSI

  	
   

  	
  4/30/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  valleycancercenter.com

  	
   

  	
  RTSI

  	
   

  	
  11/26/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  prostatecancercenters.org

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  advmedsvc.com

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  gbroc.com

  	
   

  	
  RTSI

  	
   

  	
  3/11/09

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  riverhill.com

  	
   

  	
  RTSI

  	
   

  	
  10/28/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  prostatecancercenters.net

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  

 

8

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  
	
  colorectalinstitute.com

  	
   

  	
  RTSI

  	
   

  	
  10/21/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  

 

(d) Registered
fictitious names:

 

	
  Registered Fictitious Name

  	
   

  	
  State

  
	
  21st
  Century Oncology

  	
   

  	
  Alabama

  
	
  21st
  Century Oncology of Alabama

  	
   

  	
  Alabama

  
	
  Redding
  Cancer Treatment Center, Inc.

  	
   

  	
  California

  
	
  Santa
  Monica Cancer Treatment Center, Inc.

  	
   

  	
  California

  
	
  Beverly
  Hills Radiation Oncology, Inc.

  	
   

  	
  California

  
	
  Associates
  In General And Vascular Surgery

  	
   

  	
  Florida

  
	
  Boca
  Raton Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Breast
  Care Specialists Of Florida

  	
   

  	
  Florida

  
	
  Central
  Radiation Therapy Institute

  	
   

  	
  Florida

  
	
  Charlotte
  County Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Collier
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  The
  Colo-Rectal Institute

  	
   

  	
  Florida

  
	
  The
  Colorectal Institute

  	
   

  	
  Florida

  
	
  Comprehensive
  Breast Center Of Coral Springs

  	
   

  	
  Florida

  
	
  Coral
  Springs Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Crestview
  Cancer Center

  	
   

  	
  Florida

  
	
  Defuniak
  Springs Cancer Center

  	
   

  	
  Florida

  
	
  Englewood
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Florida
  Gynecologic Oncology

  	
   

  	
  Florida

  
	
  Florida
  Specialists In Urology

  	
   

  	
  Florida

  
	
  Florida
  Urology Physicians

  	
   

  	
  Florida

  
	
  Naples
  Breast Surgery Center

  	
   

  	
  Florida

  
	
  Okaloosa
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Sarasota Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  South
  Florida Gynecologic Oncology

  	
   

  	
  Florida

  
	
  South
  Florida Radiotherapy Center

  	
   

  	
  Florida

  
	
  Southwest
  Florida Equipment

  	
   

  	
  Florida

  
	
  Southwest
  Florida Urologic Associates

  	
   

  	
  Florida

  
	
  Tamarac
  Radiation Therapy Center

  	
   

  	
  Florida

  
	
  Urology
  Treatment Center

  	
   

  	
  Florida

  
	
  Venice
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  William
  M. Letson Jr., MD

  	
   

  	
  Florida

  
	
  Danville
  Radiation Therapy Center

  	
   

  	
  Kentucky

  

 

9

 

	
  Bluegrass Cancer Center

  	
   

  	
  Kentucky

  
	
  Bluegrass Radiation Oncology Center

  	
   

  	
  Kentucky

  
	
  Cancer Centers of Michigan

  	
   

  	
  Michigan

  
	
  Heart Alert

  	
   

  	
  Michigan

  
	
  MIRO Cancer Centers

  	
   

  	
  Michigan

  
	
  A Cancer Center

  	
   

  	
  Michigan

  
	
  Michigan Institute for Radiation Oncology

  	
   

  	
  Michigan

  
	
  University Center for Internal Medicine

  	
   

  	
  Michigan

  
	
  Michigan Gynecology Center

  	
   

  	
  Michigan

  
	
  Michigan Cancer Helpline

  	
   

  	
  Michigan

  
	
  American Hematology/Oncology Center

  	
   

  	
  Michigan

  
	
  Michigan Comprehensive Cancer Institute

  	
   

  	
  Michigan

  
	
  MIRO-Monroe Cancer Center

  	
   

  	
  Michigan

  
	
  MIRO Community Cancer Center

  	
   

  	
  Michigan

  
	
  MIRO Clarkston Cancer Center

  	
   

  	
  Michigan

  
	
  MIRO-Monroe

  	
   

  	
  Michigan

  
	
  MIRO Cancer Centers

  	
   

  	
  Michigan

  
	
  MIRO-Monroe Radiation Oncology Center

  	
   

  	
  Michigan

  
	
  MIRO Cancer Care Center

  	
   

  	
  Michigan

  
	
  MIRO Affiliated Radiation Oncology Centers

  	
   

  	
  Michigan

  
	
  MIRO-Farmington Hills

  	
   

  	
  Michigan

  
	
  MIRO-Madison Heights

  	
   

  	
  Michigan

  
	
  Michigan Radiation Oncology

  	
   

  	
  Michigan

  
	
  Cancer Centers of Michigan

  	
   

  	
  Michigan

  
	
  Clark County Radiation Regional Therapy Center

  	
   

  	
  Nevada

  
	
  Radiation Oncology Center of Henderson

  	
   

  	
  Nevada

  
	
  Westchester County Radiation Therapy Regional
  Center

  	
   

  	
  New
  York

  

 

10

 

SCHEDULE IV

 

COMMERCIAL TORT CLAIMS

 

None.

 

11

 

Exhibit I to the

Collateral Agreement

 

SUPPLEMENT
NO.          dated as of [ ], to the
Guaranty and Collateral Agreement (the “Collateral Agreement”) dated as
of February 21, 2008, among RADIATION THERAPY SERVICES HOLDINGS, INC.,
a Delaware corporation (“Parent”), RADIATION THERAPY SERVICES, INC.,
a Florida corporation (“Borrower”),, each subsidiary of Borrower listed
on Schedule I thereto (each such subsidiary individually a “Subsidiary
Guarantor” and collectively, the “Subsidiary Guarantors”); the
Subsidiary Guarantors and Borrower are referred to collectively herein as the “Grantors”)
and WACHOVIA BANK, NATIONAL ASSOCIATION, (“Wachovia”), as Collateral Agent (in
such capacity, the “Collateral Agent”).

 

A.     Reference is made to the Credit Agreement
dated as of February 21, 2008 (as amended, supplemented or otherwise
modified from time to time, the “Credit Agreement”), among Parent, Borrower,
the lenders from time to time party thereto, Wachovia, as Administrative Agent
and the other financial institutions party thereto.

 

B.     Capitalized terms used in this Agreement
and not otherwise defined in this Agreement shall have the meanings assigned to
such terms in the Credit Agreement and the Collateral Agreement referred to
therein.

 

C.     The Grantors have entered into the
Collateral Agreement in order to induce the Lenders to make Loans and the
Issuing Bank to issue Letters of Credit. Section 7.14 of the Collateral
Agreement provides that additional Subsidiaries of Borrower may become
Subsidiary Guarantors under the Collateral Agreement by execution and delivery
of an instrument in the form of this Supplement. The undersigned Subsidiary
(the “New Subsidiary”) is executing this Supplement in accordance with the
requirements of the Credit Agreement to become Subsidiary Guarantors under the
Collateral Agreement in order to induce the Lenders to make additional Loans
and the Issuing Bank to issue additional Letters of Credit and as consideration
for Loans previously made and Letters of Credit previously issued.

 

Accordingly,
the Collateral Agent and the New Subsidiary agree as follows:

 

SECTION 1.       In
accordance with Section 7.14 of the Collateral Agreement, the New
Subsidiary by its signature below becomes a Subsidiary Guarantor and a Grantor
under the Collateral Agreement with the same force and effect as if originally
named therein as a Subsidiary Guarantor and a Grantor and the New Subsidiary
hereby (a) agrees to all the terms and provisions of the Collateral
Agreement applicable to it as a Subsidiary Guarantor and Grantor there-under
and (b) represents and warrants that the representations and warranties
made by it as a Grantor and Subsidiary Guarantor thereunder are true and
correct on and as of the date hereof. In furtherance of the foregoing, the New
Subsidiary, as security for the payment and performance in full of the Secured
Obligations (as defined in the Collateral Agreement), does hereby create and
grant to the Collateral Agent, its successors and assigns, for the benefit of
the Secured Parties, their successors and assigns, a security interest in and
lien on all the New Subsidiary’s right, title and interest in and to the
Collateral (as defined in the Collateral Agreement) of the

 

Exh. I-1

 

New
Subsidiary. Each reference to a “Subsidiary Guarantor” or “Grantor” in the
Collateral Agreement shall be deemed to include the New Subsidiary. The
Collateral Agreement is hereby incorporated in this Agreement by reference.

 

SECTION 2.       The
New Subsidiary represents and warrants to the Collateral Agent and the other
Secured Parties that this Supplement has been duly authorized, executed and
delivered by it and constitutes its legal, valid and binding obligation,
enforceable against it in accordance with its terms.

 

SECTION 3.       This
Supplement may be executed in counterparts, each of which shall constitute an
original, but all of which when taken together shall constitute a single
contract. This Supplement shall become effective when the Collateral Agent
shall have received a counterpart of this Supplement that bears the signature
of the New Subsidiary and the Collateral Agent has executed a counterpart
hereof. Delivery of an executed signature page to this Supplement by
facsimile transmission or Adobe PDF email shall be as effective as delivery of
a manually signed counterpart of this Supplement.

 

SECTION 4.       The
New Subsidiary hereby represents and warrants that set forth (a) under its
signature hereto is (i) the true and correct legal name of the New
Subsidiary, (ii) its jurisdiction of formation, (iii) its Federal
Taxpayer Identification Number and its organizational identification number and
(iv) the location of its chief executive office and (b) on Schedule I
hereto all Capital Stock, Instruments, Copyright, Patent and Trademark
registrations, applications and licenses owned by such New Subsidiary.

 

SECTION 5.       Except
as expressly supplemented hereby, the Collateral Agreement shall remain in full
force and effect.

 

SECTION 6.      THIS SUPPLEMENT SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 

SECTION 7.       Any
provision of this Supplement held to be invalid, illegal or unenforceable in
any jurisdiction shall, as to such jurisdiction, be ineffective to the extent
of such invalidity, illegality or unenforceability without affecting the
validity, legality and enforceability of the remaining provisions hereof and in
the Collateral Agreement; the invalidity of a particular provision in a
particular jurisdiction shall not invalidate such provision in any other
jurisdiction. The parties shall endeavor in good-faith negotiations to replace
the invalid, illegal or unenforceable provisions with valid provisions the
economic effect of which comes as close as possible to that of the invalid,
illegal or unenforceable provisions.

 

SECTION 8.       All
communications and notices hereunder shall be in writing and given as provided
in Section 7.01 of the Collateral Agreement.

 

SECTION 9.       The
New Subsidiary agrees to reimburse the Collateral Agent for its reasonable
out-of-pocket expenses in connection with this Supplement, including the
reasonable fees, other charges and disbursements of counsel for the Collateral
Agent.

 

Exh. I-2

 

IN
WITNESS WHEREOF, the New Subsidiary and the Collateral Agent have duly executed
this Supplement to the Collateral Agreement as of the day and year first above
written.

 

	
   

  	
   

  	
  [NAME
  OF NEW SUBSIDIARY],

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Name:
  

  
	
   

  	
   

  	
   

  	
  Title:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  Legal
  Name: 

  Jurisdiction of Formation:

  Location of Chief Executive Office:

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  WACHOVIA
  BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT,

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Name:
  

  Title:

  

 

Exh. I-3

 

Schedule I

to the Supplement No.   

to the Collateral Agreement

 

CAPITAL STOCK

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Number and

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Number of

  	
   

  	
  Registered

  	
   

  	
  Class of

  	
   

  	
  Percentage of

  	
   

  
	
  Issuer

  	
   

  	
  Certificate

  	
   

  	
  Owner

  	
   

  	
  Capital Stock

  	
   

  	
  Capital Stock

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

DEBT SECURITIES

 

	
  Issuer

  	
   

  	
  Principal

  Amount

  	
   

  	
  Date of Note

  	
   

  	
  Maturity Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

INTELLECTUAL PROPERTY

 

I.              Copyright Registrations

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Registered Owner

  	
   

  	
  Title

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

II.            Copyright Applications

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Date

  	
   

  
	
  Registered Owner

  	
   

  	
  Title

  	
   

  	
  Number

  	
   

  	
  Filed

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

 

III.           Copyright Licenses

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Licensee

  	
   

  	
  Licensor

  	
   

  	
  Title

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

IV.           Patents

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Registered Owner

  	
   

  	
  Mark

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

V.            Patent Applications

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Date

  	
   

  
	
  Registered Owner

  	
   

  	
  Mark

  	
   

  	
  Number

  	
   

  	
  Filed

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

VI.                                 Patent Licenses

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Licensee

  	
   

  	
  Licensor

  	
   

  	
  Mark

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

VII.          Trademark Registrations

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Registered Owner

  	
   

  	
  Type

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Exh. II-2

 

VIII.        Trademark Applications

 

	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Date

  	
   

  
	
  Registered Owner

  	
   

  	
  Type

  	
   

  	
  Number

  	
   

  	
  Filed

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

IX.                                Trademark
Licenses

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Registration

  	
   

  	
  Expiration

  	
   

  
	
  Licensee

  	
   

  	
  Licensor

  	
   

  	
  Type

  	
   

  	
  Number

  	
   

  	
  Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Exh. II-3

 

Exhibit II

to the Collateral Agreement

 

Form of Copyright Security Agreement

 

Copyright Security Agreement, dated as of [    ],
by [    ] and
[                      ]
(individually, a “Grantor”, and, collectively, the “Grantors”),
in favor of WACHOVIA BANK, NATIONAL ASSOCIATION, in its capacity as collateral
agent pursuant to the Credit Agreement (in such capacity, the “Collateral
Agent”).

 

WITNESSETH:

 

WHEREAS,
the Grantors are party to a Guaranty and Collateral Agreement dated as of February 21,
2008 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “Collateral Agreement”) in favor of the Collateral
Agent pursuant to which the Grantors are required to execute and deliver this
Copyright Security Agreement;

 

NOW,
THEREFORE, in consideration of the premises and to induce the Collateral Agent,
for the benefit of the Secured Parties, to enter into the Credit Agreement, the
Grantors hereby agree with the Collateral Agent as follows:

 

SECTION 1.
Defined Terms. Unless otherwise defined herein, terms defined in the
Collateral Agreement and used herein have the meaning given to them in the
Collateral Agreement.

 

SECTION 2.
Grant of Security Interest in Copyright Collateral. Each Grantor hereby
pledges and grants to the Collateral Agent for the benefit of the Secured
Parties a security interest in all right, title and interest in or to any and
all of the following Pledged Collateral of such Grantor:

 

(a) Copyrights
of such Grantor listed on Schedule I attached hereto; and

 

(b) all
Proceeds of any and all of the foregoing.

 

SECTION 3.
The Collateral Agreement. The security interest granted pursuant to this
Copyright Security Agreement is granted in conjunction with the security
interest granted to the Collateral Agent pursuant to the Collateral Agreement
and Grantors hereby acknowledge and affirm that the rights and remedies of the
Collateral Agent with respect to the security interest in the Copyrights made
and granted hereby are more fully set forth in the Collateral Agreement, the
terms and provisions of which are incorporated by reference herein as if fully
set forth herein. In the event that any provision of this Copyright Security
Agreement is deemed to con-

 

 

flict
with the Collateral Agreement, the provisions of the Collateral Agreement shall
control unless the Collateral Agent shall otherwise determine.

 

SECTION 4.
Termination. Upon the payment in full of the Secured Obligations and
termination of the Collateral Agreement, the Collateral Agent shall execute,
acknowledge, and deliver to the Grantors an instrument in writing in recordable
form releasing the collateral pledge, grant, assignment, lien and security
interest in the Copyrights under this Copyright Security Agreement.

 

SECTION 5.
Counterparts. This Copyright Security Agreement may be executed in any
number of counterparts, all of which shall constitute one and the same
instrument, and any party hereto may execute this Copyright Security Agreement
by signing and delivering one or more counterparts.

 

[signature page follows]

 

2

 

IN
WITNESS WHEREOF, each Grantor has caused this Copyright Security Agreement to
be executed and delivered by its duly authorized officer as of the date first
set forth above.

 

	
   

  	
  Very
  truly yours, 

  
	
   

  	
   

  
	
   

  	
  [Grantor]

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:
  

  
	
   

  	
   

  	
  Title:

  

 

	
  Accepted
  and Agreed:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  WACHOVIA
  BANK, NATIONAL ASSOCIATION,

  	
   

  	
   

  
	
  as
  Collateral Agent

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  

 

3

 

SCHEDULE I 

to

COPYRIGHT SECURITY AGREEMENT

COPYRIGHT REGISTRATIONS AND COPYRIGHT APPLICATIONS

 

Copyright
Registrations:

 

	
  OWNER

  	
   

  	
  REGISTRATION

  NUMBER

  	
   

  	
  TITLE

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Copyright
Applications:

 

	
  OWNER

  	
   

  	
  TITLE

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  

 

4

 

Exhibit III
to the 

Collateral
Agreement

 

Form of Patent Security Agreement

 

Patent Security Agreement, dated as of [    ],
by [    ] and
[                  ]
(individually, a “Grantor”, and, collectively, the “Grantors”),
in favor of WACHOVIA BANK, NATIONAL ASSOCIATION, in its capacity as collateral
agent pursuant to the Credit Agreement (in such capacity, the “Collateral
Agent”).

 

WITNESSETH:

 

WHEREAS,
the Grantors are party to a Guaranty and Collateral Agreement dated as of February 21,
2008 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “Collateral Agreement”) in favor of the Collateral
Agent pursuant to which the Grantors are required to execute and deliver this
Patent Security Agreement;

 

NOW,
THEREFORE, in consideration of the premises and to induce the Collateral Agent,
for the benefit of the Secured Parties, to enter into the Credit Agreement, the
Grantors hereby agree with the Collateral Agent as follows:

 

SECTION 1.
Defined Terms. Unless otherwise defined herein, terms defined in the
Collateral Agreement and used herein have the meaning given to them in the
Collateral Agreement.

 

SECTION 2.
Grant of Security Interest in Patent Collateral. Each Grantor hereby
pledges and grants to the Collateral Agent for the benefit of the Secured
Parties a security interest in all right, title and interest in or to any and
all of the following Pledged Collateral of such Grantor:

 

(a) Patents
of such Grantor listed on Schedule I attached hereto; and

 

(b) all
Proceeds of any and all of the foregoing.

 

SECTION 3.
The Collateral Agreement. The security interest granted pursuant to this
Patent Security Agreement is granted in conjunction with the security interest
granted to the Collateral Agent pursuant to the Collateral Agreement and
Grantors hereby acknowledge and affirm that the rights and remedies of the
Collateral Agent with respect to the security interest in the Patents made and
granted hereby are more fully set forth in the Collateral Agreement, the

 

 

terms
and provisions of which are incorporated by reference herein as if fully set
forth herein. In the event that any provision of this Patent Security Agreement
is deemed to conflict with the Collateral Agreement, the provisions of the
Collateral Agreement shall control unless the Collateral Agent shall otherwise
determine.

 

SECTION 4.
Termination. Upon the payment in full of the Secured Obligations and
termination of the Collateral Agreement, the Collateral Agent shall execute,
acknowledge, and deliver to the Grantors an instrument in writing in recordable
form releasing the collateral pledge, grant, assignment, lien and security
interest in the Patents under this Patent Security Agreement.

 

SECTION 5.
Counterparts. This Patent Security Agreement may be executed in any
number of counterparts, all of which shall constitute one and the same
instrument, and any party hereto may execute this Patent Security Agreement by
signing and delivering one or more counterparts.

 

[signature
page follows]

 

2

 

IN
WITNESS WHEREOF, each Grantor has caused this Patent Security Agreement to be
executed and delivered by its duly authorized officer as of the date first set
forth above.

 

	
   

  	
   

  	
  Very
  truly yours,

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [Grantors]

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Name:
  

  
	
   

  	
   

  	
   

  	
  Title:

  

 

	
  Accepted
  and Agreed:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  WACHOVIA
  BANK, NATIONAL ASSOCIATION,

  	
   

  	
   

  
	
  as
  Collateral Agent

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  

 

3

 

SCHEDULE I 

to

PATENT SECURITY AGREEMENT

PATENT REGISTRATIONS AND PATENT APPLICATIONS

 

Patents:

 

	
  OWNER

  	
   

  	
  REGISTRATION

  NUMBER

  	
   

  	
  NAME

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Patent
Applications:

 

	
  OWNER

  	
   

  	
  APPLICATION

  NUMBER

  	
   

  	
  NAME

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

4

 

Exhibit IV
to the 

Collateral
Agreement

 

Form of Trademark Security Agreement

 

Trademark Security Agreement, dated as of [   ],
by [   ] and
[                ]
(individually, a “Grantor”, and, collectively, the “Grantors”), in
favor of WACHOVIA BANK, NATIONAL ASSOCIATION, in its capacity as collateral
agent pursuant to the Credit Agreement (in such capacity, the “Collateral
Agent”).

 

WITNESSETH:

 

WHEREAS,
the Grantors are party to a Guaranty and Collateral Agreement dated as of February 21,
2008 (as amended, amended and restated, supplemented or otherwise modified from
time to time, the “Collateral Agreement”) in favor of the Collateral
Agent pursuant to which the Grantors are required to execute and deliver this
Trademark Security Agreement;

 

NOW,
THEREFORE, in consideration of the premises and to induce the Collateral Agent,
for the benefit of the Secured Parties, to enter into the Credit Agreement, the
Grantors hereby agree with the Collateral Agent as follows:

 

SECTION 1.
Defined Terms. Unless otherwise defined herein, terms defined in the
Collateral Agreement and used herein have the meaning given to them in the
Collateral Agreement.

 

SECTION 2.
Grant of Security Interest in Trademark Collateral. Each Grantor hereby
pledges and grants to the Collateral Agent for the benefit of the Secured
Parties a security interest in all of its right, title and interest in or to
any and all of the following Pledged Collateral of such Grantor:

 

(a) Trademarks
of such Grantor listed on Schedule I attached hereto;

 

(b) all
Goodwill associated with such Trademarks; and

 

(c) all
Proceeds of any and all of the foregoing (other than any United States
intent-to-use trademark application to the extent and for so long as creation
by a Grantor of a security interest therein would impair the validity or
enforceability of such intent-to-use trademark application).

 

Notwithstanding
the foregoing, no Security Interest or pledge shall be deemed granted in, or
with respect to, any United States intent-to-use trademark application to the
extent

 

 

and
for so long as creation by a Grantor of a Security Interest therein would
impair the validity or enforceability of such intent-to-use trademark
application.

 

SECTION 3.
The Collateral Agreement. The security interest granted pursuant to this
Trademark Security Agreement is granted in conjunction with the security
interest granted to the Collateral Agent pursuant to the Collateral Agreement
and Grantors hereby acknowledge and affirm that the rights and remedies of the
Collateral Agent with respect to the security interest in the Trademarks made
and granted hereby are more fully set forth in the Collateral Agreement, the
terms and provisions of which are incorporated by reference herein as if fully
set forth herein. In the event that any provision of this Trademark Security
Agreement is deemed to conflict with the Collateral Agreement, the provisions
of the Collateral Agreement shall control unless the Collateral Agent shall
otherwise determine.

 

SECTION 4.
Termination. Upon the payment in full of the Secured Obligations and
termination of the Collateral Agreement, the Collateral Agent shall execute,
acknowledge, and deliver to the Grantors an instrument in writing in recordable
form releasing the collateral pledge, grant, assignment, lien and security
interest in the Trademarks under this Trademark Security Agreement.

 

SECTION 5.
Counterparts. This Trademark Security Agreement may be executed in any
number of counterparts, all of which shall constitute one and the same
instrument, and any party hereto may execute this Trademark Security Agreement
by signing and delivering one or more counterparts.

 

[signature page follows]

 

2

 

IN
WITNESS WHEREOF, each Grantor has caused this Trademark Security Agreement to
be executed and delivered by its duly authorized officer as of the date first
set forth above.

 

	
   

  	
   

  	
  Very
  truly yours,

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [Grantors]

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
   

  	
  Title:

  

 

 

	
  Accepted and Agreed:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  WACHOVIA
  BANK, NATIONAL ASSOCIATION,

  	
   

  	
   

  
	
  as
  Collateral Agent

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  

 

3

 

SCHEDULE I 

to

TRADEMARK SECURITY AGREEMENT

TRADEMARK REGISTRATIONS AND TRADEMARK APPLICATIONS

 

Trademark
Registrations:

 

	
  OWNER

  	
   

  	
  REGISTRATION

  NUMBER

  	
   

  	
  TRADEMARK

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Trademark
Applications:

 

	
  OWNER

  	
   

  	
  APPLICATION

  NUMBER

  	
   

  	
  TRADEMARK

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

4

 

EXECUTION COPY

 

SCHEDULES

 

TO THE

 

GUARANTY AND COLLATERAL AGREEMENT

 

dated as of

 

February 21, 2008

 

among

 

RADIATION THERAPY SERVICES HOLDINGS, INC.,

 

RADIATION THERAPY SERVICES, INC. 

(as successor to RTS MERGERCO, INC.),

 

as Borrower

 

THE SUBSIDIARIES OF RADIATION THERAPY SERVICES, INC.

FROM TIME TO TIME PARTY HERETO

 

and

 

WACHOVIA BANK, NATIONAL ASSOCIATION

 

as Collateral Agent

 

 

SCHEDULE I

 

SUBSIDIARY GUARANTORS

 

21st
Century Oncology of Alabama, Inc.

Arizona
Radiation Therapy Management Services, Inc.

California
Radiation Therapy Management Services, Inc.

21st
Century Oncology of Jacksonville, Inc.

21st
Century Oncology, Inc.

21st
Century Oncology of Harford County Maryland, LLC

Berlin
Radiation Therapy Treatment Center, LLC

American
Consolidated Technologies, LLC

Nevada
Radiation Therapy Management Services, Incorporated

21st
Century Oncology of New Jersey, Inc.

New
York Radiation Therapy Management Services, Inc.

North
Carolina Radiation Therapy Management Services, Inc.

West
Virginia Radiation Therapy Services, Inc.

21st
Century Oncology of Arizona, Inc.

Devoto
Construction of Southwest Florida, Inc.

Financial
Services of Southwest Florida, LLC

Radiation
Therapy Services International, Inc.

21st
Century Oncology Management Services, Inc.

Maryland
Radiation Therapy Management Services, Inc.

21st
Century Oncology of Prince Georges County, Maryland, LLC

Michigan
Radiation Therapy Management Services, Inc.

21st
Century Oncology of South Carolina, LLC

 

2

 

SCHEDULE II

 

PLEDGED STOCK; PLEDGED NOTES

 

	
  Name of Entity

  	
   

  	
  Record Owner

  	
   

  	
  Certificate No.

  	
   

  	
  No. Shares/Interest

  	
   

  	
  Percent Pledged

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  RTS
  Mergerco, Inc.

  	
   

  	
  Radiation
  Therapy Services, Holdings, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation
  Therapy Services, Holdings, Inc.

  	
   

  	
  Radiation
  Therapy Investments, LLC 1

  	
   

  	
  1

  	
   

  	
  1000

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  Radiation
  Therapy Services Holdings, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of Alabama, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Arizona
  Radiation Therapy Management Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  California
  Radiation Therapy Management Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of Jacksonville, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  3

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Devoto
  Construction of Southwest Florida, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Financial
  Services of Southwest Florida, LLC

  	
   

  	
  Radiation
  Therapy Services, Inc. (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  6

  	
   

  	
  500

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc. (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  6

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Radiation
  Therapy Services International, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  3

  	
   

  	
  10

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology Management Services, Inc.

  	
   

  	
  21st Century Oncology, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Maryland
  Radiation Therapy Management Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of Harford County Maryland, LLC

  	
   

  	
  Maryland
  Radiation Therapy Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  

 

3

 

	
  Name of Entity

  	
   

  	
  Record Owner

  	
   

  	
  Certificate No.

  	
   

  	
  No. Shares/Interest

  	
   

  	
  Percent Pledged

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of Prince Georges County, Maryland, LLC

  	
   

  	
  Maryland
  Radiation Therapy Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Berlin
  Radiation Therapy Treatment Center, LLC.

  	
   

  	
  Maryland
  Radiation Therapy Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Michigan
  Radiation Therapy Management Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  American
  Consolidated Technologies, L.L.C.

  	
   

  	
  Michigan
  Radiation Therapy Management Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Nevada
  Radiation Therapy Management Services, Incorporated

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  7

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of New Jersey, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  200

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  New
  York Radiation Therapy Management Services, Incorporated

  	
   

  	
  Radiation
  Therapy Services, Inc. (f/k/a Radiation Therapy Regional Centers, Inc.)

  	
   

  	
  7

  	
   

  	
  600

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  North
  Carolina Radiation Therapy Management Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Century Oncology of South Carolina, LLC.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  N/A

  	
   

  	
  Member

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  West
  Virginia Radiation Therapy Services, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21st
  Oncology of Arizona, Inc.

  	
   

  	
  Radiation
  Therapy Services, Inc.

  	
   

  	
  1

  	
   

  	
  100

  	
   

  	
  100

  	
  %

  

 

PLEDGED NOTES

 

None.

 

4

 

SCHEDULE III

 

INTELLECTUAL PROPERTY

 

1.             Company Intellectual Property

 

(a)           Trademarks:

 

	
  Mark

  	
   

  	
  Country

  	
   

  	
  Status

  	
   

  	
  App.

  No./

  Reg.

  No.

  	
   

  	
  App.

  Date/

  Reg.

  Date

  	
   

  	
  Goods/Services

  	
   

  	
  Owner

  
	
  21ST CENTURY ONCOLOGY

  	
   

  	
  U.S. State (Alabama)

  	
   

  	
  Registered

  	
   

  	
  109244

  	
   

  	
  7/7/04

  	
   

  	
  (Int. Cl. 35) Advertising
  and business.

  	
   

  	
  21st Century Oncology of
  AL, Inc. Alabama Corporation 2234 Colonial Blvd. Fort Myers, FL 33907

  

 

(b)                    Copyrights:

 

	
  Title

  	
   

  	
  Status

  	
   

  	
  App.No./ 

  Reg. No.

  	
   

  	
  App.

  Date/

  Reg.

  Date

  	
   

  	
  Owner

  
	
  Corporate
  compliance manual.

  	
   

  	
  Registered

  	
   

  	
  TXu860539

  	
   

  	
  6/12/98

  	
   

  	
  Radiation
  Therapy Services, Inc.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  PROCAT-protocol
  office assistant for clinical trail software.

  	
   

  	
  Registered

  	
   

  	
  TXu728845

  	
   

  	
  8/2/99

  	
   

  	
  21st
  Century Oncology, Inc.

  

 

(c)                    Domain Names:

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp. Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncology.biz

  	
   

  	
  Margarita
  Suarez

  	
   

  	
  3/22/09

  
	
   

  	
   

  	
  c/o
  Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncology.com

  	
   

  	
  RTSI
  

  	
   

  	
  12/15/08

  
	
   

  	
   

  	
  Radiation
  Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Regional
  Ctr.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncology.info

  	
   

  	
  Margarita
  Suarez

  	
   

  	
  3/23/09

  
	
   

  	
   

  	
  c/o
  Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, FL 33907

  	
   

  	
   

  

 

5

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncology.net

  	
   

  	
  Radiation Therapy

  	
   

  	
  3/23/09

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncologyinc.biz

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/4/17

  
	
   

  	
   

  	
  Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncologyinc.com

  	
   

  	
  Radiation Therapy

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncologyinc.info

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  c/o Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncologyinc.net

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  c/o Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  owan.com

  	
   

  	
  RTSI

  	
   

  	
  7/22/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  owan.net

  	
   

  	
  Radiation Therapy

  	
   

  	
  11/13/10

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radiationtherapyservices.com

  	
   

  	
  RTSI

  	
   

  	
  7/18/08

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radtherapyassoc.com

  	
   

  	
  Radiation Therapy

  	
   

  	
  4/15/08

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  twenty-first-century.com

  	
   

  	
  Twenty First Century

  	
   

  	
  9/28/09

  
	
   

  	
   

  	
  Oncology

  	
   

  	
   

  
	
   

  	
   

  	
  1850 Boyscout Dr.

  	
   

  	
   

  
	
   

  	
   

  	
  Number 101A

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radiationtherapyservicesinc.biz

  	
   

  	
  Margarita Suarez

  	
   

  	
  1/4/17

  
	
   

  	
   

  	
  c/o Radiation Therapy

  	
   

  	
   

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, FL 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radiationtherapyservicesinc.com

  	
   

  	
  Radiation Therapy

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234 Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort Myers, Florida 33907

  	
   

  	
   

  

 

6

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radiationtherapyservicesinc.info

  	
   

  	
  Radiation
  Therapy

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  radiationtherapyservicesinc.net

  	
   

  	
  Radiation
  Therapy

  	
   

  	
  1/5/17

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  21stcenturyoncology.us

  	
   

  	
  Radiation
  Therapy

  	
   

  	
  3/22/17

  
	
   

  	
   

  	
  Services, Inc.

  	
   

  	
   

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  glogutstein.com

  	
   

  	
  ATTN:

  	
   

  	
  9/30/16

  
	
   

  	
   

  	
  GLOGUTSTEIN.COM

  	
   

  	
   

  
	
   

  	
   

  	
  c/o/
  Network Solutions

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  goldbergersurgery.com

  	
   

  	
  RTSI

  	
   

  	
  9/17/16

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  mrmgmt.com

  	
   

  	
  RTSI

  	
   

  	
  4/13/16

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  dolphinmedical-az.com

  	
   

  	
  RTSI

  	
   

  	
  7/18/11

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  advmedsvc.org

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  tvgynonc.com

  	
   

  	
  RTSI

  	
   

  	
  4/1/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  prostateseeds.org

  	
   

  	
  RTSI

  	
   

  	
  3/12/11

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  imaginginitiatives.com

  	
   

  	
  RTSI

  	
   

  	
  7/14/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  prostatecancercenters.com

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  greenbeltcancercenter.com

  	
   

  	
  RTSI

  	
   

  	
  7/24/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  

 

7

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  southwestfloridaurology.com

  	
   

  	
  RTSI

  	
   

  	
  1/29/12

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  swfua.com

  	
   

  	
  RTSI

  	
   

  	
  1/29/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  advmedsvc.net

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  rtsx.com

  	
   

  	
  RTSI

  	
   

  	
  5/2/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  riversideoncologycenter.com

  	
   

  	
  RTSI

  	
   

  	
  12/20/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  prostateseeds.net

  	
   

  	
  RTSI

  	
   

  	
  3/12/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  flagynonc.com

  	
   

  	
  RTSI

  	
   

  	
  6/8/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  rtsx2.com

  	
   

  	
  RTSI

  	
   

  	
  4/30/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  valleycancercenter.com

  	
   

  	
  RTSI

  	
   

  	
  11/26/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  prostatecancercenters.org

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  advmedsvc.com

  	
   

  	
  RTSI

  	
   

  	
  3/21/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  gbroc.com

  	
   

  	
  RTSI

  	
   

  	
  3/11/09

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  riverhill.com

  	
   

  	
  RTSI

  	
   

  	
  10/28/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  

 

8

 

	
  domain name

  	
   

  	
  Registrant

  	
   

  	
  Exp.

  Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  prostatecancercenters.net

  	
   

  	
  RTSI

  	
   

  	
  11/3/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  colorectalinstitute.com

  	
   

  	
  RTSI

  	
   

  	
  10/21/08

  
	
   

  	
   

  	
  2234
  Colonial Blvd.

  	
   

  	
   

  
	
   

  	
   

  	
  Fort
  Myers, Florida 33907

  	
   

  	
   

  

 

(d)                   Registered fictitious names:

 

	
  Registered Fictitious Name

  	
   

  	
  State

  
	
   

  	
   

  	
   

  
	
  21st
  Century Oncology

  	
   

  	
  Alabama

  
	
  21st
  Century Oncology of Alabama

  	
   

  	
  Alabama

  
	
  Redding
  Cancer Treatment Center, Inc.

  	
   

  	
  California

  
	
  Santa
  Monica Cancer Treatment Center, Inc.

  	
   

  	
  California

  
	
  Beverly
  Hills Radiation Oncology, Inc.

  	
   

  	
  California

  
	
  Associates
  In General And Vascular Surgery

  	
   

  	
  Florida

  
	
  Boca
  Raton Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Breast
  Care Specialists Of Florida

  	
   

  	
  Florida

  
	
  Central
  Radiation Therapy Institute

  	
   

  	
  Florida

  
	
  Charlotte
  County Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Collier
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  The
  Colo-Rectal Institute

  	
   

  	
  Florida

  
	
  The
  Colorectal Institute

  	
   

  	
  Florida

  
	
  Comprehensive
  Breast Center Of Coral Springs

  	
   

  	
  Florida

  
	
  Coral
  Springs Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Crestview
  Cancer Center

  	
   

  	
  Florida

  
	
  Defuniak
  Springs Cancer Center

  	
   

  	
  Florida

  
	
  Englewood
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Florida
  Gynecologic Oncology

  	
   

  	
  Florida

  
	
  Florida
  Specialists In Urology

  	
   

  	
  Florida

  
	
  Florida
  Urology Physicians

  	
   

  	
  Florida

  
	
  Naples
  Breast Surgery Center

  	
   

  	
  Florida

  
	
  Okaloosa
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  Sarasota
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  South
  Florida Gynecologic Oncology

  	
   

  	
  Florida

  
	
  South
  Florida Radiotherapy Center

  	
   

  	
  Florida

  
	
  Southwest
  Florida Equipment

  	
   

  	
  Florida

  
	
  Southwest
  Florida Urologic Associates

  	
   

  	
  Florida

  
	
  Tamarac
  Radiation Therapy Center

  	
   

  	
  Florida

  
	
  Urology
  Treatment Center

  	
   

  	
  Florida

  
	
  Venice
  Radiation Therapy Regional Center

  	
   

  	
  Florida

  
	
  William
  M. Letson Jr., MD

  	
   

  	
  Florida

  
	
  Danville
  Radiation Therapy Center

  	
   

  	
  Kentucky

  

 

9

 

	
  Bluegrass Cancer Center

  	
   

  	
  Kentucky

  
	
  Bluegrass Radiation
  Oncology Center

  	
   

  	
  Kentucky

  
	
  Cancer Centers of Michigan

  	
   

  	
  Michigan

  
	
  Heart Alert

  	
   

  	
  Michigan

  
	
  MIRO Cancer Centers

  	
   

  	
  Michigan

  
	
  A Cancer Center

  	
   

  	
  Michigan

  
	
  Michigan Institute for
  Radiation Oncology

  	
   

  	
  Michigan

  
	
  University Center for
  Internal Medicine

  	
   

  	
  Michigan

  
	
  Michigan Gynecology Center

  	
   

  	
  Michigan

  
	
  Michigan Cancer Helpline

  	
   

  	
  Michigan

  
	
  American
  Hematology/Oncology Center

  	
   

  	
  Michigan

  
	
  Michigan Comprehensive
  Cancer Institute

  	
   

  	
  Michigan

  
	
  MIRO-Monroe Cancer Center

  	
   

  	
  Michigan

  
	
  MIRO Community Cancer Center

  	
   

  	
  Michigan

  
	
  MIRO Clarkston Cancer
  Center

  	
   

  	
  Michigan

  
	
  MIRO-Monroe

  	
   

  	
  Michigan

  
	
  MIRO Cancer Centers

  	
   

  	
  Michigan

  
	
  MIRO-Monroe Radiation
  Oncology Center

  	
   

  	
  Michigan

  
	
  MIRO Cancer Care Center

  	
   

  	
  Michigan

  
	
  MIRO Affiliated Radiation
  Oncology Centers

  	
   

  	
  Michigan

  
	
  MIRO-Farmington Hills

  	
   

  	
  Michigan

  
	
  MIRO-Madison Heights

  	
   

  	
  Michigan

  
	
  Michigan Radiation
  Oncology

  	
   

  	
  Michigan

  
	
  Cancer Centers of Michigan

  	
   

  	
  Michigan

  
	
  Clark County Radiation
  Regional Therapy Center

  	
   

  	
  Nevada

  
	
  Radiation Oncology Center
  of Henderson

  	
   

  	
  Nevada

  
	
  Westchester County Radiation
  Therapy Regional Center

  	
   

  	
  New York

  

 

10

 

SCHEDULE IV

 

COMMERCIAL TORT CLAIMS

 

None.

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]